<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure - Bijkerk, V - 2024 | Cochrane Library</title> <meta content="Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure - Bijkerk, V - 2024 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013197.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure - Bijkerk, V - 2024 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013197.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013197.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure" name="citation_title"/> <meta content="Veerle Bijkerk" name="citation_author"/> <meta content="veerle.bijkerk@radboudumc.nl" name="citation_author_email"/> <meta content="Lotte MC Jacobs" name="citation_author"/> <meta content="Radboud University Medical Center" name="citation_author_institution"/> <meta content="Kim I Albers" name="citation_author"/> <meta content="Radboud University Medical Center" name="citation_author_institution"/> <meta content="Kurinchi Selvan Gurusamy" name="citation_author"/> <meta content="University College London" name="citation_author_institution"/> <meta content="Cornelis JHM van Laarhoven" name="citation_author"/> <meta content="Radboud University Medical Center" name="citation_author_institution"/> <meta content="Christiaan Keijzer" name="citation_author"/> <meta content="Radboud University Medical Center" name="citation_author_institution"/> <meta content="Michiel C WarlÃ©" name="citation_author"/> <meta content="Radboud University Medical Center" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD013197.pub2" name="citation_doi"/> <meta content="2024" name="citation_date"/> <meta content="2024/01/30" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013197.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013197.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013197.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Abdomen [surgery]; *Anesthetics; *Laparoscopy [adverse effects]; *Neuromuscular Blockade [adverse effects]; Pain, Postoperative [drug therapy, prevention &amp; control]; Quality of Life" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013197.pub2&amp;doi=10.1002/14651858.CD013197.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="uQyIsxpV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013197\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013197\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013197\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013197\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ko","ms","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013197.pub2",title:"Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure",firstPublishedDate:"Jan 30, 2024 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Hepato-Biliary Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013197.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013197.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> EspaÃ±ol </option> <option class="content-language-option" data-languagecode="fa" value="fa"> ÙØ§Ø±Ø³Û </option> <option class="content-language-option" data-languagecode="fr" value="fr"> FranÃ§ais </option> <option class="content-language-option" data-languagecode="hi" value="hi"> à¤¹à¤¿à¤¨à¥à¤¦à¥ </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> æ¥æ¬èª </option> <option class="content-language-option" data-languagecode="ko" value="ko"> íêµ­ì´ </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> PortuguÃªs </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Ð ÑÑÑÐºÐ¸Ð¹ </option> <option class="content-language-option" data-languagecode="ro" value="ro"> RomÃ¢nÄ </option> <option class="content-language-option" data-languagecode="ta" value="ta"> à®¤à®®à®¿à®´à¯ </option> <option class="content-language-option" data-languagecode="th" value="th"> à¸ à¸²à¸©à¸²à¹à¸à¸¢ </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> ç¹é«ä¸­æ </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> ç®ä½ä¸­æ </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013197.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013197.pub2/full/es"> EspaÃ±ol </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013197.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013197.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;ÚÚ©ÛØ¯Ù&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;RÃ©sumÃ© scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;ì´ë¡&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;æè¦&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en tÃ©rminos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;Ø®ÙØ§ØµÙ Ø¨Ù Ø²Ø¨Ø§Ù Ø³Ø§Ø¯Ù&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;RÃ©sumÃ© simplifiÃ©&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;ì¬ì´ ë§ ìì½&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym jÄzykiem&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;ç®è¯­æ¦è¦&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;æ·ºé¡¯ææçå£èªçµè«&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013197.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013197.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013197.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013197.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views:Â </span> <span>729 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013197.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-sec-0136"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-sec-0048"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-sec-0130"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/appendices#CD013197-sec-0141"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/supinfo/CD013197-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/supinfo/CD013197-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright Â© 2024 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/information#CD013197-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Veerle Bijkerk</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/information#CD013197-cr-0005">Lotte MC Jacobs</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/information#CD013197-cr-0006">Kim I Albers</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/information#CD013197-cr-0007">Kurinchi Selvan Gurusamy</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/information#CD013197-cr-0008">Cornelis JHM van Laarhoven</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/information#CD013197-cr-0009">Christiaan Keijzer</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013197.pub2/information#CD013197-cr-0010">Michiel C WarlÃ©</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/information/en#CD013197-sec-0145">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 30 January 2024 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013197.pub2">https://doi.org/10.1002/14651858.CD013197.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013197-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013197-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013197-abs-0014">EspaÃ±ol</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013197-abs-0009">ÙØ§Ø±Ø³Û</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013197-abs-0011">FranÃ§ais</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013197-abs-0006">íêµ­ì´</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013197-abs-0003">ç®ä½ä¸­æ</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013197-abs-0001" lang="en"> <section id="CD013197-sec-0001"> <h3 class="title" id="CD013197-sec-0001">Background</h3> <p>Laparoscopic surgery is the preferred option for many procedures. To properly perform laparoscopic surgery, it is essential that sudden movements and abdominal contractions in patients are prevented, as it limits the surgeon's view. There has been a growing interest in the potential beneficial effect of deep neuromuscular blockade (NMB) in laparoscopic surgery. Deep NMB improves the surgical field by preventing abdominal contractions, and it is thought to decrease postoperative pain. However, it is uncertain if deep NMB improves intraoperative safety and thereby improves clinical outcomes. </p> </section> <section id="CD013197-sec-0002"> <h3 class="title" id="CD013197-sec-0002">Objectives</h3> <p>To evaluate the benefits and harms of deep neuromuscular blockade versus no, shallow, or moderate neuromuscular blockade during laparoscopic intraâ or transperitoneal procedures in adults. </p> </section> <section id="CD013197-sec-0003"> <h3 class="title" id="CD013197-sec-0003">Search methods</h3> <p>We used standard, extensive Cochrane search methods. The latest search date was 31 July 2023. </p> </section> <section id="CD013197-sec-0004"> <h3 class="title" id="CD013197-sec-0004">Selection criteria</h3> <p>We included randomised clinical trials (irrespective of language, blinding, or publication status) in adults undergoing laparoscopic intraâ or transperitoneal procedures comparing deep NMB to moderate, shallow, or no NMB. We excluded trials that did not report any of the primary or secondary outcomes of our review. </p> </section> <section id="CD013197-sec-0005"> <h3 class="title" id="CD013197-sec-0005">Data collection and analysis</h3> <p>We used standard Cochrane methods. Our primary outcomes were 1. allâcause mortality, 2. healthârelated quality of life, and 3. proportion of participants with serious adverse events. Our secondary outcomes were 4. proportion of participants with nonâserious adverse events, 5. readmissions within three months, 6. shortâterm pain scores, 7. measurements of postoperative recovery, and 8. operating time. We used GRADE to assess the certainty of evidence for each outcome. </p> </section> <section id="CD013197-sec-0006"> <h3 class="title" id="CD013197-sec-0006">Main results</h3> <p>We included 42 randomised clinical trials with 3898 participants. Most trials included participants undergoing intraperitoneal oncological resection surgery. We present the Peto fixedâeffect model for most dichotomous outcomes as only sparse events were reported. </p> <p><i>Comparison 1: deep versus moderate NMB</i> </p> <p>Thirtyâeight trials compared deep versus moderate NMB. Deep NMB may have no effect on mortality, but the evidence is very uncertain (Peto odds ratio (OR) 7.22, 95% confidence interval (CI) 0.45 to 115.43; 12 trials, 1390 participants; very lowâcertainty evidence). Deep NMB likely results in little to no difference in healthârelated quality of life up to four days postoperative (mean difference (MD) 4.53 favouring deep NMB on the Quality of Recoveryâ40 score, 95% CI 0.96 to 8.09; 5 trials, 440 participants; moderateâcertainty evidence; mean difference lower than the mean clinically important difference of 10 points). The evidence is very uncertain about the effect of deep NMB on intraoperatively serious adverse events (deep NMB 38/1150 versus moderate NMB 38/1076; Peto OR 0.95, 95% CI 0.59 to 1.52; 21 trials, 2231 participants; very lowâcertainty evidence), shortâterm serious adverse events (up to 60 days) (deep NMB 37/912 versus moderate NMB 42/852; Peto OR 0.90, 95% CI 0.56 to 1.42; 16 trials, 1764 participants; very lowâcertainty evidence), and shortâterm nonâserious adverse events (Peto OR 0.94, 95% CI 0.65 to 1.35; 11 trials, 1232 participants; very lowâcertainty evidence). </p> <p>Deep NMB likely does not alter the duration of surgery (MD â0.51 minutes, 95% CI â3.35 to 2.32; 34 trials, 3143 participants; moderateâcertainty evidence). The evidence is uncertain if deep NMB alters the length of hospital stay (MD â0.22 days, 95% CI â0.49 to 0.06; 19 trials, 2084 participants; lowâcertainty evidence) or pain scores one hour after surgery (MD â0.31 points on the numeric rating scale, 95% CI â0.59 to â0.03; 22 trials, 1823 participants; very lowâcertainty evidence; mean clinically important difference 1 point) and 24 hours after surgery (MD â0.60 points on the numeric rating scale, 95% CI â1.05 to â0.15; 16 trials, 1404 participants; very lowâcertainty evidence; mean clinically important difference 1 point). </p> <p><i>Comparison 2: deep versus shallow NMB</i> </p> <p>Three trials compared deep versus shallow NMB. The trials did not report on mortality and healthârelated quality of life. The evidence is very uncertain about the effect of deep NMB compared to shallow NMB on the proportion of serious adverse events (RR 1.66, 95% CI 0.50 to 5.57; 2 trials, 158 participants; very lowâcertainty evidence). </p> <p><i>Comparison 3: deep versus no NMB</i> </p> <p>One trial compared deep versus no NMB. There was no mortality in this trial, and healthârelated quality of life was not reported. The proportion of serious adverse events was 0/25 in the deep NMB group and 1/25 in the no NMB group. </p> </section> <section id="CD013197-sec-0007"> <h3 class="title" id="CD013197-sec-0007">Authors' conclusions</h3> <p>There was insufficient evidence to draw conclusions about the effects of deep NMB compared to moderate NMB on allâcause mortality and serious adverse events. Deep NMB likely results in little to no difference in healthârelated quality of life and duration of surgery compared to moderate NMB, and it may have no effect on the length of hospital stay. Due to the very lowâcertainty evidence, we do not know what the effect is of deep NMB on nonâserious adverse events, pain scores, or readmission rates. Randomised clinical trials with adequate reporting of all adverse events would reduce the current uncertainties. </p> <p>Due to the low number of identified trials and the very low certainty of evidence, we do not know what the effect of deep NMB on serious adverse events is compared to shallow NMB and no NMB. We found no trials evaluating mortality and healthârelated quality of life. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013197-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013197-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013197-abs-0015">EspaÃ±ol</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013197-abs-0010">ÙØ§Ø±Ø³Û</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013197-abs-0012">FranÃ§ais</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013197-abs-0007">íêµ­ì´</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013197-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD013197-abs-0013">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013197-abs-0004">ç®ä½ä¸­æ</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD013197-abs-0005">ç¹é«ä¸­æ</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013197-abs-0002" lang="en"> <h3>Does deep muscle relaxation during laparoscopic surgery improve outcomes?</h3> <p><b>Key messages</b> </p> <p>â Deep muscle relaxation during laparoscopic surgery may not affect mortality (death) and morbidity (ill heath), but we are very uncertain about the results. </p> <p>â Deep muscle relaxation probably makes little to no difference in healthârelated quality of life (wellâbeing) up to four days after the surgery. </p> <p><b>What is deep muscle relaxation in laparoscopic surgery?</b> </p> <p>Surgery of the abdomen is increasingly performed by laparoscopy. Laparoscopy is an operation using a camera inserted through one or several small cuts (incisions) (usually 0.5 cm to 1.5 cm) in the skin, for example, near the belly button. To improve the surgeon's working conditions, there has been a growing interest in the potential beneficial effect of deep muscle relaxation (deep neuromuscular blockade) to prevent patients' movements and abdominal contractions. There is evidence that surgeons rate working conditions higher when using deep neuromuscular blockade. This could result in improvement in patient's outcomes, such as a reduction in mortality, fewer complications, or fewer unwarranted events. This review compares deep neuromuscular blockade to different levels of superficial or no neuromuscular blockade. </p> <p><b>What did we want to find out?</b> </p> <p>Does deep muscle relaxation during laparoscopic surgery improve patients' outcomes?</p> <p><b>What did we do?</b> </p> <p>We searched for studies that compared deep muscle relaxation to one of the following levels of more superficial muscle relaxation: </p> <p>â no muscle relaxation;</p> <p>â shallow muscle relaxation;</p> <p>â moderate muscle relaxation.</p> <p><b>What did we find?</b> </p> <p>We found 42 studies that involved 3898 people who underwent any type of laparoscopic surgery in the abdomen. In most cases, these were surgeries to the gut or stomach (20 studies). The studies were conducted across the world. Most studies compared deep muscle relaxation to moderate muscle relaxation (38 studies). Followâup of complications and mortality ranged from three days to 60 days after surgery. Pharmaceutical companies or forâprofit organisations funded 22 of the studies. </p> <p><b>Main results</b> </p> <p>Mortality and serious unwanted effects almost did not occur in the comparison of deep muscle relaxation and moderate muscle relaxation. Therefore, it is not possible to conclude whether deep muscle relaxation reduces any of those outcomes. There are probably no differences in healthârelated quality of life shortly after surgery and in duration of surgery. It is uncertain whether deep muscle relaxation changes pain scores after surgery, duration of hospital stay, or number of readmissions. </p> <p>We found too few studies for the comparison of deep muscle relaxation to shallow muscle relaxation and no muscle relaxation to draw conclusions. </p> <p><b>What are the limitations of the evidence?</b> </p> <p>For most outcomes, our confidence in the evidence is limited. This is due to the low number of unwanted effects reported and concerns about how some of the studies were conducted. </p> <p><b>How up to date is this evidence?</b> </p> <p>The evidence is up to date to 31 July 2023.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013197-sec-0136" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013197-sec-0136"></div> <h3 class="title" id="CD013197-sec-0137">Implications for practice</h3> <section id="CD013197-sec-0137"> <p>There is very lowâcertainty evidence that there is no beneficial effect of deep neuromuscular blockade (NMB) regarding mortality and serious adverse events intraoperatively and up to three months postoperative. </p> <p>Deep NMB likely results in little to no difference in healthârelated quality of life compared to moderate NMB. The evidence is very uncertain about the effect of deep NMB on nonâserious adverse events, length of hospital stay, or pain scores. </p> </section> <h3 class="title" id="CD013197-sec-0138">Implications for research</h3> <section id="CD013197-sec-0138"> <p>We need further randomised clinical trials with adequate reporting of all (serious) adverse events and postoperative complications to evaluate whether deep NMB has a beneficial effect on safety. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013197-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013197-sec-0008"></div> <div class="table" id="CD013197-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span>Â <span class="table-title">Summary of findings table â Deep neuromuscular blockade (NMB) compared to moderate NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Deep neuromuscular blockade (NMB) compared to moderate NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults undergoing intraâ and transperitoneal laparoscopic procedures<br/><b>Setting:</b> secondary or tertiary care setting<br/><b>Intervention:</b> deep neuromuscular blockade (NMB)<br/><b>Comparison:</b> moderate NMB </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>â of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with moderate NMB</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with deep neuromuscular blockade (NMB)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allâcause mortality shortâterm<br/>followâup: 3 to 60 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/>(0 to 0) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Peto OR 7.22</b><br/>(0.45 to 115.43) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1390<br/>(12 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Healthârelated quality of life<br/>assessed with: Quality of Recovery questionnaire<br/>Scale from: 40 to 200<br/>followâup: 1 to 4 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean healthârelated quality of life ranged from <b>142 to 175</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>4.53 higher</b><br/>(0.96 higher to 8.09 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>440<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Moderate<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD smaller than minimal clinical important difference of 6 to 10 points on the Quality of Recoveryâ40 </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events (SAEs) start of surgery until 8 hours after surgery</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b><br/>(21 to 54) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Peto OR 0.95</b><br/>(0.59 to 1.52) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2231<br/>(21 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Shortâterm serious adverse events (SAEs)<br/>followâup: 3 to 60 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>49 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 1000</b><br/>(28 to 70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Peto OR 0.90</b><br/>(0.56 to 1.42) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1764<br/>(16 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_440720204377651870" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_440720204377651870</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Summary of findings of secondary outcomes can be found in additional table 1. <br/><sup>b</sup> Downgraded one level for serious risk of bias: most trials were at unclear risk of bias.<br/><sup>c</sup> Downgraded two levels for very serious imprecision: the optimal information size was not met, none of the sequential boundaries for benefit, harm, or futility were crossed; number of events was below 100; and the confidence interval of the point estimate included both benefit and harm. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013197-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span>Â <span class="table-title">Summary of findings table â Deep neuromuscular blockade (NMB) compared to shallow NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Deep neuromuscular blockade (NMB) compared to shallow NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults undergoing intraâ and transperitoneal laparoscopic procedures<br/><b>Setting:</b> secondary or tertiary care setting<br/><b>Intervention:</b> deep neuromuscular blockade (NMB)<br/><b>Comparison:</b> shallow NMB </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>â of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with shallow NMB</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with deep neuromuscular blockade (NMB)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allâcause mortality â not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not assessed in the trials</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Healthârelated quality of life â not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not assessed in the trials</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Shortâterm serious adverse events (SAEs)<br/>followâup: 21 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>51 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b><br/>(26 to 286) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.66</b><br/>(0.50 to 5.57) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>158<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>a,</sup><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_445519884891204110" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_445519884891204110</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level for serious risk of bias: one trial was at unclear risk of bias due to methodological limitations.<br/><sup>b</sup> Downgraded two levels for very serious imprecision: the optimal information size was not met, none of the sequential boundaries for benefit, harm, or futility were crossed; number of events was below 100; and the confidence interval of the point estimate included both benefit and harm. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013197-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span>Â <span class="table-title">Summary of findings table â Deep neuromuscular blockade (NMB) compared to no NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Deep neuromuscular blockade (NMB) compared to no NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults undergoing intraâ and transperitoneal laparoscopic procedures<br/><b>Setting:</b> secondary or tertiary care setting<br/><b>Intervention:</b> deep neuromuscular blockade (NMB)<br/><b>Comparison:</b> no NMB </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>â of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with no NMB</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with deep neuromuscular blockade (NMB)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allâcause mortality start of surgery â not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported in the trial</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Healthârelated quality of life â not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not assessed in the trial</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious adverse events (SAEs) start of surgery until 8 hours after surgery</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>25<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Very low<sup>a,</sup><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1/25 SAE occurred intraoperatively in the no NMB group and 0/25 in the deep NMB group.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_445520113909905564" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_445520113909905564</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level for serious risk of bias as the trial was at unclear risk of bias. <br/><sup>b</sup> Downgraded two levels for very serious imprecision: few events and no point estimation calculation possible. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013197-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013197-sec-0009"></div> <section id="CD013197-sec-0010"> <h3 class="title" id="CD013197-sec-0010">Description of the condition</h3> <p>In an attempt to reduce the impact of surgery, there has been a tremendous increase in the number of laparoscopic surgeries, as laparoscopy is associated with quicker convalescence, reduced postoperative pain, and shorter duration of surgery (<a href="./references#CD013197-bbs2-0128" title="BuiaA , StockhausenF . Laparoscopic surgery: a qualified systematic review. World Journal of Methodology2015;5(4):238-54.">Buia 2015</a>; <a href="./references#CD013197-bbs2-0130" title="ChenQL , PanY , CaiJQ , WuD , ChenK , MouYP . Laparoscopic versus open resection for gastric gastrointestinal stromal tumors: an updated systematic review and meta-analysis. World Journal of Surgical Oncology2014;12:206. [DOI: 10.1186/1477-7819-12-206]">Chen 2014</a>; <a href="./references#CD013197-bbs2-0131" title="ChengQ , PangTC , HollandsMJ , RichardsonAJ , PleassH , JohnstonES , et al. Systematic review and meta-analysis of laparoscopic versus open distal gastrectomy. Journal of Gastrointestinal Surgery2014;18(6):1087-99. [DOI: 10.1007/s11605-014-2519-z]">Cheng 2014</a>; <a href="./references#CD013197-bbs2-0138" title="FonouniH , MehrabiA , GolrizM , ZeierM , MÃ¼ller-StichBP , SchemmerP , et al. Comparison of the laparoscopic versus open live donor nephrectomy: an overview of surgical complications and outcome. Langenbecks Archiv fur Chirurgie2014;399(5):543-51. [DOI: 10.1007/s00423-014-1196-4]">Fonouni 2014</a>; <a href="./references#CD013197-bbs2-0142" title="GalaalK , BryantA , FisherAD , Al-KhaduriM , KewF , LopesAD . Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database of Systematic Reviews2012, Issue 9. Art. No: CD006655. [DOI: 10.1002/14651858.CD006655.pub2]">Galaal 2012</a>; <a href="./references#CD013197-bbs2-0156" title="KeusF , De JongJA , GooszenHG , vanLaarhovenCJ . Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis. Cochrane Database of Systematic Reviews2006, Issue 4. Art. No: CD006231. [DOI: 10.1002/14651858.CD006231]">Keus 2006</a>; <a href="./references#CD013197-bbs2-0157" title="KeusF , GooszenHG , vanLaarhovenCJ . Open, small-incision, or laparoscopic cholecystectomy for patients with symptomatic cholecystolithiasis. An overview of Cochrane Hepato-Biliary Group reviews. Cochrane Database of Systematic Reviews2010, Issue 1. Art. No: CD008318. [DOI: 10.1002/14651858.CD008318]">Keus 2010</a>; <a href="./references#CD013197-bbs2-0175" title="RezaMM , BlascoJA , AndradasE , CanteroR , MayolJ . Systematic review of laparoscopic versus open surgery for colorectal cancer. British Journal of Surgery2006;93(8):921-8. [DOI: 10.1007/s11605-014-2492-6]">Reza 2006</a>; <a href="./references#CD013197-bbs2-0186" title="VennixS , PelzersL , BouvyN , BeetsGL , PierieJP , WiggersT , et al. Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database of Systematic Reviews2014, Issue 4. Art. No: CD005200. [DOI: 10.1002/14651858.CD005200.pub3]">Vennix 2014</a>; <a href="./references#CD013197-bbs2-0191" title="WilsonCH , SanniA , RixDA , SoomroNA . Laparoscopic versus open nephrectomy for live kidney donors. Cochrane Database of Systematic Reviews2011, Issue 11. Art. No: CD006124. [DOI: 10.1002/14651858.CD006124.pub2]">Wilson 2011</a>). The necessary elevation of intraâabdominal pressure during laparoscopic surgery affects vascular and haemodynamic systems, thereby temporarily decreasing intraâabdominal perfusion (<a href="./references#CD013197-bbs2-0155" title="JunghansT , BÃ¶hmB , GrÃ¼ndelK , SchwenkW , MÃ¼llerJM . Does pneumoperitoneum with different gases, body positions and intraperitoneal pressures influence renal and hepatic blood flow?Surgery1997;121(2):206-11.">Junghans 1997</a>; <a href="./references#CD013197-bbs2-0160" title="LeisterI , SchÃ¼lerP , VollmarB , FÃ¼zesiL , KahlerE , BeckerH , et al. Microcirculation and excretory function of the liver under conditions of carbon dioxide pneumoperitoneum. Surgical Endoscopy2004;18(9):1358-63.">Leister 2004</a>; <a href="./references#CD013197-bbs2-0176" title="SchillingMK , RedaelliC , KrÃ¤henbÃ¼hlL , SignerC , BÃ¼chlerMW . Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Journal of the American College of Surgeons1997;184(4):378-82.">Schilling 1997</a>; <a href="./references#CD013197-bbs2-0178" title="SodhaS , NazarianS , AdsheadJM , VasdevN , Mohan-SG. Effect of pneumoperitoneum on renal function and physiology in patients undergoing robotic renal surgery. Current Urology2016;9(1):1-4.">Sodha 2016</a>). To perform laparoscopic surgery effectively, it is essential that sudden movements and abdominal contractions in patients are prevented, as it limits the surgeon's view. Intraâabdominal pressure is often increased when surgical sight is not optimal. Nonetheless, there is increasing evidence that lowering intraâabdominal pressure has advantages for patient outcomes (<a href="./references#CD013197-bbs2-0173" title="Reijnders-BoerboomGT , AlbersKI , JacobsLM , HeldenEV , RosmanC , DÃ­az-CambroneroO , et al. Low intra-abdominal pressure in laparoscopic surgery: a systematic review and meta-analysis. International Journal of Surgery2023;109(5):1400-11.">ReijndersâBoerboom 2023</a>). </p> </section> <section id="CD013197-sec-0011"> <h3 class="title" id="CD013197-sec-0011">Description of the intervention</h3> <p>Neuromuscular blocking agents (NMBAs) are used during surgery to facilitate endotracheal intubation and intraoperatively to improve surgical conditions. NMBAs can be divided into nonâdepolarising and depolarising agents. Only nonâdepolarising agents are used to obtain deep NMB. The method of action of nonâdepolarising agents such as cisatracurium, vecuronium, atracurium, and rocuronium is competitive binding to acetylcholine receptors at the neuromuscular junction of skeletal muscles, preventing acetylcholineâinduced depolarisation and thereby contraction of the muscles (<a href="./references#CD013197-bbs2-0123" title="Appiah-AnkamJ , HunterJM . Pharmacology of neuromuscular blocking drugs. Continuing Education in Anaesthesia, Critical Care and Pain2004;4(1):2-7.">AppiahâAnkam 2004</a>). </p> <p>Depth of muscle relaxation is measured by acceleromyography by means of the soâcalled trainâofâfour (TOF) twitch stimulation (<a href="./references#CD013197-bbs2-0141" title="Fuchs-BuderT , Schreiber J-U, MeistelmanC . Monitoring neuromuscular block: an update. Anaesthesia2009;64(Suppl 1):82-9.">FuchsâBuder 2009</a>). To quantify the amount of muscle relaxation, the ulnar nerve is supramaximally stimulated four times, and the response of muscle twitches is measured. With an increasing depth of muscle paralysis induced by nonâdepolarising agents, the response to stimulation fades. In the case of moderate neuromuscular blockade (NMB), one to three twitches appear, which corresponds to approximately 75% to 90% of receptors blocked. When TOF response is absent, the postâtetanic count (PTC) measures the response after a tetanic stimulus (<a href="./references#CD013197-bbs2-0140" title="Fuchs-BuderT , ClaudiusC , SkovgaardLT , ErikssonLI , MirakhurRK , Viby-MogensenJ . Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiologica Scandinavica2007;51:789-808.">FuchsâBuder 2007</a>). Deep NMB is defined as no TOF response and a PTC of one or two (<a href="./references#CD013197-bbs2-0122" title="AlbersKI , Diaz-CambroneroO , KeijzerC , SnoeckMM , WarlÃ©MC , Fuchs-BuderT . Revisiting the classification of neuromuscular blockade, aligning clinical practice and research. Anesthesia &amp; Analgesia2019;129(5):e176-8.">Albers 2019</a>). </p> <p>A major concern about the use of NMBAs, especially after the application of deep NMB, is the occurrence of residual muscle paralysis. Residual NMB is associated with increased mortality and morbidity due to, for example, the risk of pulmonary complications. However, after the introduction of sugammadex, a reversal agent for nonâdepolarising NMBAs, recovery of muscle relaxation is quicker, and the occurrence of residual paralysis decreases substantially (<a href="./references#CD013197-bbs2-0151" title="HristovskaAM , DuchP , AllingstrupM , AfshariA . Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database of Systematic Reviews2017, Issue 8. Art. No: CD012763. [DOI: 10.1002/14651858.CD012763]">Hristovska 2017</a>). Sugammadex binds to free plasma nonâdepolarising NMBAs resulting in a quick reversal of muscle paralysis, enabling the use of NMB until the end of surgery. </p> </section> <section id="CD013197-sec-0012"> <h3 class="title" id="CD013197-sec-0012">How the intervention might work</h3> <p>It is thought that deep NMB provides better intraoperative surgical conditions by improving the surgical field and preventing abdominal contractions and sudden movements. This was confirmed in previous systematic reviews on deep NMB (<a href="./references#CD013197-bbs2-0127" title="BruintjesMH , vanHeldenEV , BraatAE , DahanA , SchefferGJ , vanLaarhovenCJ , et al. Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery: a systematic review and meta-analysis. British Journal of Anaesthesia2017;118(6):834-42.">Bruintjes 2017</a>; <a href="./references#CD013197-bbs2-0162" title="MadsenMV , Staehr-RyeAK , GÃ¤tkeMR , ClaudiusC . Neuromuscular blockade for optimising surgical conditions during abdominal and gynaecological surgery: a systematic review. Acta Anaesthesiologica Scandinavica2015;59(1):1-16.">Madsen 2015</a>; <a href="./references#CD013197-bbs2-0171" title="ParkSK , SonYG , YooS , LimT , KimWH , KimJT . Deep vs. moderate neuromuscular blockade during laparoscopic surgery: a systematic review and meta-analysis. European Journal of Anaesthesiology2018;35(11):867-75.">Park 2018</a>; <a href="./references#CD013197-bbs2-0172" title="RavalAD , DeshpandeS , RabarS , KoufopoulouM , NeupaneB , IheanachoI , et al. Does deep neuromuscular blockade during laparoscopy procedures change patient, surgical, and healthcare resource outcomes? A systematic review and meta-analysis of randomized controlled trials. PLOS One2020;15(4):e0231452.">Raval 2020</a>). Improvement of surgical conditions could improve intraoperative safety and reduce intraâ and postoperative complications. </p> <p>The depth of NMB is measured by the abductor pollicis longus, a peripheral muscle that belongs to the muscle groups that recover slowest from muscle relaxation (<a href="./references#CD013197-bbs2-0159" title="LeikinJB , PaloucekFP . Poisoning and Toxicology Handbook. Fourth edition. London (UK): Taylor &amp; Francis, 2007.">Leikin 2007</a>; <a href="./references#CD013197-bbs2-0170" title="PansardJL , ChauvinM , LebraultC , GauneauP , DuvaldestinP . Effect of an intubating dose of succinylcholine and atracurium on the diaphragm and the adductor pollicis muscle in humans. Anesthesiology1987;67(3):326-30.">Pansard 1987</a>). Recovery of function at the ulnar nerve is used as the gold standard that extubation can be performed safely. However, it is known that different muscle groups recover differently from NMBAs. Muscles of the diaphragm and abdomen recover more quickly, resulting in possible abdominal contractions with moderate NMB (<a href="./references#CD013197-bbs2-0148" title="HemmerlingTM , LeN . Neuromuscular monitoring: an update for the clinician. Canadian Journal of Anesthesia2007;54(1):58-72.">Hemmerling 2007</a>; <a href="./references#CD013197-bbs2-0163" title="MenckeT , SchmartzD , Fuchs-BuderT . Neuromuscular monitoring. Anaesthesist2013;62(10):847-61.">Mencke 2013</a>). </p> <p>Deep NMB can prevent unnecessary raising of intraâabdominal pressure during laparoscopy. There is a growing interest in performing laparoscopic surgery under lowâpressure pneumoperitoneum to reduce ischaemiaâreperfusion injury (<a href="./references#CD013197-bbs2-0146" title="GurusamyKS , SamrajK , DavidsonBR . Low pressure versus standard pressure pneumoperitoneum in laparoscopic cholecystectomy. Cochrane Database of Systematic Reviews2014, Issue 3. Art. No: CD006930. [DOI: 10.1002/14651858.CD006930.pub3]">Gurusamy 2014</a>; <a href="./references#CD013197-bbs2-0152" title="HuaJ , GongJ , YaoL , ZhouB , SongZ . Low-pressure versus standard-pressure pneumoperitoneum for laparoscopic cholecystectomy: a systematic review and meta-analysis. American Journal of Surgery2014;208(1):143-50.">Hua 2014</a>; <a href="./references#CD013197-bbs2-0192" title="Ãzdemir-van BrunschotDM , vanLaarhovenKC , SchefferGJ , PouwelsS , WeverKE , WarlÃ©MC . What is the evidence for the use of low-pressure pneumoperitoneum? A systematic review. Surgical Endoscopy2016;30(5):2049-65.">Ãzdemirâvan Brunschot 2016</a>). Deep NMB can facilitate an adequate surgical field while operating with lowâpressure pneumoperitoneum (<a href="./references#CD013197-bbs2-0018" title="KimMH , LeeKY , LeeKY , MinBS , YooYC . Maintaining optimal surgical conditions with low insufflation pressures is possible with deep neuromuscular blockade during laparoscopic colorectal surgery: a prospective, randomized, double-blind, parallel-group clinical trial. Medicine2016;95(9):e2920. ">Kim 2016</a>; <a href="./references#CD013197-bbs2-0023" title="KooBW , OhAY , NaHS , LeeHJ , KangSB , KimDW , et al. Effects of depth of neuromuscular block on surgical conditions during laparoscopic colorectal surgery: a randomised controlled trial. Anaesthesia2018;73(9):1090-6. ">Koo 2018</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0041" title="YooYC , KimNY , ShinS , ChoiYD , HongJH , KimCY , et al. The intraocular pressure under deep versus moderate neuromuscular blockade during low-pressure robot assisted laparoscopic radical prostatectomy in a randomized trial. PLOS One2015;10(8):e0135412. ">Yoo 2015</a>). </p> <p>Last, it is proposed that deep NMB may have a positive impact on postoperative inflammation. By binding various nicotinic acetylcholine receptors in the antiâinflammatory cascade, a deep NMB itself could have antiâinflammatory effects (<a href="./references#CD013197-bbs2-0137" title="FanelliV , MoritaY , CappelloP , GhazarianM , SugumarB , DelsedimeL , et al. Neuromuscular blocking agent cisatracurium attenuates lung injury by inhibition of nicotinic acetylcholine receptor-Î±1. Anesthesiology2016;124(1):132-40.">Fanelli 2016</a>). Moreover, due to the easier performance of surgery, surgeryâinduced cellular stress and damage are reduced, consequently reducing the postoperative inflammation reaction. </p> </section> <section id="CD013197-sec-0013"> <h3 class="title" id="CD013197-sec-0013">Why it is important to do this review</h3> <p>The effect of deep NMB has been studied in several randomised clinical trials. Previously published systematic reviews and metaâanalyses found evidence that deep NMB in laparoscopic procedures provides better intraoperative surgical field rating scores. However, due to a lack of sufficient evidence, clinical outcomes such as safety and quality of recovery could not be assessed (<a href="./references#CD013197-bbs2-0127" title="BruintjesMH , vanHeldenEV , BraatAE , DahanA , SchefferGJ , vanLaarhovenCJ , et al. Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery: a systematic review and meta-analysis. British Journal of Anaesthesia2017;118(6):834-42.">Bruintjes 2017</a>; <a href="./references#CD013197-bbs2-0162" title="MadsenMV , Staehr-RyeAK , GÃ¤tkeMR , ClaudiusC . Neuromuscular blockade for optimising surgical conditions during abdominal and gynaecological surgery: a systematic review. Acta Anaesthesiologica Scandinavica2015;59(1):1-16.">Madsen 2015</a>; <a href="./references#CD013197-bbs2-0171" title="ParkSK , SonYG , YooS , LimT , KimWH , KimJT . Deep vs. moderate neuromuscular blockade during laparoscopic surgery: a systematic review and meta-analysis. European Journal of Anaesthesiology2018;35(11):867-75.">Park 2018</a>; <a href="./references#CD013197-bbs2-0172" title="RavalAD , DeshpandeS , RabarS , KoufopoulouM , NeupaneB , IheanachoI , et al. Does deep neuromuscular blockade during laparoscopy procedures change patient, surgical, and healthcare resource outcomes? A systematic review and meta-analysis of randomized controlled trials. PLOS One2020;15(4):e0231452.">Raval 2020</a>). With the expansion of the body of evidence due to recently published randomised clinical trials, we aimed to assess with the best level of evidence for the effects of deep NMB in adults undergoing laparoscopic abdominal procedures regarding clinical outcomes. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013197-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013197-sec-0014"></div> <p>To evaluate the benefits and harms of deep neuromuscular blockade versus no, shallow, or moderate neuromuscular blockade during laparoscopic intraâ or transperitoneal procedures in adults. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013197-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013197-sec-0015"></div> <section id="CD013197-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013197-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included randomised clinical trials irrespective of format, language, or publication date. We included unpublished trials only if methodological descriptions and trial data were provided. As stated in the protocol, we considered quasiârandomised clinical studies and observational studies that we identified in our search for their report on harms (<a href="./references#CD013197-bbs2-0194" title="BruintjesMH , AlbersKI , GurusamyKS , RoversMM , vanLaarhovenCJ , WarleMC . Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure. Cochrane Database of Systematic Reviews2018, Issue 11. Art. No: CD013197. [DOI: 10.1002/14651858.CD013197]">Bruintjes 2018</a>). This allowed identification of rare adverse events and late adverse events that are often overlooked in randomised clinical trials (<a href="./references#CD013197-bbs2-0179" title="StorebÃ¸OJ , PedersenN , RamstadE , KielsholmML , NielsenSS , KroghHB , et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents â assessment of adverse events in non-randomised studies. Cochrane Database of Systematic Reviews 2018, Issue 5. Art. No: CD012069. [DOI: 10.1002/14651858.CD012069.pub2]">StorebÃ¸ 2018</a>). </p> </section> <section id="CD013197-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included adults (aged 18 years and older) undergoing laparoscopic intraperitoneal and transperitoneal surgery. </p> </section> <section id="CD013197-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included all trials comparing deep NMB to moderate, shallow, or no NMB. We made the following comparisons. </p> <p> <ul id="CD013197-list-0001"> <li> <p>Deep NMB versus moderate NMB</p> </li> <li> <p>Deep NMB versus shallow NMB</p> </li> <li> <p>Deep NMB versus no NMB</p> </li> </ul> </p> <p>We included any type of nonâdepolarising NMBA.</p> </section> <section id="CD013197-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>We used the longest followâup data for our main analyses.</p> <section id="CD013197-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD013197-list-0002"> <li> <p>Allâcause mortality</p> <ul id="CD013197-list-0003"> <li> <p>Mortality from the start of surgery until eight hours after surgery</p> </li> <li> <p>Shortâterm mortality: inâhospital mortality or mortality within three months</p> </li> <li> <p>Longâterm mortality: more than three months</p> </li> </ul> </li> <li> <p>Healthârelated quality of life (measured on a validated scale such as 36âItem Short Form Health Survey (SFâ36), Quality of Recoveryâ40, or other similar validated scales) </p> <ul id="CD013197-list-0004"> <li> <p>Shortâterm (within three months)</p> </li> <li> <p>Mediumâterm (longer than three months to one year)</p> </li> </ul> </li> <li> <p>Proportion of participants with serious adverse event (SAE) (defined as any untoward medical occurrence that resulted in death, was lifeâthreatening, required hospitalisation or prolongation of existing hospitalisation, or resulted in persistent or significant disability or incapacity (<a href="./references#CD013197-bbs2-0153" title="International Council for Harmonisation of technical requirements for pharmaceuticals for human use (ICH). ICH Harmonised Guideline. Integrated addendum to ICH E6(R1): guideline for good clinical practice E6(R2). database.ich.org/sites/default/files/E6_R2_Addendum.pdf (accessed 31 May 2023).">ICHâGCP 2016</a>)) </p> <ul id="CD013197-list-0005"> <li> <p>From the start of surgery until eight hours after surgery</p> </li> <li> <p>Shortâterm (within three months)</p> </li> </ul> </li> </ul> </p> </section> <section id="CD013197-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD013197-list-0006"> <li> <p>Proportion of participants with nonâserious adverse events (nSAE), defined as adverse events that do not fulfil the criteria for SAE </p> <ul id="CD013197-list-0007"> <li> <p>From the start of surgery until eight hours after surgery</p> </li> <li> <p>Shortâterm (within three months)</p> </li> </ul> </li> <li> <p>Readmission within three months</p> </li> <li> <p>Shortâterm pain scores, measured using a numerical rating score</p> <ul id="CD013197-list-0008"> <li> <p>One hour postoperative or during the stay in the postanaesthesia care unit (PACU)</p> </li> <li> <p>24 hours postoperative</p> </li> <li> <p>One week postoperative</p> </li> <li> <p>Two weeks postoperative</p> </li> </ul> </li> <li> <p>Measurements of postoperative recovery</p> <ul id="CD013197-list-0009"> <li> <p>Length of hospital stay</p> </li> <li> <p>Time to return to normal activity</p> </li> <li> <p>Time to return to work</p> </li> </ul> </li> <li> <p>Operating time</p> </li> </ul> </p> <p>The choice of these outcome measurements was made to assess whether deep NMB improves clinical outcomes such as healthârelated quality of life and enhanced recovery after surgery. It was consciously chosen not to assess nonâclinical outcomes such as surgical rating scores. We excluded studies if they did not report any of the primary or secondary outcomes. </p> </section> </section> </section> <section id="CD013197-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <p>If a review author was also a contributor to a study that was of interest to this review, that review author was not involved in the selection process for their study. </p> <section id="CD013197-sec-0024"> <h4 class="title">Electronic searches</h4> <p>The Cochrane HepatoâBiliary Group Information Specialist searched the Cochrane HepatoâBiliary Group Controlled Trials Register via the Cochrane Register of Studies Web on 31 July 2023. We also searched the Cochrane Central Register of Controlled Trials (2023; Issue 1) in the Cochrane Library, MEDLINE ALL Ovid (1946 to 31 July 2023), Embase Ovid (1974 to 31 July 2023), Latin American and Caribbean Health Science Literature (LILACS) (VHL Regional Portal; 1982 to 31 July 2023), Science Citation Index Expanded (1900 to 31 July 2023), and Conference Proceedings Citation IndexâScience (1990 to 31 July 2023). The latter two were searched simultaneously through Web of Science. </p> <p><a href="./appendices#CD013197-sec-0142">Appendix 1</a> presents the search strategies with the actual date range of the searches. We did not impose a language restriction. </p> </section> <section id="CD013197-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We also searched the following databases for ongoing trials in July 2023.</p> <p> <ul id="CD013197-list-0010"> <li> <p><a href="https://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="http://www.who.int/ictrp" target="_blank">www.who.int/ictrp</a>) </p> </li> </ul> </p> <p>The search terms used are given in <a href="./appendices#CD013197-sec-0142">Appendix 1</a>. </p> <p>We performed a search for errata or retractions of eligible trials on PubMed (<a href="http://www.ncbi.nlm.nih.gov/pubmed" target="_blank">www.ncbi.nlm.nih.gov/pubmed</a>) on 17 March 2023 as errata can reveal important limitations or even fatal flaws in included trials (<a href="./references#CD013197-bbs2-0158" title="LefebvreC , GlanvilleJ , BriscoeS , LittlewoodA , MarshallC , Metzendorf M-I, et al. Technical supplement to Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.">Lefebvre 2022</a>). We found no significant errata or retractions. </p> <p>We manually searched for additional references in the reference lists of the included trials. </p> </section> </section> <section id="CD013197-sec-0026"> <h3 class="title" id="CD013197-sec-0026">Data collection and analysis</h3> <p>If a review author was also a contributor to a study that was of interest to this review, that review author was not involved in the data extraction or assessment of risk of bias process for their study. </p> <section id="CD013197-sec-0027"> <h4 class="title">Selection of studies</h4> <p>We assessed eligible trials via the criteria defined in <a href="#CD013197-sec-0017">Types of studies</a>. Per trial, at least two review authors (KIA, LMCJ, MCW, VB) independently screened title and abstracts for inclusion. All potential studies were coded as either 'retrieve' (eligible, potentially eligible, or unclear) or 'do not retrieve'. At least two review authors per trial (KIA, LMCJ, VB) independently screened full texts of potentially eligible studies, identified studies for inclusion, and recorded reasons for exclusion of ineligible studies. We resolved disagreements through discussion or consulted a third review author. We collated multiple reports of the same trial. The initial search is shown in the PRISMA study flow diagram (<a href="#CD013197-fig-0001">Figure 1</a>; <a href="./references#CD013197-bbs2-0168" title="PageMJ , McKenzieJE , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.)2021;372:n71.">Page 2021a</a>; <a href="./references#CD013197-bbs2-0169" title="PageMJ , MoherD , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ (Clinical Research Ed.)2021;372:n160.">Page 2021b</a>). </p> <div class="figure" id="CD013197-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt=": PRISMA flow diagram (Page 2021a; Page 2021b). Date of search 31 July 2023." data-id="CD013197-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><a href="#CD013197-fig-0001">Figure 1</a>: PRISMA flow diagram (<a href="./references#CD013197-bbs2-0168" title="PageMJ , McKenzieJE , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.)2021;372:n71.">Page 2021a</a>; <a href="./references#CD013197-bbs2-0169" title="PageMJ , MoherD , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ (Clinical Research Ed.)2021;372:n160.">Page 2021b</a>). Date of search 31 July 2023. </p> </div> </div> </div> </section> <section id="CD013197-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (LMCJ and VB) independently extracted the following data using standardised data collection forms which were first tested on one study in the review. </p> <p> <ul id="CD013197-list-0011"> <li> <p>General: title, first author, journal, year of publication, language</p> </li> <li> <p>Study design (parallel, crossâover trial, or clusterârandomised trial)</p> </li> <li> <p>Settings: country of origin, number of clinical sites, inclusion and exclusion criteria</p> </li> <li> <p>Participants: number of participants, sex, age, weight, body mass index</p> </li> <li> <p>Surgery: type of laparoscopy, pressure level of pneumoperitoneum</p> </li> <li> <p>Intervention: level of NMB (and specification) of experimental and control group, type and amount of NMBA used, type and amount of reversal agent used </p> </li> <li> <p>Outcomes: primary and secondary outcomes specified and collected, time points reported, and if outcome data were reported in an unusual way </p> </li> <li> <p>Notes: funding for the trial, notable conflicts of interest of trial authors</p> </li> </ul> </p> <p>Information on extracted data can be found in the <a href="./references#CD013197-sec-0151" title="">Characteristics of included studies</a>, <a href="./references#CD013197-sec-0152" title="">Characteristics of excluded studies</a>, and <a href="./references#CD013197-sec-0153" title="">Characteristics of ongoing studies</a> tables, and <a href="#CD013197-sec-0060">Risk of bias in included studies</a> section. Both review authors (LMCJ and VB) entered data into Covidence (<a href="./references#CD013197-bbs2-0133" title="Covidence. Version accessed 31 May 2023. Melbourne, Australia: Veritas Health Innovation. Available at covidence.org.">Covidence</a>). They resolved disagreements by discussion or by consulting a third review author (MCW). One author (LMCJ) imported the data into Review Manager Web (<a href="./references#CD013197-bbs2-0174" title="Review Manager Web (RevMan Web). Version 6.3.0. The Cochrane Collaboration, 2023. Available at revman.cochrane.org.">RevMan Web 2023</a>). The other author (VB) doubleâchecked the entered data for accuracy. </p> </section> <section id="CD013197-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (LMCJ, KIA, VB) independently assessed the risk of bias (high, low, or unclear risk of bias) for each included study. In accordance with the protocol, we used the RoB 1 tool (<a href="./references#CD013197-bbs2-0194" title="BruintjesMH , AlbersKI , GurusamyKS , RoversMM , vanLaarhovenCJ , WarleMC . Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure. Cochrane Database of Systematic Reviews2018, Issue 11. Art. No: CD013197. [DOI: 10.1002/14651858.CD013197]">Bruintjes 2018</a>; <a href="./references#CD013197-bbs2-0149" title="HigginsJP , AltmanDG , SterneJA . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017. Available from training.cochrane.org/handbook/archive/v5.2.">Higgins 2017</a>). We reported the following domains. </p> <section id="CD013197-sec-0030"> <h5 class="title">Random sequence generation</h5> <p> <ul id="CD013197-list-0012"> <li> <p>Low risk of bias: the study authors performed sequence generation using computer randomânumber generation or a randomânumber table. Drawing lots, tossing a coin, shuffling cards, and throwing dice were adequate if an independent person not otherwise involved in the study performed them. </p> </li> <li> <p>Unclear risk of bias: the study authors did not specify the method of sequence generation.</p> </li> <li> <p>High risk of bias: the sequence generation method was not random. We planned to include such studies only for the assessment of harms. </p> </li> </ul> </p> </section> <section id="CD013197-sec-0031"> <h5 class="title">Allocation concealment</h5> <p> <ul id="CD013197-list-0013"> <li> <p>Low risk of bias: the participant allocations could not have been foreseen in advance of or during enrolment. A central and independent randomisation unit controlled allocation. The investigators were unaware of the allocation sequence (e.g. if the allocation sequence was hidden in sequentially numbered, opaque, and sealed envelopes). </p> </li> <li> <p>Unclear risk of bias: the study authors did not describe the method used to conceal the allocation, so the intervention allocations may have been foreseen before or during enrolment. </p> </li> <li> <p>High risk of bias: it was likely that the investigators who assigned the participants knew the allocation sequence. We planned to include such studies only for the assessment of harms. </p> </li> </ul> </p> </section> <section id="CD013197-sec-0032"> <h5 class="title">Blinding of participants and personnel</h5> <p> <ul id="CD013197-list-0014"> <li> <p>Low risk of bias: any of the following: blinding of participants and key study personnel ensured, and it was unlikely that the blinding could have been broken; or (rarely) no blinding or incomplete blinding, but the review authors judged that the outcome was not likely to be influenced by lack of blinding, such as allâcause mortality or SAEs. </p> </li> <li> <p>Unclear risk of bias: any of the following: insufficient information to permit judgement of 'low risk' or 'high risk'; or the trial did not address this outcome. </p> </li> <li> <p>High risk of bias: any of the following: no blinding or incomplete blinding, and the outcome was likely to be influenced by lack of blinding; or blinding of key study participants and personnel attempted, but likely that the blinding could have been broken, and the outcome was likely to have been influenced by lack of blinding. </p> </li> </ul> </p> </section> <section id="CD013197-sec-0033"> <h5 class="title">Blinding of outcome assessment</h5> <p> <ul id="CD013197-list-0015"> <li> <p>Low risk of bias: any of the following: blinding of outcome assessment ensured, and unlikely that the blinding could have been broken; or (rarely) no blinding of outcome assessment, but the review authors judged that the outcome measurement was not likely to be influenced by lack of blinding, such as allâcause mortality or SAEs. </p> </li> <li> <p>Unclear risk of bias: any of the following: insufficient information to permit judgement of 'low risk' or 'high risk'; or the trial did not address this outcome. </p> </li> <li> <p>High risk of bias: any of the following: no blinding of outcome assessment, and the outcome measurement was likely to be influenced by lack of blinding; or blinding of outcome assessment, but likely that the blinding could have been broken, and the outcome measurement was likely to be influenced by lack of blinding. </p> </li> </ul> </p> </section> <section id="CD013197-sec-0034"> <h5 class="title">Incomplete outcome data</h5> <p> <ul id="CD013197-list-0016"> <li> <p>Low risk of bias: missing data were unlikely to make treatment effects depart from plausible values. The study used sufficient methods, such as multiple imputation, to handle missing data. </p> </li> <li> <p>Unclear risk of bias: there was insufficient information to assess whether missing data in combination with the method used to handle missing data were likely to induce bias in the results. </p> </li> <li> <p>High risk of bias: the results were likely to be biased due to missing data.</p> </li> </ul> </p> </section> <section id="CD013197-sec-0035"> <h5 class="title">Selective outcome reporting</h5> <p> <ul id="CD013197-list-0017"> <li> <p>Low risk of bias: the trial reported at least the following outcomes: allâcause mortality, healthârelated quality of life, and SAEs. If the original trial protocol was available, the outcomes should have been those set out in that protocol. If we obtain the trial protocol from a trial registry (e.g. <a href="http://ClinicalTrials.gov" target="_blank">ClinicalTrials.gov</a>), the outcomes sought should have been those stated in the original protocol if the trial protocol was registered before or at the time that the trial was begun. If the trial protocol was registered after the trial had begun, we would not consider those outcomes to be reliable. </p> </li> <li> <p>Unclear risk of bias: not all predefined or clinically relevant and reasonably expected outcomes were reported fully, or it was unclear whether data on these outcomes were recorded or not. </p> </li> <li> <p>High risk of bias: one or more predefined or clinically relevant and reasonably expected outcomes were not reported, despite the fact that data on these outcomes should have been available and even recorded. </p> </li> </ul> </p> </section> <section id="CD013197-sec-0036"> <h5 class="title">Other bias</h5> <p> <ul id="CD013197-list-0018"> <li> <p>Low risk of bias: the trial appeared to be free of other components that could have put it at risk of bias, for example, inappropriate control or dose or administration of control, baseline differences, and early stopping. We also took into account if studies reported on calibration of the trainâofâfour watch, defined deep NMB as no responses to trainâofâfour and at least one response to postâtetanicâcount, and if they mentioned the use of additional amounts of neuromuscularâblocking agent as an escape in the moderate neuromuscular group in case of insufficient surgical field. </p> </li> <li> <p>Unclear risk of bias: the trial may or may not have been free of other components that could have put it at risk of bias or unintendedly influence the outcomes. </p> </li> <li> <p>High risk of bias: there were other factors in the trial that could have put it at risk of bias, for example, inappropriate control or dose or administration of control, baseline differences, early stopping, and inappropriate measurement of neuromuscular monitoring as this could result in unintended intergroup differences in level of NMB. </p> </li> </ul> </p> <p>We resolved disagreements between the assessing review authors by discussion or by consulting a third review author (MW). </p> </section> <section id="CD013197-sec-0037"> <h5 class="title">Overall risk of bias</h5> <p>If a trial was at low risk of bias in all domains, we considered it at low risk of bias overall. If a trial was at 'unclear risk of bias' or 'high risk of bias' in one or more of the specified individual domains, we considered it at high risk of bias overall (<a href="./references#CD013197-bbs2-0149" title="HigginsJP , AltmanDG , SterneJA . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017. Available from training.cochrane.org/handbook/archive/v5.2.">Higgins 2017</a>). </p> </section> </section> <section id="CD013197-sec-0038"> <h4 class="title">Measures of treatment effect</h4> <p>We planned to perform a metaâanalysis for the three different comparisons. However, only the first and second comparison (deep NMB versus moderate NMB and deep NMB versus shallow NMB) had a sufficient number of trials available to perform the metaâanalysis. For dichotomous outcomes (proportion of participants with SAE, readmission rate, etc.), we calculated the risk ratio (RR) and 95% confidence interval (CI) or Peto odds ratio (OR) and 95% CI depending on the number of events per group. For continuous data (e.g. healthârelated quality of life), we calculated the mean differences (MDs) with 95% CIs. All trials reporting healthârelated quality of life used the same scale, so it was not necessary to use a standardised mean difference. We regarded pain scores as a continuous outcome to prevent losing important information and, therefore, measured MDs. </p> <p>It was planned to calculate the hazard ratio (HR) for longâterm mortality. However, combined mortality was still too low to calculate this outcome. We used the randomâeffects metaâanalysis for our main analysis and the fixedâeffect model as sensitivity analysis. For dichotomous outcomes with sparse events, we presented the Peto fixedâeffect model. </p> </section> <section id="CD013197-sec-0039"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the individual participant undergoing a laparoscopic intraâ or transperitoneal procedure. We planned to take into account crossâover and clusterârandomised trials, but none were identified. </p> </section> <section id="CD013197-sec-0040"> <h4 class="title">Dealing with missing data</h4> <p>We performed analysis on an intentionâtoâtreat basis. Whenever possible, we analysed all participants in the group to which they were randomised. We contacted authors of trials with missing or unclear data. </p> <p>When we were unable to obtain information from the investigators regarding continuous data, we calculated the mean and standard deviation from the median and interquartile range according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013197-bbs2-0150" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageM , et al, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.">Higgins 2022</a>; <a href="./references#CD013197-bbs2-0187" title="WanX , WangW , LiuJ , TongT . Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Medical Research Methodology2014;14(1):135.">Wan 2014</a>). When calculation of the standard deviation was not possible, we imputed the standard deviation as the highest standard deviation in the remaining trials in the outcome. We used sensitivity analyses to assess the impact of including such studies. </p> </section> <section id="CD013197-sec-0041"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity amongst trials using the I<sup>2</sup> statistic. An I<sup>2</sup> statistic greater than 50% represented substantial heterogeneity. In these analyses we performed subgroup analyses to explore heterogeneity. </p> </section> <section id="CD013197-sec-0042"> <h4 class="title">Assessment of reporting biases</h4> <p>We included both published and unpublished studies. Moreover, we searched for published protocols and trial registrations for the included studies. As we included more than 10 studies, we visually assessed reporting bias by use of funnel plots (<a href="./references#CD013197-bbs2-0136" title="EggerM , DaveySG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.)1997;315(7109):629-34.">Egger 1997</a>). </p> </section> <section id="CD013197-sec-0043"> <h4 class="title">Data synthesis</h4> <p>We only performed metaâanalyses on the first and second comparison (deep NMB versus moderate NMB and deep NMB versus shallow NMB) where the studies were sufficiently similar for pooling, using Review Manager Web (<a href="./references#CD013197-bbs2-0174" title="Review Manager Web (RevMan Web). Version 6.3.0. The Cochrane Collaboration, 2023. Available at revman.cochrane.org.">RevMan Web 2023</a>). We calculated the MDs with 95% CIs for continuous outcomes and RR or OR with 95% CIs for dichotomous variables. We presented the randomâeffects model for most outcomes as there was significant heterogeneity amongst trials, and it was the most conservative model. If metaâanalysis was not appropriate due to an insufficient number of eligible studies, we provided a narrative description. </p> </section> <section id="CD013197-sec-0044"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to conduct the following subgroup analyses to identify sources of heterogeneity.</p> <p> <ul id="CD013197-list-0019"> <li> <p>Trials at low risk of bias compared to trials at high risk of bias.</p> </li> <li> <p>Type of laparoscopic procedures: trials with hepatobiliary surgery compared with trials with gastrointestinal surgery, compared with trials with gynaecological surgery, compared with trials with urological surgery. </p> </li> <li> <p>Level of pressure of pneumoperitoneum: trials with lowâpressure pneumoperitoneum (10 mmHg or less) compared to trials with standardâpressure pneumoperitoneum (greater than 10 mmHg). </p> </li> <li> <p>Body mass index: trials with healthy weight body mass index (18.5 kg/m<sup>2</sup> to 25 kg/m<sup>2</sup>) compared to trials with overweight or obese participants (greater than 25 kg/m<sup>2</sup>). No trials reported underweight participants. </p> </li> </ul> </p> <p>Subgroup analyses on trials with low and high risk of bias and on type of laparoscopic procedure have not been conducted, as it led to fewer than five trials per subgroup for the individual outcomes. We assessed differences between subgroups by performing a test for heterogeneity across subgroups and analysing the I<sup>2</sup> statistic. </p> </section> <section id="CD013197-sec-0045"> <h4 class="title">Sensitivity analysis</h4> <p>We performed a sensitivity analysis by imputing data for binary outcomes using various scenarios, such as bestâworst and worstâbest scenarios. Due to the low number of incidents in the mortality analysis and the readmission analysis, we did not perform these analyses for these outcomes. For continuous data, we performed an analysis excluding all studies with imputed data. As we identified no suitable clusterârandomised clinical trials, we did not conduct an analysis with the adjusted effect estimates. </p> <section id="CD013197-sec-0046"> <h5 class="title">Assessment of imprecision with Trial Sequential Analysis</h5> <p>Cumulative metaâanalyses are at risk of producing random errors due to sparse data and multiple testing of accumulating data (<a href="./references#CD013197-bbs2-0125" title="BrokJ , ThorlundK , GluudC , WetterslevJ . Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology2008;61:763-9.">Brok 2008</a>; <a href="./references#CD013197-bbs2-0126" title="BrokJ , ThorlundK , WetterslevJ , GluudC . Apparently conclusive meta-analyses may be inconclusive â Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. International Journal of Epidemiology2009;38(1):287-98.">Brok 2009</a>; <a href="./references#CD013197-bbs2-0181" title="ThorlundK , DevereauxPJ , WetterslevJ , GuyattG , IoannidisJP , ThabaneL , et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses. International Journal of Epidemiology2009;38(1):276-86.">Thorlund 2009</a>; <a href="./references#CD013197-bbs2-0182" title="ThorlundK , AnemaA , MillsE . Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals. Clinical Epidemiology2010;2:57-66.">Thorlund 2010</a>; <a href="./references#CD013197-bbs2-0188" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial Sequential Analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Medical Epidemiology2008;61(1):64-75.">Wetterslev 2008</a>; <a href="./references#CD013197-bbs2-0189" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in a random-effects meta-analysis. BMC Medical Research Methodology2009;9:86.">Wetterslev 2009</a>; <a href="./references#CD013197-bbs2-0190" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis in systematic reviews with meta-analysis. BioMed Central Medical Research Methodology2017;17(1):39.">Wetterslev 2017</a>); therefore, Trial Sequential Analysis can be applied as a secondary analysis to control this risk. Trial Sequential Analysis considers the choice of statistical model (fixedâeffect or randomâeffects metaâanalysis) and diversity, and provides the Trial Sequential Analysisâadjusted CIs (<a href="./references#CD013197-bbs2-0183" title="ThorlundK , EngstrÃ¸mJ , WetterslevJ , BrokJ , ImbergerG , GluudC . User Manual for Trial Sequential Analysis (TSA); 2nd edition. Copenhagen Trial Unit, 2017. Available from ctu.dk/tsa/learn-more (accessed 9 October 2023).">Thorlund 2017</a>; <a href="./references#CD013197-bbs2-0185" title="TSA â Trial Sequential Analysis. Version 0.9.5.10 Beta. Copenhagen: Copenhagen Trial Unit, 2017. ctu.dk/tsa/downloads/.">TSA 2017</a>). </p> <p>The underlying assumption of Trial Sequential Analysis is that testing for statistical significance may be performed each time a new trial is included in the metaâanalysis. The trial references are arranged automatically by the programme according to the year of publication; if more than one trial is published in a year, the programme sorts out the references alphabetically, according to the last name of the first author. Based on the calculated diversityâadjusted required information size (DARIS; i.e. the number of participants needed in a metaâanalysis to detect or reject a certain intervention effect), we can construct the trial sequential monitoring boundaries for benefit, harm, and futility (<a href="./references#CD013197-bbs2-0125" title="BrokJ , ThorlundK , GluudC , WetterslevJ . Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology2008;61:763-9.">Brok 2008</a>; <a href="./references#CD013197-bbs2-0126" title="BrokJ , ThorlundK , WetterslevJ , GluudC . Apparently conclusive meta-analyses may be inconclusive â Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. International Journal of Epidemiology2009;38(1):287-98.">Brok 2009</a>; <a href="./references#CD013197-bbs2-0182" title="ThorlundK , AnemaA , MillsE . Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals. Clinical Epidemiology2010;2:57-66.">Thorlund 2010</a>; <a href="./references#CD013197-bbs2-0188" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial Sequential Analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Medical Epidemiology2008;61(1):64-75.">Wetterslev 2008</a>; <a href="./references#CD013197-bbs2-0189" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in a random-effects meta-analysis. BMC Medical Research Methodology2009;9:86.">Wetterslev 2009</a>; <a href="./references#CD013197-bbs2-0190" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis in systematic reviews with meta-analysis. BioMed Central Medical Research Methodology2017;17(1):39.">Wetterslev 2017</a>). These boundaries determine the statistical inference one may draw regarding the cumulative metaâanalysis that does not reach the DARIS; if the trial sequential monitoring boundary for benefit or harm is crossed before the DARIS is reached, firm evidence can be established, and further trials may be superfluous. If the boundaries for benefit or harm are not crossed, it is most probably necessary to continue running trials to detect or reject a certain intervention effect. However, if the cumulative Zâcurve crosses the trial sequential monitoring boundaries for futility, no additional trials may be required. </p> <p>In our Trial Sequential Analysis for the dichotomous outcomes, we based the DARIS on event proportion in the control group, assuming a plausible relative risk ratio of 10%, risk of type I error of 1.25% for the seven primary outcomes and 0.83 for the 11 secondary outcomes (<a href="./references#CD013197-bbs2-0154" title="JakobsenJC , WetterslevJ , WinkelP , LangeT , GluudC . Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BioMed Central Medical Research Methodology2014;14(1):120. [DOI: 10.1186/1471-2288-14-120]">Jakobsen 2014</a>), risk of type II error of 10% (power 90%), and the diversity of trials included in the metaâanalysis (<a href="./references#CD013197-bbs2-0129" title="CastelliniG , BruschettiniM , GianolaS , GluudC , MojaL . Assessing imprecision in Cochrane systematic reviews: a comparison of GRADE and Trial Sequential Analysis. Systematic Reviews2018;7(1):110.">Castellini 2018</a>; <a href="./references#CD013197-bbs2-0154" title="JakobsenJC , WetterslevJ , WinkelP , LangeT , GluudC . Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BioMed Central Medical Research Methodology2014;14(1):120. [DOI: 10.1186/1471-2288-14-120]">Jakobsen 2014</a>). </p> <p>For continuous data, we used a risk of type I error of 1.25% for the seven primary outcomes and 0.83% for the 11 secondary outcomes (<a href="./references#CD013197-bbs2-0154" title="JakobsenJC , WetterslevJ , WinkelP , LangeT , GluudC . Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BioMed Central Medical Research Methodology2014;14(1):120. [DOI: 10.1186/1471-2288-14-120]">Jakobsen 2014</a>), a risk of type II error of 10% (power 90%), and the diversity of trials included in the metaâanalysis. For healthârelated quality of life, as assessed by the quality of recovery questionnaires, we considered 10 points a minimal relevant difference (MIREDIF) (<a href="./references#CD013197-bbs2-0134" title="De Oliveira GS Jr, FitzgeraldPC , MarcusRJ , AhmadS , McCarthyRJ . A dose-ranging study of the effect of transversus abdominis block on postoperative quality of recovery and analgesia after outpatient laparoscopy. Anesthesia &amp; Analgesia2011;113(5):1218-25.">De Oliveira 2011</a>; <a href="./references#CD013197-bbs2-0166" title="MylesPS , MylesDB , GalagherW , ChewC , MacDonaldN , DennisA . Minimal clinically important difference for three quality of recovery scales. Anesthesiology2016;125(1):39-45.">Myles 2016</a>; <a href="./references#CD013197-bbs2-0192" title="Ãzdemir-van BrunschotDM , vanLaarhovenKC , SchefferGJ , PouwelsS , WeverKE , WarlÃ©MC . What is the evidence for the use of low-pressure pneumoperitoneum? A systematic review. Surgical Endoscopy2016;30(5):2049-65.">Ãzdemirâvan Brunschot 2016</a>). For pain, we used a MIREDIF of 1 point on the visual analogue scale (VAS) (<a href="./references#CD013197-bbs2-0184" title="ToddKH , FunkJP . The minimum clinically important difference in physician-assigned visual analog pain scores. Academic Emergency Medicine1996;3(2):142-6.">Todd 1996</a>). For length of hospital stay, we used a MIREDIF of one day. For the duration of surgery, we considered a MIREDIF of 15 minutes. A control group variance for each of the continuous outcomes was used as observed in the trials and the diversity observed in the metaâanalysis. We used the DerâSimonian randomâeffects model with Trial Sequential Analysis software, version 0.9.5.10 beta (<a href="./references#CD013197-bbs2-0185" title="TSA â Trial Sequential Analysis. Version 0.9.5.10 Beta. Copenhagen: Copenhagen Trial Unit, 2017. ctu.dk/tsa/downloads/.">TSA 2017</a>). </p> <p>In Trial Sequential Analysis, assessment of imprecision is downgraded by two levels if the accrued number of participants is below 50% of the DARIS, and one level if between 50% and 100% of DARIS. We did not downgrade if futility or DARIS was reached or crossed by the cumulative Zâscore. A more detailed description of Trial Sequential Analysis and the software programme can be found at <a href="http://www.ctu.dk/tsa/" target="_blank">www.ctu.dk/tsa/</a> (<a href="./references#CD013197-bbs2-0183" title="ThorlundK , EngstrÃ¸mJ , WetterslevJ , BrokJ , ImbergerG , GluudC . User Manual for Trial Sequential Analysis (TSA); 2nd edition. Copenhagen Trial Unit, 2017. Available from ctu.dk/tsa/learn-more (accessed 9 October 2023).">Thorlund 2017</a>). </p> </section> </section> <section id="CD013197-sec-0047"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We constructed summary of findings tables with GRADEpro GDT software (<a href="./references#CD013197-bbs2-0144" title="GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime), (accessed 9 October 2023). Available at gradepro.org.">GRADEpro GDT</a>). We constructed separate summary of findings tables for each of the three comparisons including the three primary outcomes, that is, allâcause mortality, healthârelated quality of life, and proportion of participants with SAEs (<a href="./full#CD013197-tbl-0001">summary of findings Table 1</a>; <a href="./full#CD013197-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD013197-tbl-0003">summary of findings Table 3</a>). In addition, we created an additional SoF for the secondary outcomes of the comparison on deep versus moderate NMB (<a href="#CD013197-tbl-0004">Table 1</a>). We assessed the certainty of evidence using GRADE (<a href="./references#CD013197-bbs2-0147" title='GuyattGH , OxmanAD , KunzR , VistGE , Falck-YtterY , SchÃ¼nemannHJ , GRADE Working Group. What is "quality of evidence" and why is it important to clinicians?BMJ (Clinical Research Ed.)2008;336(7651):995-8.'>Guyatt 2008</a>). We assessed the outcome results at maximum followâup, providing also the time of followâup (range). </p> <div class="table" id="CD013197-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span>Â <span class="table-title">Summary of findings table secondary outcomes â deep neuromuscular blockade (NMB) compared to moderate NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Summary of findings secondary outcomes: deep neuromuscular blockade (NMB) compared to moderate NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> adults undergoing intraâ and transperitoneal laparoscopic procedures </p> <p><b>Setting:</b> secondary or tertiary care setting </p> <p><b>Intervention:</b> deep NMB </p> <p><b>Comparison:</b> moderate NMB </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> </b> (95% CI) </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect</b> <br/><b>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>â of participants</b> <br/><b>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence</b> <br/><b>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with moderate NMB</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with deep NMB</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nonâserious adverse events (nSAEs) start of surgery until 8 hours after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>43 per 1000</b><br/>(26 to 70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Peto OR 0.68</b><br/>(0.41 to 1.11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1210<br/>(11 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>a,b,c</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Shortâterm nonâserious adverse events (nSAEs)<br/>followâup: 3 to 60 days </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>121 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>114 per 1000</b><br/>(79 to 163) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Peto OR 0.94</b><br/>(0.65 to 1.35) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1232<br/>(11 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>a,d</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Readmissions<br/>followâup: 7 days to 3 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>12 per 1000</b><br/>(4 to 38) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Peto OR 0.50</b><br/>(0.16 to 1.57) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>675<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>a,b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain 1 hour after surgery or at post anaesthesia care unit<br/>Scale: 0 to 10 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain 1 hour after surgery or at postanaesthesia care unit ranged from <b>2.6 to 6.5</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.31 lower</b><br/>(0.59 lower to 0.03 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1823<br/>(22 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>a,c,e</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain 24 hours<br/>Scale: 0 to 10 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain 24 hours ranged from <b>2.3 to 5.6</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.6 lower</b><br/>(1.05 lower to 0.15 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1404<br/>(16 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>a,f</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Length of hospital stay</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay ranged from <b>1.6 to 11.5</b> days </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.22 days lower</b><br/>(0.49 lower to 0.06 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2084<br/>(19 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Low<sup>a,c</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Operating time</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean operating time ranged from <b>38 to 250</b> minutes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.51 minutes lower</b><br/>(3.35 lower to 2.32 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3143<br/>(34 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ</p> <p>Moderate<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>NMB:</b> neuromuscular blockade; <b>MD:</b> mean difference; <b>RCT:</b> randomised clinical trial. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level for serious risk of bias: most trials were at unclear risk of bias.<br/><sup>b</sup> Downgraded two levels for very serious imprecision: the optimal information size was not met, none of the sequential boundaries for benefit, harm, or futility were crossed; number of events was below 100; and the confidence interval of the point estimate included both benefit and harm.<br/><sup>c</sup> Downgraded one level for serious inconsistency: there may be substantial heterogeneity as noted by the I<sup>2</sup> statistic (IÂ² = 71%).<br/><sup>d</sup> Downgraded two levels for very serious imprecision: the optimal information size was not met, none of the sequential boundaries for benefit, harm, or futility were crossed; and the confidence interval of the point estimate included both benefit and harm.<br/><sup>e</sup> Downgraded one level for publication bias: there may be a high probability of publication bias as observed in the funnel plot.<br/><sup>f</sup> Downgraded two levels for very serious inconsistency: there may be considerable heterogeneity as noted by the I<sup>2</sup> statistic (IÂ² = 88%). </p> </div> </div> <p>GRADE considers the assessment of five domains: risk of bias, inconsistency of the effect, imprecision of effect estimates, indirectness of the evidence, and risk of publication bias. We used Trial Sequential Analysis to calculate the optimal information size when assessing imprecision (<a href="./references#CD013197-bbs2-0143" title="GartlehnerG , Nussbaumer-StreitB , WagnerG , PatelS , Swinson-EvansT , DobrescuA , et al. Increased risks for random errors are common in outcomes graded as high certainty of evidence. Journal of Clinical Epidemiology2019;106:50-9.">Gartlehner 2019</a>; <a href="./references#CD013197-bbs2-0154" title="JakobsenJC , WetterslevJ , WinkelP , LangeT , GluudC . Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BioMed Central Medical Research Methodology2014;14(1):120. [DOI: 10.1186/1471-2288-14-120]">Jakobsen 2014</a>). Two review authors (LMCJ and VB) individually assessed the certainty of evidence. If a review author was also a contributor to a study that was of interest to this review, that review author was not involved in the assessment of the certainty of the evidence process for their study. </p> <p>Regarding risk of bias, we used the overall judgement for an outcome. 'Low' risk of bias indicates 'no limitation (the certainty was downgraded)'; and 'high' risk of bias (including 'unclear' risk of bias) indicates either 'serious limitation' or 'very serious limitation (the certainty was downgraded two levels)'. </p> <p>The levels of evidence are defined as 'high', 'moderate', 'low', or 'very low'. These grades are defined as follows. </p> <p> <ul id="CD013197-list-0020"> <li> <p>High certainty: we are very confident that the true effect lies close to that of the estimate of the effect. </p> </li> <li> <p>Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> </li> <li> <p>Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. </p> </li> <li> <p>Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </li> </ul> </p> <p>We justified all decisions to downgrade the certainty of evidence of the included studies using the footnotes, and where necessary, provided comments to aid the reader's understanding of the review. We considered whether there was additional outcome information that was not incorporated into the metaâanalyses, noted these in the comments, and stated when it supported or contradicted the information from the metaâanalyses. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013197-sec-0048" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013197-sec-0048"></div> <section id="CD013197-sec-0049"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD013197-sec-0151" title="">Characteristics of included studies</a>; <a href="./references#CD013197-sec-0152" title="">Characteristics of excluded studies</a>; and <a href="./references#CD013197-sec-0153" title="">Characteristics of ongoing studies</a> tables. </p> <section id="CD013197-sec-0050"> <h4 class="title">Results of the search</h4> <p>The electronic search identified 2904 records and we identified three records through handsearching of reference lists. We excluded 609 duplicate records. We screened the title and abstracts of the remaining 2298 records, of which we excluded 2176. We evaluated the remaining 122 records in the fullâtext assessment. Of these, we excluded 57 records with reasons, and 21 records were ongoing trials. In total, 42 trials (44 records) met our inclusion criteria and were included. A PRISMA flow chart of our search is presented in <a href="#CD013197-fig-0001">Figure 1</a> (<a href="./references#CD013197-bbs2-0168" title="PageMJ , McKenzieJE , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.)2021;372:n71.">Page 2021a</a>; <a href="./references#CD013197-bbs2-0169" title="PageMJ , MoherD , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ (Clinical Research Ed.)2021;372:n160.">Page 2021b</a>). </p> </section> <section id="CD013197-sec-0051"> <h4 class="title">Included studies</h4> <p>All were randomised clinical trials. Thirtyâfive were singleâcentre trials, conducted in 13 countries; Australia (<a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>), Belgium (<a href="./references#CD013197-bbs2-0003" title="BaeteS , VercruysseG , Vander LaenenM , De VooghtP , Van MelkebeekJ , DylstD , et al. The effect of deep versus moderate neuromuscular block on surgical conditions and postoperative respiratory function in bariatric laparoscopic surgery: a randomized, double blind clinical trial. Anesthesia &amp; Analgesia2017;124(5):1469-75. ">Baete 2017</a>; <a href="./references#CD013197-bbs2-0035" title="DuboisPE , PutzL , JamartJ , MarottaML , GourdinM , DonnezO . Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. European Journal of Anaesthesiology2014;31(8):430-6. PutzL , DransartC , JamartJ , Marotta M-L, DelnoozG , DuboisPE . Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial. Journal of Clinical Anesthesia2016;35:107-13. ">Putz 2016</a>), China (<a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0016" title="HuangH , ZhouL , YuY , LiuS , XuH , XuZ , et al. Comparison of deep and moderate neuromuscular blockade on intestinal mucosal barrier in laparoscopic gastrectomy: a prospective, randomized, double-blind clinical trial. Frontiers in Medicine2021;8:789597. ">Huang 2021</a>; <a href="./references#CD013197-bbs2-0042" title="ZhuSJ , ZhangXL , XieQ , ZhouYF , WangKR . Comparison of the effects of deep and moderate neuromuscular block on respiratory system compliance and surgical space conditions during robot-assisted laparoscopic radical prostatectomy: a randomized clinical study. Journal of Zhejiang University. Science B2020;21(8):637-45. ">Zhu 2020</a>), Denmark (<a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a>; <a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a>), Egypt (<a href="./references#CD013197-bbs2-0001" title="Abu YazedMM , AhmedSA . Deep versus moderate neuromuscular block in laparoscopic bariatric surgeries: effect on surgical conditions and pulmonary complications. Egyptian Journal of Anaesthesia2019;35(1):5-58. ">Abu Yazed 2019</a>; <a href="./references#CD013197-bbs2-0004" title="BakhetWZ . A randomized trial comparing deep and moderate neuromuscular blockade in patients undergoing ambulatory gynecologic laparoscopy. Ain-Shams Journal of Anesthesiology2020;12(1):25. ">Bakhet 2020</a>), France (<a href="./references#CD013197-bbs2-0013" title="Fuchs-BuderT , SchmartzD , BaumannC , HiltL , Nomine-CriquiC , MeistelmanC , et al. Deep neuromuscular blockade improves surgical conditions during gastric bypass surgery for morbid obesity: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):486-93. ">FuchsâBuder 2019</a>), Germany (<a href="./references#CD013197-bbs2-0006" title="BlobnerM , FrickC , StaubleR , FeussnerH , SchallerS , UnterbuchnerC , et al. Neuromuscular blockade improves surgical conditions (NISCO). Surgical Endoscopy2014;29(3):627-36. ">Blobner 2014</a>), Greece (<a href="./references#CD013197-bbs2-0017" title="KathopoulisN , ProtopapasA , StamatakisE , ChatzipapasI , ZacharakisD , GrigoriadisT , et al. Deep versus moderate neuromuscular blockade in gynecologic laparoscopic operations: randomized controlled trial. Journal of Personalized Medicine2022;12(4):561. ">Kathopoulis 2022</a>), Italy (<a href="./references#CD013197-bbs2-0011" title="CovielloA , IannielloM , BuonannoP , Di FalcoN , IacovazzoC , MarescaA , et al. Effects of depth of neuromuscular block on surgical operating conditions in women undergoing gynecologic laparoscopic surgery: a randomized clinical trial. Journal of Anesthesia, Analgesia and Critical Care2023;3(1):2. [DOI: 10.1186/s44158-023-00086-7]">Coviello 2023</a>), Korea (<a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0010" title="Choi B-M, Ki S-H, Lee Y-H, Gong C-S, Kim H-S, Lee I-S, et al. Effects of depth of neuromuscular block on postoperative pain during laparoscopic gastrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(11):863-70. ">Choi 2019</a>; <a href="./references#CD013197-bbs2-0018" title="KimMH , LeeKY , LeeKY , MinBS , YooYC . Maintaining optimal surgical conditions with low insufflation pressures is possible with deep neuromuscular blockade during laparoscopic colorectal surgery: a prospective, randomized, double-blind, parallel-group clinical trial. Medicine2016;95(9):e2920. ">Kim 2016</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0020" title="KimJE , MinSK , HaE , LeeD , KimJY , KwakHJ . Effects of deep neuromuscular block with low-pressure pneumoperitoneum on respiratory mechanics and biotrauma in a steep Trendelenburg position. Scientific Reports2021;11(1):1935. ">Kim 2021a</a>; <a href="./references#CD013197-bbs2-0021" title="KimMH , KimNY , YooYC , KongHJ , LeeHS , JoA , et al. Influence of deep neuromuscular blockade on perioperative stress response in patients undergoing robot-assisted gastrectomy: a prospective double-blinded randomized-controlled trial. Journal of Personalized Medicine2021;11(12):1308. ">Kim 2021b</a>; <a href="./references#CD013197-bbs2-0022" title="KooBW , OhAY , SeoKS , HanJW , HanHS , YoonYS . Randomized clinical trial of moderate versus deep neuromuscular block for low-pressure pneumoperitoneum during laparoscopic cholecystectomy. World Journal of Surgery2016;40(12):2898-903. ">Koo 2016</a>; <a href="./references#CD013197-bbs2-0023" title="KooBW , OhAY , NaHS , LeeHJ , KangSB , KimDW , et al. Effects of depth of neuromuscular block on surgical conditions during laparoscopic colorectal surgery: a randomised controlled trial. Anaesthesia2018;73(9):1090-6. ">Koo 2018</a>; <a href="./references#CD013197-bbs2-0024" title="KooBW , OhAY , RyuJH , LeeYJ , HanJW , NamSW , et al. Effects of deep neuromuscular blockade on the stress response during laparoscopic gastrectomy randomized controlled trials. Scientific Reports2019;9(1):12411. ">Koo 2019</a>; <a href="./references#CD013197-bbs2-0025" title="Koo C-H, ParkI , AhnS , LeeS , Ryu J-H. Effect of neuromuscular blockade on intraoperative respiratory mechanics and surgical space conditions during robot-assisted radical prostatectomy: a prospective randomized controlled trial. Journal of Clinical Medicine2021;10(21):5090. ">Koo 2021</a>; <a href="./references#CD013197-bbs2-0026" title="LeeJ , AnJ , LeeDH , KimE , WooK , KimKH . Cortisol secretory patterns in deep and moderate neuromuscular blockades in laparoscopic surgery under total intravenous anesthesia: a prospective, single-blinded, randomized controlled trial. Medicine2022;101(39):e30702. ">Lee 2022</a>; <a href="./references#CD013197-bbs2-0031" title="Na H-S, Lim D-J, Koo B-W, Oh A-Y, Lee P-B. The influence of moderate or deep neuromuscular block status on anesthetic depth monitoring system during total intravenous anesthesia using propofol and remifentanil: a randomized trial. Science Progress2021;104(2):368504211010629. ">Na 2021</a>; <a href="./references#CD013197-bbs2-0032" title="NamSW , OhAY , KooBW , KimBY , HanJ , ChungSH . Effects of depth of neuromuscular blockade on the BIS-guided propofol requirement: a randomized controlled trial. Medicine2021;100(29):e26576. ">Nam 2021</a>; <a href="./references#CD013197-bbs2-0040" title="YiIK , KimJS , HurH , HanDG , KimJE . Effects of deep neuromuscular block on surgical pleth index-guided remifentanil administration in laparoscopic herniorrhaphy: a prospective randomized trial. Scientific Reports2022;12(1):19176. ">Yi 2022</a>; <a href="./references#CD013197-bbs2-0041" title="YooYC , KimNY , ShinS , ChoiYD , HongJH , KimCY , et al. The intraocular pressure under deep versus moderate neuromuscular blockade during low-pressure robot assisted laparoscopic radical prostatectomy in a randomized trial. PLOS One2015;10(8):e0135412. ">Yoo 2015</a>), the Netherlands (<a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0030" title="MartiniCH , BoonM , BeversRF , AartsLP , DahanA , ThompsonJP . Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. British Journal of Anaesthesia2014;112(3):498-505. ">Martini 2014</a>; <a href="./references#CD013197-bbs2-0038" title="TorensmaB , MartiniCH , BoonM , OlofsenE , VeldBI , LiemRS , et al. Deep neuromuscular block improves surgical conditions during bariatric surgery and reduces postoperative pain: a randomized double blind controlled trial. PLOS One2016;11(12):e0167907. ">Torensma 2016</a>), Spain (<a href="./references#CD013197-bbs2-0005" title="BarrioJ , ErrandoCL , Garcia-RamonJ , SellesR , San MiguelG , GallegoJ . Influence of depth of neuromuscular blockade on surgical conditions during low-pressure pneumoperitoneum laparoscopic cholecystectomy: a randomized blinded study. Journal of Clinical Anesthesia2017;42:26-30. ">Barrio 2017</a>), and the USA (<a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>). Seven were multicentre trials conducted in nine countries (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0034" title="ParkSH , HuhH , ChoiSI , KimJH , JangYJ , ParkJM , et al. Impact of the deep neuromuscular block on oncologic quality of laparoscopic surgery in obese gastric cancer patients: a randomized clinical trial. Journal of the American College of Surgeons2022;234(3):326-39. ">Park 2022</a>; <a href="./references#CD013197-bbs2-0036" title="RosenbergJ , HerringWJ , BlobnerM , MulierJP , Rahe-MeyerN , WooT , et al. Deep neuromuscular blockade improves laparoscopic surgical conditions: a randomized, controlled study. Advances in Therapy2017;34(4):925-36. ">Rosenberg 2017</a>). <a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a> and <a href="./references#CD013197-bbs2-0035" title="DuboisPE , PutzL , JamartJ , MarottaML , GourdinM , DonnezO . Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. European Journal of Anaesthesiology2014;31(8):430-6. PutzL , DransartC , JamartJ , Marotta M-L, DelnoozG , DuboisPE . Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial. Journal of Clinical Anesthesia2016;35:107-13. ">Putz 2016</a> both included two different manuscripts for the same trial and we combined data from both manuscripts. </p> <section id="CD013197-sec-0052"> <h5 class="title">Participants and settings</h5> <p>Twenty trials studied the effect of deep NMB in gastrointestinal surgery (<a href="./references#CD013197-bbs2-0001" title="Abu YazedMM , AhmedSA . Deep versus moderate neuromuscular block in laparoscopic bariatric surgeries: effect on surgical conditions and pulmonary complications. Egyptian Journal of Anaesthesia2019;35(1):5-58. ">Abu Yazed 2019</a>; <a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0003" title="BaeteS , VercruysseG , Vander LaenenM , De VooghtP , Van MelkebeekJ , DylstD , et al. The effect of deep versus moderate neuromuscular block on surgical conditions and postoperative respiratory function in bariatric laparoscopic surgery: a randomized, double blind clinical trial. Anesthesia &amp; Analgesia2017;124(5):1469-75. ">Baete 2017</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0010" title="Choi B-M, Ki S-H, Lee Y-H, Gong C-S, Kim H-S, Lee I-S, et al. Effects of depth of neuromuscular block on postoperative pain during laparoscopic gastrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(11):863-70. ">Choi 2019</a>; <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a>; <a href="./references#CD013197-bbs2-0013" title="Fuchs-BuderT , SchmartzD , BaumannC , HiltL , Nomine-CriquiC , MeistelmanC , et al. Deep neuromuscular blockade improves surgical conditions during gastric bypass surgery for morbid obesity: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):486-93. ">FuchsâBuder 2019</a>; <a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0016" title="HuangH , ZhouL , YuY , LiuS , XuH , XuZ , et al. Comparison of deep and moderate neuromuscular blockade on intestinal mucosal barrier in laparoscopic gastrectomy: a prospective, randomized, double-blind clinical trial. Frontiers in Medicine2021;8:789597. ">Huang 2021</a>; <a href="./references#CD013197-bbs2-0018" title="KimMH , LeeKY , LeeKY , MinBS , YooYC . Maintaining optimal surgical conditions with low insufflation pressures is possible with deep neuromuscular blockade during laparoscopic colorectal surgery: a prospective, randomized, double-blind, parallel-group clinical trial. Medicine2016;95(9):e2920. ">Kim 2016</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0021" title="KimMH , KimNY , YooYC , KongHJ , LeeHS , JoA , et al. Influence of deep neuromuscular blockade on perioperative stress response in patients undergoing robot-assisted gastrectomy: a prospective double-blinded randomized-controlled trial. Journal of Personalized Medicine2021;11(12):1308. ">Kim 2021b</a>; <a href="./references#CD013197-bbs2-0023" title="KooBW , OhAY , NaHS , LeeHJ , KangSB , KimDW , et al. Effects of depth of neuromuscular block on surgical conditions during laparoscopic colorectal surgery: a randomised controlled trial. Anaesthesia2018;73(9):1090-6. ">Koo 2018</a>; <a href="./references#CD013197-bbs2-0024" title="KooBW , OhAY , RyuJH , LeeYJ , HanJW , NamSW , et al. Effects of deep neuromuscular blockade on the stress response during laparoscopic gastrectomy randomized controlled trials. Scientific Reports2019;9(1):12411. ">Koo 2019</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0032" title="NamSW , OhAY , KooBW , KimBY , HanJ , ChungSH . Effects of depth of neuromuscular blockade on the BIS-guided propofol requirement: a randomized controlled trial. Medicine2021;100(29):e26576. ">Nam 2021</a>; <a href="./references#CD013197-bbs2-0034" title="ParkSH , HuhH , ChoiSI , KimJH , JangYJ , ParkJM , et al. Impact of the deep neuromuscular block on oncologic quality of laparoscopic surgery in obese gastric cancer patients: a randomized clinical trial. Journal of the American College of Surgeons2022;234(3):326-39. ">Park 2022</a>; <a href="./references#CD013197-bbs2-0038" title="TorensmaB , MartiniCH , BoonM , OlofsenE , VeldBI , LiemRS , et al. Deep neuromuscular block improves surgical conditions during bariatric surgery and reduces postoperative pain: a randomized double blind controlled trial. PLOS One2016;11(12):e0167907. ">Torensma 2016</a>; <a href="./references#CD013197-bbs2-0040" title="YiIK , KimJS , HurH , HanDG , KimJE . Effects of deep neuromuscular block on surgical pleth index-guided remifentanil administration in laparoscopic herniorrhaphy: a prospective randomized trial. Scientific Reports2022;12(1):19176. ">Yi 2022</a>), six trials in hepatobiliary surgery (<a href="./references#CD013197-bbs2-0005" title="BarrioJ , ErrandoCL , Garcia-RamonJ , SellesR , San MiguelG , GallegoJ . Influence of depth of neuromuscular blockade on surgical conditions during low-pressure pneumoperitoneum laparoscopic cholecystectomy: a randomized blinded study. Journal of Clinical Anesthesia2017;42:26-30. ">Barrio 2017</a>; <a href="./references#CD013197-bbs2-0006" title="BlobnerM , FrickC , StaubleR , FeussnerH , SchallerS , UnterbuchnerC , et al. Neuromuscular blockade improves surgical conditions (NISCO). Surgical Endoscopy2014;29(3):627-36. ">Blobner 2014</a>; <a href="./references#CD013197-bbs2-0022" title="KooBW , OhAY , SeoKS , HanJW , HanHS , YoonYS . Randomized clinical trial of moderate versus deep neuromuscular block for low-pressure pneumoperitoneum during laparoscopic cholecystectomy. World Journal of Surgery2016;40(12):2898-903. ">Koo 2016</a>; <a href="./references#CD013197-bbs2-0031" title="Na H-S, Lim D-J, Koo B-W, Oh A-Y, Lee P-B. The influence of moderate or deep neuromuscular block status on anesthetic depth monitoring system during total intravenous anesthesia using propofol and remifentanil: a randomized trial. Science Progress2021;104(2):368504211010629. ">Na 2021</a>; <a href="./references#CD013197-bbs2-0036" title="RosenbergJ , HerringWJ , BlobnerM , MulierJP , Rahe-MeyerN , WooT , et al. Deep neuromuscular blockade improves laparoscopic surgical conditions: a randomized, controlled study. Advances in Therapy2017;34(4):925-36. ">Rosenberg 2017</a>; <a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a>), seven trials in gynaecological surgery (<a href="./references#CD013197-bbs2-0004" title="BakhetWZ . A randomized trial comparing deep and moderate neuromuscular blockade in patients undergoing ambulatory gynecologic laparoscopy. Ain-Shams Journal of Anesthesiology2020;12(1):25. ">Bakhet 2020</a>; <a href="./references#CD013197-bbs2-0011" title="CovielloA , IannielloM , BuonannoP , Di FalcoN , IacovazzoC , MarescaA , et al. Effects of depth of neuromuscular block on surgical operating conditions in women undergoing gynecologic laparoscopic surgery: a randomized clinical trial. Journal of Anesthesia, Analgesia and Critical Care2023;3(1):2. [DOI: 10.1186/s44158-023-00086-7]">Coviello 2023</a>; <a href="./references#CD013197-bbs2-0017" title="KathopoulisN , ProtopapasA , StamatakisE , ChatzipapasI , ZacharakisD , GrigoriadisT , et al. Deep versus moderate neuromuscular blockade in gynecologic laparoscopic operations: randomized controlled trial. Journal of Personalized Medicine2022;12(4):561. ">Kathopoulis 2022</a>; <a href="./references#CD013197-bbs2-0020" title="KimJE , MinSK , HaE , LeeD , KimJY , KwakHJ . Effects of deep neuromuscular block with low-pressure pneumoperitoneum on respiratory mechanics and biotrauma in a steep Trendelenburg position. Scientific Reports2021;11(1):1935. ">Kim 2021a</a>; <a href="./references#CD013197-bbs2-0026" title="LeeJ , AnJ , LeeDH , KimE , WooK , KimKH . Cortisol secretory patterns in deep and moderate neuromuscular blockades in laparoscopic surgery under total intravenous anesthesia: a prospective, single-blinded, randomized controlled trial. Medicine2022;101(39):e30702. ">Lee 2022</a>; <a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a>; <a href="./references#CD013197-bbs2-0035" title="DuboisPE , PutzL , JamartJ , MarottaML , GourdinM , DonnezO . Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. European Journal of Anaesthesiology2014;31(8):430-6. PutzL , DransartC , JamartJ , Marotta M-L, DelnoozG , DuboisPE . Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial. Journal of Clinical Anesthesia2016;35:107-13. ">Putz 2016</a>), eight trials in urological surgery (<a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0025" title="Koo C-H, ParkI , AhnS , LeeS , Ryu J-H. Effect of neuromuscular blockade on intraoperative respiratory mechanics and surgical space conditions during robot-assisted radical prostatectomy: a prospective randomized controlled trial. Journal of Clinical Medicine2021;10(21):5090. ">Koo 2021</a>; <a href="./references#CD013197-bbs2-0030" title="MartiniCH , BoonM , BeversRF , AartsLP , DahanA , ThompsonJP . Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. British Journal of Anaesthesia2014;112(3):498-505. ">Martini 2014</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>; <a href="./references#CD013197-bbs2-0041" title="YooYC , KimNY , ShinS , ChoiYD , HongJH , KimCY , et al. The intraocular pressure under deep versus moderate neuromuscular blockade during low-pressure robot assisted laparoscopic radical prostatectomy in a randomized trial. PLOS One2015;10(8):e0135412. ">Yoo 2015</a>; <a href="./references#CD013197-bbs2-0042" title="ZhuSJ , ZhangXL , XieQ , ZhouYF , WangKR . Comparison of the effects of deep and moderate neuromuscular block on respiratory system compliance and surgical space conditions during robot-assisted laparoscopic radical prostatectomy: a randomized clinical study. Journal of Zhejiang University. Science B2020;21(8):637-45. ">Zhu 2020</a>), and one trial included people undergoing abdominal, urological, and gynaecological surgery (<a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>). Ten trials performed laparoscopic surgery at lowâpressure pneumoperitoneum (below 12 mmHg) (<a href="./references#CD013197-bbs2-0005" title="BarrioJ , ErrandoCL , Garcia-RamonJ , SellesR , San MiguelG , GallegoJ . Influence of depth of neuromuscular blockade on surgical conditions during low-pressure pneumoperitoneum laparoscopic cholecystectomy: a randomized blinded study. Journal of Clinical Anesthesia2017;42:26-30. ">Barrio 2017</a>; <a href="./references#CD013197-bbs2-0011" title="CovielloA , IannielloM , BuonannoP , Di FalcoN , IacovazzoC , MarescaA , et al. Effects of depth of neuromuscular block on surgical operating conditions in women undergoing gynecologic laparoscopic surgery: a randomized clinical trial. Journal of Anesthesia, Analgesia and Critical Care2023;3(1):2. [DOI: 10.1186/s44158-023-00086-7]">Coviello 2023</a>; <a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0022" title="KooBW , OhAY , SeoKS , HanJW , HanHS , YoonYS . Randomized clinical trial of moderate versus deep neuromuscular block for low-pressure pneumoperitoneum during laparoscopic cholecystectomy. World Journal of Surgery2016;40(12):2898-903. ">Koo 2016</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0036" title="RosenbergJ , HerringWJ , BlobnerM , MulierJP , Rahe-MeyerN , WooT , et al. Deep neuromuscular blockade improves laparoscopic surgical conditions: a randomized, controlled study. Advances in Therapy2017;34(4):925-36. ">Rosenberg 2017</a>; <a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a>; <a href="./references#CD013197-bbs2-0041" title="YooYC , KimNY , ShinS , ChoiYD , HongJH , KimCY , et al. The intraocular pressure under deep versus moderate neuromuscular blockade during low-pressure robot assisted laparoscopic radical prostatectomy in a randomized trial. PLOS One2015;10(8):e0135412. ">Yoo 2015</a>; <a href="./references#CD013197-bbs2-0042" title="ZhuSJ , ZhangXL , XieQ , ZhouYF , WangKR . Comparison of the effects of deep and moderate neuromuscular block on respiratory system compliance and surgical space conditions during robot-assisted laparoscopic radical prostatectomy: a randomized clinical study. Journal of Zhejiang University. Science B2020;21(8):637-45. ">Zhu 2020</a>). Five trials applied lowâpressure pneumoperitoneum only in the deep NMB group and standardâpressure pneumoperitoneum in the control group (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0018" title="KimMH , LeeKY , LeeKY , MinBS , YooYC . Maintaining optimal surgical conditions with low insufflation pressures is possible with deep neuromuscular blockade during laparoscopic colorectal surgery: a prospective, randomized, double-blind, parallel-group clinical trial. Medicine2016;95(9):e2920. ">Kim 2016</a>; <a href="./references#CD013197-bbs2-0020" title="KimJE , MinSK , HaE , LeeD , KimJY , KwakHJ . Effects of deep neuromuscular block with low-pressure pneumoperitoneum on respiratory mechanics and biotrauma in a steep Trendelenburg position. Scientific Reports2021;11(1):1935. ">Kim 2021a</a>; <a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a>). </p> <p>Twentyâone trials maintained anaesthesia with propofol (<a href="./references#CD013197-bbs2-0001" title="Abu YazedMM , AhmedSA . Deep versus moderate neuromuscular block in laparoscopic bariatric surgeries: effect on surgical conditions and pulmonary complications. Egyptian Journal of Anaesthesia2019;35(1):5-58. ">Abu Yazed 2019</a>; <a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0003" title="BaeteS , VercruysseG , Vander LaenenM , De VooghtP , Van MelkebeekJ , DylstD , et al. The effect of deep versus moderate neuromuscular block on surgical conditions and postoperative respiratory function in bariatric laparoscopic surgery: a randomized, double blind clinical trial. Anesthesia &amp; Analgesia2017;124(5):1469-75. ">Baete 2017</a>; <a href="./references#CD013197-bbs2-0005" title="BarrioJ , ErrandoCL , Garcia-RamonJ , SellesR , San MiguelG , GallegoJ . Influence of depth of neuromuscular blockade on surgical conditions during low-pressure pneumoperitoneum laparoscopic cholecystectomy: a randomized blinded study. Journal of Clinical Anesthesia2017;42:26-30. ">Barrio 2017</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0010" title="Choi B-M, Ki S-H, Lee Y-H, Gong C-S, Kim H-S, Lee I-S, et al. Effects of depth of neuromuscular block on postoperative pain during laparoscopic gastrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(11):863-70. ">Choi 2019</a>; <a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0017" title="KathopoulisN , ProtopapasA , StamatakisE , ChatzipapasI , ZacharakisD , GrigoriadisT , et al. Deep versus moderate neuromuscular blockade in gynecologic laparoscopic operations: randomized controlled trial. Journal of Personalized Medicine2022;12(4):561. ">Kathopoulis 2022</a>; <a href="./references#CD013197-bbs2-0020" title="KimJE , MinSK , HaE , LeeD , KimJY , KwakHJ . Effects of deep neuromuscular block with low-pressure pneumoperitoneum on respiratory mechanics and biotrauma in a steep Trendelenburg position. Scientific Reports2021;11(1):1935. ">Kim 2021a</a>; <a href="./references#CD013197-bbs2-0022" title="KooBW , OhAY , SeoKS , HanJW , HanHS , YoonYS . Randomized clinical trial of moderate versus deep neuromuscular block for low-pressure pneumoperitoneum during laparoscopic cholecystectomy. World Journal of Surgery2016;40(12):2898-903. ">Koo 2016</a>; <a href="./references#CD013197-bbs2-0024" title="KooBW , OhAY , RyuJH , LeeYJ , HanJW , NamSW , et al. Effects of deep neuromuscular blockade on the stress response during laparoscopic gastrectomy randomized controlled trials. Scientific Reports2019;9(1):12411. ">Koo 2019</a>; <a href="./references#CD013197-bbs2-0026" title="LeeJ , AnJ , LeeDH , KimE , WooK , KimKH . Cortisol secretory patterns in deep and moderate neuromuscular blockades in laparoscopic surgery under total intravenous anesthesia: a prospective, single-blinded, randomized controlled trial. Medicine2022;101(39):e30702. ">Lee 2022</a>; <a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a>; <a href="./references#CD013197-bbs2-0030" title="MartiniCH , BoonM , BeversRF , AartsLP , DahanA , ThompsonJP . Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. British Journal of Anaesthesia2014;112(3):498-505. ">Martini 2014</a>; <a href="./references#CD013197-bbs2-0031" title="Na H-S, Lim D-J, Koo B-W, Oh A-Y, Lee P-B. The influence of moderate or deep neuromuscular block status on anesthetic depth monitoring system during total intravenous anesthesia using propofol and remifentanil: a randomized trial. Science Progress2021;104(2):368504211010629. ">Na 2021</a>; <a href="./references#CD013197-bbs2-0032" title="NamSW , OhAY , KooBW , KimBY , HanJ , ChungSH . Effects of depth of neuromuscular blockade on the BIS-guided propofol requirement: a randomized controlled trial. Medicine2021;100(29):e26576. ">Nam 2021</a>; <a href="./references#CD013197-bbs2-0036" title="RosenbergJ , HerringWJ , BlobnerM , MulierJP , Rahe-MeyerN , WooT , et al. Deep neuromuscular blockade improves laparoscopic surgical conditions: a randomized, controlled study. Advances in Therapy2017;34(4):925-36. ">Rosenberg 2017</a>; <a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a>; <a href="./references#CD013197-bbs2-0038" title="TorensmaB , MartiniCH , BoonM , OlofsenE , VeldBI , LiemRS , et al. Deep neuromuscular block improves surgical conditions during bariatric surgery and reduces postoperative pain: a randomized double blind controlled trial. PLOS One2016;11(12):e0167907. ">Torensma 2016</a>; <a href="./references#CD013197-bbs2-0042" title="ZhuSJ , ZhangXL , XieQ , ZhouYF , WangKR . Comparison of the effects of deep and moderate neuromuscular block on respiratory system compliance and surgical space conditions during robot-assisted laparoscopic radical prostatectomy: a randomized clinical study. Journal of Zhejiang University. Science B2020;21(8):637-45. ">Zhu 2020</a>), and 18 trials with volatile agents (<a href="./references#CD013197-bbs2-0004" title="BakhetWZ . A randomized trial comparing deep and moderate neuromuscular blockade in patients undergoing ambulatory gynecologic laparoscopy. Ain-Shams Journal of Anesthesiology2020;12(1):25. ">Bakhet 2020</a>; <a href="./references#CD013197-bbs2-0006" title="BlobnerM , FrickC , StaubleR , FeussnerH , SchallerS , UnterbuchnerC , et al. Neuromuscular blockade improves surgical conditions (NISCO). Surgical Endoscopy2014;29(3):627-36. ">Blobner 2014</a>; <a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0011" title="CovielloA , IannielloM , BuonannoP , Di FalcoN , IacovazzoC , MarescaA , et al. Effects of depth of neuromuscular block on surgical operating conditions in women undergoing gynecologic laparoscopic surgery: a randomized clinical trial. Journal of Anesthesia, Analgesia and Critical Care2023;3(1):2. [DOI: 10.1186/s44158-023-00086-7]">Coviello 2023</a>; <a href="./references#CD013197-bbs2-0013" title="Fuchs-BuderT , SchmartzD , BaumannC , HiltL , Nomine-CriquiC , MeistelmanC , et al. Deep neuromuscular blockade improves surgical conditions during gastric bypass surgery for morbid obesity: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):486-93. ">FuchsâBuder 2019</a>; <a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0018" title="KimMH , LeeKY , LeeKY , MinBS , YooYC . Maintaining optimal surgical conditions with low insufflation pressures is possible with deep neuromuscular blockade during laparoscopic colorectal surgery: a prospective, randomized, double-blind, parallel-group clinical trial. Medicine2016;95(9):e2920. ">Kim 2016</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0021" title="KimMH , KimNY , YooYC , KongHJ , LeeHS , JoA , et al. Influence of deep neuromuscular blockade on perioperative stress response in patients undergoing robot-assisted gastrectomy: a prospective double-blinded randomized-controlled trial. Journal of Personalized Medicine2021;11(12):1308. ">Kim 2021b</a>; <a href="./references#CD013197-bbs2-0023" title="KooBW , OhAY , NaHS , LeeHJ , KangSB , KimDW , et al. Effects of depth of neuromuscular block on surgical conditions during laparoscopic colorectal surgery: a randomised controlled trial. Anaesthesia2018;73(9):1090-6. ">Koo 2018</a>; <a href="./references#CD013197-bbs2-0025" title="Koo C-H, ParkI , AhnS , LeeS , Ryu J-H. Effect of neuromuscular blockade on intraoperative respiratory mechanics and surgical space conditions during robot-assisted radical prostatectomy: a prospective randomized controlled trial. Journal of Clinical Medicine2021;10(21):5090. ">Koo 2021</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0035" title="DuboisPE , PutzL , JamartJ , MarottaML , GourdinM , DonnezO . Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. European Journal of Anaesthesiology2014;31(8):430-6. PutzL , DransartC , JamartJ , Marotta M-L, DelnoozG , DuboisPE . Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial. Journal of Clinical Anesthesia2016;35:107-13. ">Putz 2016</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>; <a href="./references#CD013197-bbs2-0040" title="YiIK , KimJS , HurH , HanDG , KimJE . Effects of deep neuromuscular block on surgical pleth index-guided remifentanil administration in laparoscopic herniorrhaphy: a prospective randomized trial. Scientific Reports2022;12(1):19176. ">Yi 2022</a>; <a href="./references#CD013197-bbs2-0041" title="YooYC , KimNY , ShinS , ChoiYD , HongJH , KimCY , et al. The intraocular pressure under deep versus moderate neuromuscular blockade during low-pressure robot assisted laparoscopic radical prostatectomy in a randomized trial. PLOS One2015;10(8):e0135412. ">Yoo 2015</a>). <a href="./references#CD013197-bbs2-0016" title="HuangH , ZhouL , YuY , LiuS , XuH , XuZ , et al. Comparison of deep and moderate neuromuscular blockade on intestinal mucosal barrier in laparoscopic gastrectomy: a prospective, randomized, double-blind clinical trial. Frontiers in Medicine2021;8:789597. ">Huang 2021</a> maintained anaesthesia with combined propofol and sevoflurane. <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a> and <a href="./references#CD013197-bbs2-0034" title="ParkSH , HuhH , ChoiSI , KimJH , JangYJ , ParkJM , et al. Impact of the deep neuromuscular block on oncologic quality of laparoscopic surgery in obese gastric cancer patients: a randomized clinical trial. Journal of the American College of Surgeons2022;234(3):326-39. ">Park 2022</a> did not provide the anaesthetic agents used. </p> <p>In 14 out of 41 trials reporting body mass index, the mean weight could be classified as overweight (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0004" title="BakhetWZ . A randomized trial comparing deep and moderate neuromuscular blockade in patients undergoing ambulatory gynecologic laparoscopy. Ain-Shams Journal of Anesthesiology2020;12(1):25. ">Bakhet 2020</a>; <a href="./references#CD013197-bbs2-0005" title="BarrioJ , ErrandoCL , Garcia-RamonJ , SellesR , San MiguelG , GallegoJ . Influence of depth of neuromuscular blockade on surgical conditions during low-pressure pneumoperitoneum laparoscopic cholecystectomy: a randomized blinded study. Journal of Clinical Anesthesia2017;42:26-30. ">Barrio 2017</a>; <a href="./references#CD013197-bbs2-0006" title="BlobnerM , FrickC , StaubleR , FeussnerH , SchallerS , UnterbuchnerC , et al. Neuromuscular blockade improves surgical conditions (NISCO). Surgical Endoscopy2014;29(3):627-36. ">Blobner 2014</a>; <a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a>; <a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a>; <a href="./references#CD013197-bbs2-0034" title="ParkSH , HuhH , ChoiSI , KimJH , JangYJ , ParkJM , et al. Impact of the deep neuromuscular block on oncologic quality of laparoscopic surgery in obese gastric cancer patients: a randomized clinical trial. Journal of the American College of Surgeons2022;234(3):326-39. ">Park 2022</a>; <a href="./references#CD013197-bbs2-0035" title="DuboisPE , PutzL , JamartJ , MarottaML , GourdinM , DonnezO . Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. European Journal of Anaesthesiology2014;31(8):430-6. PutzL , DransartC , JamartJ , Marotta M-L, DelnoozG , DuboisPE . Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial. Journal of Clinical Anesthesia2016;35:107-13. ">Putz 2016</a>; <a href="./references#CD013197-bbs2-0036" title="RosenbergJ , HerringWJ , BlobnerM , MulierJP , Rahe-MeyerN , WooT , et al. Deep neuromuscular blockade improves laparoscopic surgical conditions: a randomized, controlled study. Advances in Therapy2017;34(4):925-36. ">Rosenberg 2017</a>; <a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>), and in six trials as obese (<a href="./references#CD013197-bbs2-0001" title="Abu YazedMM , AhmedSA . Deep versus moderate neuromuscular block in laparoscopic bariatric surgeries: effect on surgical conditions and pulmonary complications. Egyptian Journal of Anaesthesia2019;35(1):5-58. ">Abu Yazed 2019</a>; <a href="./references#CD013197-bbs2-0003" title="BaeteS , VercruysseG , Vander LaenenM , De VooghtP , Van MelkebeekJ , DylstD , et al. The effect of deep versus moderate neuromuscular block on surgical conditions and postoperative respiratory function in bariatric laparoscopic surgery: a randomized, double blind clinical trial. Anesthesia &amp; Analgesia2017;124(5):1469-75. ">Baete 2017</a>; <a href="./references#CD013197-bbs2-0013" title="Fuchs-BuderT , SchmartzD , BaumannC , HiltL , Nomine-CriquiC , MeistelmanC , et al. Deep neuromuscular blockade improves surgical conditions during gastric bypass surgery for morbid obesity: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):486-93. ">FuchsâBuder 2019</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0038" title="TorensmaB , MartiniCH , BoonM , OlofsenE , VeldBI , LiemRS , et al. Deep neuromuscular block improves surgical conditions during bariatric surgery and reduces postoperative pain: a randomized double blind controlled trial. PLOS One2016;11(12):e0167907. ">Torensma 2016</a>). Participants in the remaining trials had a healthy body mass index. </p> </section> <section id="CD013197-sec-0053"> <h5 class="title">Intervention</h5> <p>One trial compared deep NMB to no NMB (<a href="./references#CD013197-bbs2-0006" title="BlobnerM , FrickC , StaubleR , FeussnerH , SchallerS , UnterbuchnerC , et al. Neuromuscular blockade improves surgical conditions (NISCO). Surgical Endoscopy2014;29(3):627-36. ">Blobner 2014</a>), three trials compared deep NMB to shallow NMB (<a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a>; <a href="./references#CD013197-bbs2-0035" title="DuboisPE , PutzL , JamartJ , MarottaML , GourdinM , DonnezO . Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. European Journal of Anaesthesiology2014;31(8):430-6. PutzL , DransartC , JamartJ , Marotta M-L, DelnoozG , DuboisPE . Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial. Journal of Clinical Anesthesia2016;35:107-13. ">Putz 2016</a>; <a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a>), and the remaining trials compared deep NMB to moderate NMB. Most trials defined deep NMB as PTC one to two or as PTC below five; however, three trials defined deep NMB as any PTC count with TOF of zero (<a href="./references#CD013197-bbs2-0001" title="Abu YazedMM , AhmedSA . Deep versus moderate neuromuscular block in laparoscopic bariatric surgeries: effect on surgical conditions and pulmonary complications. Egyptian Journal of Anaesthesia2019;35(1):5-58. ">Abu Yazed 2019</a>; <a href="./references#CD013197-bbs2-0026" title="LeeJ , AnJ , LeeDH , KimE , WooK , KimKH . Cortisol secretory patterns in deep and moderate neuromuscular blockades in laparoscopic surgery under total intravenous anesthesia: a prospective, single-blinded, randomized controlled trial. Medicine2022;101(39):e30702. ">Lee 2022</a>; <a href="./references#CD013197-bbs2-0035" title="DuboisPE , PutzL , JamartJ , MarottaML , GourdinM , DonnezO . Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. European Journal of Anaesthesiology2014;31(8):430-6. PutzL , DransartC , JamartJ , Marotta M-L, DelnoozG , DuboisPE . Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial. Journal of Clinical Anesthesia2016;35:107-13. ">Putz 2016</a>). Most trials obtained deep NMB by the administration of rocuronium. Only <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a> did not exactly report the agent used. All trials administered sugammadex at 2 mg/kg to 8 mg/kg to reverse deep NMB. </p> </section> <section id="CD013197-sec-0054"> <h5 class="title">Comparisons</h5> <p>Most trials defined moderate NMB as a TOF count of one to two. Five trials defined moderate NMB as TOF one to three (<a href="./references#CD013197-bbs2-0005" title="BarrioJ , ErrandoCL , Garcia-RamonJ , SellesR , San MiguelG , GallegoJ . Influence of depth of neuromuscular blockade on surgical conditions during low-pressure pneumoperitoneum laparoscopic cholecystectomy: a randomized blinded study. Journal of Clinical Anesthesia2017;42:26-30. ">Barrio 2017</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0011" title="CovielloA , IannielloM , BuonannoP , Di FalcoN , IacovazzoC , MarescaA , et al. Effects of depth of neuromuscular block on surgical operating conditions in women undergoing gynecologic laparoscopic surgery: a randomized clinical trial. Journal of Anesthesia, Analgesia and Critical Care2023;3(1):2. [DOI: 10.1186/s44158-023-00086-7]">Coviello 2023</a>; <a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0026" title="LeeJ , AnJ , LeeDH , KimE , WooK , KimKH . Cortisol secretory patterns in deep and moderate neuromuscular blockades in laparoscopic surgery under total intravenous anesthesia: a prospective, single-blinded, randomized controlled trial. Medicine2022;101(39):e30702. ">Lee 2022</a>). Three trials aimed for a TOF of one in the moderate group (<a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0017" title="KathopoulisN , ProtopapasA , StamatakisE , ChatzipapasI , ZacharakisD , GrigoriadisT , et al. Deep versus moderate neuromuscular blockade in gynecologic laparoscopic operations: randomized controlled trial. Journal of Personalized Medicine2022;12(4):561. ">Kathopoulis 2022</a>). <a href="./references#CD013197-bbs2-0013" title="Fuchs-BuderT , SchmartzD , BaumannC , HiltL , Nomine-CriquiC , MeistelmanC , et al. Deep neuromuscular blockade improves surgical conditions during gastric bypass surgery for morbid obesity: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):486-93. ">FuchsâBuder 2019</a> aimed for a TOF of one to four, <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a> and <a href="./references#CD013197-bbs2-0036" title="RosenbergJ , HerringWJ , BlobnerM , MulierJP , Rahe-MeyerN , WooT , et al. Deep neuromuscular blockade improves laparoscopic surgical conditions: a randomized, controlled study. Advances in Therapy2017;34(4):925-36. ">Rosenberg 2017</a> for a TOF of two to four. Shallow NMB was defined as induction dose NMBA with only rescue dose at request. <a href="./references#CD013197-bbs2-0006" title="BlobnerM , FrickC , StaubleR , FeussnerH , SchallerS , UnterbuchnerC , et al. Neuromuscular blockade improves surgical conditions (NISCO). Surgical Endoscopy2014;29(3):627-36. ">Blobner 2014</a> defined no NMB as no administration of NMBAs, only at request, which was done in 40% of the cases. Most control groups used rocuronium as NMBA, except in <a href="./references#CD013197-bbs2-0030" title="MartiniCH , BoonM , BeversRF , AartsLP , DahanA , ThompsonJP . Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. British Journal of Anaesthesia2014;112(3):498-505. ">Martini 2014</a>, which used atracurium/mivacurium, <a href="./references#CD013197-bbs2-0041" title="YooYC , KimNY , ShinS , ChoiYD , HongJH , KimCY , et al. The intraocular pressure under deep versus moderate neuromuscular blockade during low-pressure robot assisted laparoscopic radical prostatectomy in a randomized trial. PLOS One2015;10(8):e0135412. ">Yoo 2015</a> used atracurium, and <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a> used rocuronium or cisatracurium or atracurium. Most comparisons groups used sugammadex 2 mg/kg to 4 mg/kg to reverse residual NMB, but 18 trials used neostigmine 15 Î¼g/kg to 70 Î¼g/kg, sometimes combined with atropine or glycopyrrolate (<a href="./references#CD013197-bbs2-0001" title="Abu YazedMM , AhmedSA . Deep versus moderate neuromuscular block in laparoscopic bariatric surgeries: effect on surgical conditions and pulmonary complications. Egyptian Journal of Anaesthesia2019;35(1):5-58. ">Abu Yazed 2019</a>; <a href="./references#CD013197-bbs2-0003" title="BaeteS , VercruysseG , Vander LaenenM , De VooghtP , Van MelkebeekJ , DylstD , et al. The effect of deep versus moderate neuromuscular block on surgical conditions and postoperative respiratory function in bariatric laparoscopic surgery: a randomized, double blind clinical trial. Anesthesia &amp; Analgesia2017;124(5):1469-75. ">Baete 2017</a>; <a href="./references#CD013197-bbs2-0006" title="BlobnerM , FrickC , StaubleR , FeussnerH , SchallerS , UnterbuchnerC , et al. Neuromuscular blockade improves surgical conditions (NISCO). Surgical Endoscopy2014;29(3):627-36. ">Blobner 2014</a>; <a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a>; <a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0020" title="KimJE , MinSK , HaE , LeeD , KimJY , KwakHJ . Effects of deep neuromuscular block with low-pressure pneumoperitoneum on respiratory mechanics and biotrauma in a steep Trendelenburg position. Scientific Reports2021;11(1):1935. ">Kim 2021a</a>; <a href="./references#CD013197-bbs2-0022" title="KooBW , OhAY , SeoKS , HanJW , HanHS , YoonYS . Randomized clinical trial of moderate versus deep neuromuscular block for low-pressure pneumoperitoneum during laparoscopic cholecystectomy. World Journal of Surgery2016;40(12):2898-903. ">Koo 2016</a>; <a href="./references#CD013197-bbs2-0023" title="KooBW , OhAY , NaHS , LeeHJ , KangSB , KimDW , et al. Effects of depth of neuromuscular block on surgical conditions during laparoscopic colorectal surgery: a randomised controlled trial. Anaesthesia2018;73(9):1090-6. ">Koo 2018</a>; <a href="./references#CD013197-bbs2-0024" title="KooBW , OhAY , RyuJH , LeeYJ , HanJW , NamSW , et al. Effects of deep neuromuscular blockade on the stress response during laparoscopic gastrectomy randomized controlled trials. Scientific Reports2019;9(1):12411. ">Koo 2019</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0030" title="MartiniCH , BoonM , BeversRF , AartsLP , DahanA , ThompsonJP . Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. British Journal of Anaesthesia2014;112(3):498-505. ">Martini 2014</a>; <a href="./references#CD013197-bbs2-0031" title="Na H-S, Lim D-J, Koo B-W, Oh A-Y, Lee P-B. The influence of moderate or deep neuromuscular block status on anesthetic depth monitoring system during total intravenous anesthesia using propofol and remifentanil: a randomized trial. Science Progress2021;104(2):368504211010629. ">Na 2021</a>; <a href="./references#CD013197-bbs2-0035" title="DuboisPE , PutzL , JamartJ , MarottaML , GourdinM , DonnezO . Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. European Journal of Anaesthesiology2014;31(8):430-6. PutzL , DransartC , JamartJ , Marotta M-L, DelnoozG , DuboisPE . Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial. Journal of Clinical Anesthesia2016;35:107-13. ">Putz 2016</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>; <a href="./references#CD013197-bbs2-0040" title="YiIK , KimJS , HurH , HanDG , KimJE . Effects of deep neuromuscular block on surgical pleth index-guided remifentanil administration in laparoscopic herniorrhaphy: a prospective randomized trial. Scientific Reports2022;12(1):19176. ">Yi 2022</a>; <a href="./references#CD013197-bbs2-0041" title="YooYC , KimNY , ShinS , ChoiYD , HongJH , KimCY , et al. The intraocular pressure under deep versus moderate neuromuscular blockade during low-pressure robot assisted laparoscopic radical prostatectomy in a randomized trial. PLOS One2015;10(8):e0135412. ">Yoo 2015</a>; <a href="./references#CD013197-bbs2-0042" title="ZhuSJ , ZhangXL , XieQ , ZhouYF , WangKR . Comparison of the effects of deep and moderate neuromuscular block on respiratory system compliance and surgical space conditions during robot-assisted laparoscopic radical prostatectomy: a randomized clinical study. Journal of Zhejiang University. Science B2020;21(8):637-45. ">Zhu 2020</a>). </p> </section> <section id="CD013197-sec-0055"> <h5 class="title">Outcomes</h5> <p>Thirtyâone trials reported on at least one of the three primary outcomes (<a href="./references#CD013197-bbs2-0001" title="Abu YazedMM , AhmedSA . Deep versus moderate neuromuscular block in laparoscopic bariatric surgeries: effect on surgical conditions and pulmonary complications. Egyptian Journal of Anaesthesia2019;35(1):5-58. ">Abu Yazed 2019</a>; <a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0004" title="BakhetWZ . A randomized trial comparing deep and moderate neuromuscular blockade in patients undergoing ambulatory gynecologic laparoscopy. Ain-Shams Journal of Anesthesiology2020;12(1):25. ">Bakhet 2020</a>; <a href="./references#CD013197-bbs2-0005" title="BarrioJ , ErrandoCL , Garcia-RamonJ , SellesR , San MiguelG , GallegoJ . Influence of depth of neuromuscular blockade on surgical conditions during low-pressure pneumoperitoneum laparoscopic cholecystectomy: a randomized blinded study. Journal of Clinical Anesthesia2017;42:26-30. ">Barrio 2017</a>; <a href="./references#CD013197-bbs2-0006" title="BlobnerM , FrickC , StaubleR , FeussnerH , SchallerS , UnterbuchnerC , et al. Neuromuscular blockade improves surgical conditions (NISCO). Surgical Endoscopy2014;29(3):627-36. ">Blobner 2014</a>; <a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0010" title="Choi B-M, Ki S-H, Lee Y-H, Gong C-S, Kim H-S, Lee I-S, et al. Effects of depth of neuromuscular block on postoperative pain during laparoscopic gastrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(11):863-70. ">Choi 2019</a>; <a href="./references#CD013197-bbs2-0011" title="CovielloA , IannielloM , BuonannoP , Di FalcoN , IacovazzoC , MarescaA , et al. Effects of depth of neuromuscular block on surgical operating conditions in women undergoing gynecologic laparoscopic surgery: a randomized clinical trial. Journal of Anesthesia, Analgesia and Critical Care2023;3(1):2. [DOI: 10.1186/s44158-023-00086-7]">Coviello 2023</a>; <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a>; <a href="./references#CD013197-bbs2-0013" title="Fuchs-BuderT , SchmartzD , BaumannC , HiltL , Nomine-CriquiC , MeistelmanC , et al. Deep neuromuscular blockade improves surgical conditions during gastric bypass surgery for morbid obesity: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):486-93. ">FuchsâBuder 2019</a>; <a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0016" title="HuangH , ZhouL , YuY , LiuS , XuH , XuZ , et al. Comparison of deep and moderate neuromuscular blockade on intestinal mucosal barrier in laparoscopic gastrectomy: a prospective, randomized, double-blind clinical trial. Frontiers in Medicine2021;8:789597. ">Huang 2021</a>; <a href="./references#CD013197-bbs2-0018" title="KimMH , LeeKY , LeeKY , MinBS , YooYC . Maintaining optimal surgical conditions with low insufflation pressures is possible with deep neuromuscular blockade during laparoscopic colorectal surgery: a prospective, randomized, double-blind, parallel-group clinical trial. Medicine2016;95(9):e2920. ">Kim 2016</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0021" title="KimMH , KimNY , YooYC , KongHJ , LeeHS , JoA , et al. Influence of deep neuromuscular blockade on perioperative stress response in patients undergoing robot-assisted gastrectomy: a prospective double-blinded randomized-controlled trial. Journal of Personalized Medicine2021;11(12):1308. ">Kim 2021b</a>; <a href="./references#CD013197-bbs2-0024" title="KooBW , OhAY , RyuJH , LeeYJ , HanJW , NamSW , et al. Effects of deep neuromuscular blockade on the stress response during laparoscopic gastrectomy randomized controlled trials. Scientific Reports2019;9(1):12411. ">Koo 2019</a>; <a href="./references#CD013197-bbs2-0026" title="LeeJ , AnJ , LeeDH , KimE , WooK , KimKH . Cortisol secretory patterns in deep and moderate neuromuscular blockades in laparoscopic surgery under total intravenous anesthesia: a prospective, single-blinded, randomized controlled trial. Medicine2022;101(39):e30702. ">Lee 2022</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a>; <a href="./references#CD013197-bbs2-0032" title="NamSW , OhAY , KooBW , KimBY , HanJ , ChungSH . Effects of depth of neuromuscular blockade on the BIS-guided propofol requirement: a randomized controlled trial. Medicine2021;100(29):e26576. ">Nam 2021</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0034" title="ParkSH , HuhH , ChoiSI , KimJH , JangYJ , ParkJM , et al. Impact of the deep neuromuscular block on oncologic quality of laparoscopic surgery in obese gastric cancer patients: a randomized clinical trial. Journal of the American College of Surgeons2022;234(3):326-39. ">Park 2022</a>; <a href="./references#CD013197-bbs2-0036" title="RosenbergJ , HerringWJ , BlobnerM , MulierJP , Rahe-MeyerN , WooT , et al. Deep neuromuscular blockade improves laparoscopic surgical conditions: a randomized, controlled study. Advances in Therapy2017;34(4):925-36. ">Rosenberg 2017</a>; <a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>; <a href="./references#CD013197-bbs2-0040" title="YiIK , KimJS , HurH , HanDG , KimJE . Effects of deep neuromuscular block on surgical pleth index-guided remifentanil administration in laparoscopic herniorrhaphy: a prospective randomized trial. Scientific Reports2022;12(1):19176. ">Yi 2022</a>; <a href="./references#CD013197-bbs2-0041" title="YooYC , KimNY , ShinS , ChoiYD , HongJH , KimCY , et al. The intraocular pressure under deep versus moderate neuromuscular blockade during low-pressure robot assisted laparoscopic radical prostatectomy in a randomized trial. PLOS One2015;10(8):e0135412. ">Yoo 2015</a>). The other trials were included for analysis of at least one of the secondary outcomes. Fourteen trials performed analysis of outcomes on an intentionâtoâtreat basis (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0006" title="BlobnerM , FrickC , StaubleR , FeussnerH , SchallerS , UnterbuchnerC , et al. Neuromuscular blockade improves surgical conditions (NISCO). Surgical Endoscopy2014;29(3):627-36. ">Blobner 2014</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0011" title="CovielloA , IannielloM , BuonannoP , Di FalcoN , IacovazzoC , MarescaA , et al. Effects of depth of neuromuscular block on surgical operating conditions in women undergoing gynecologic laparoscopic surgery: a randomized clinical trial. Journal of Anesthesia, Analgesia and Critical Care2023;3(1):2. [DOI: 10.1186/s44158-023-00086-7]">Coviello 2023</a>; <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a>; <a href="./references#CD013197-bbs2-0013" title="Fuchs-BuderT , SchmartzD , BaumannC , HiltL , Nomine-CriquiC , MeistelmanC , et al. Deep neuromuscular blockade improves surgical conditions during gastric bypass surgery for morbid obesity: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):486-93. ">FuchsâBuder 2019</a>; <a href="./references#CD013197-bbs2-0018" title="KimMH , LeeKY , LeeKY , MinBS , YooYC . Maintaining optimal surgical conditions with low insufflation pressures is possible with deep neuromuscular blockade during laparoscopic colorectal surgery: a prospective, randomized, double-blind, parallel-group clinical trial. Medicine2016;95(9):e2920. ">Kim 2016</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0030" title="MartiniCH , BoonM , BeversRF , AartsLP , DahanA , ThompsonJP . Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. British Journal of Anaesthesia2014;112(3):498-505. ">Martini 2014</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0034" title="ParkSH , HuhH , ChoiSI , KimJH , JangYJ , ParkJM , et al. Impact of the deep neuromuscular block on oncologic quality of laparoscopic surgery in obese gastric cancer patients: a randomized clinical trial. Journal of the American College of Surgeons2022;234(3):326-39. ">Park 2022</a>; <a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a>). Twentyâtwo trials had no dropouts related to the outcomes or dropouts did not occur (<a href="./references#CD013197-bbs2-0001" title="Abu YazedMM , AhmedSA . Deep versus moderate neuromuscular block in laparoscopic bariatric surgeries: effect on surgical conditions and pulmonary complications. Egyptian Journal of Anaesthesia2019;35(1):5-58. ">Abu Yazed 2019</a>; <a href="./references#CD013197-bbs2-0003" title="BaeteS , VercruysseG , Vander LaenenM , De VooghtP , Van MelkebeekJ , DylstD , et al. The effect of deep versus moderate neuromuscular block on surgical conditions and postoperative respiratory function in bariatric laparoscopic surgery: a randomized, double blind clinical trial. Anesthesia &amp; Analgesia2017;124(5):1469-75. ">Baete 2017</a>; <a href="./references#CD013197-bbs2-0004" title="BakhetWZ . A randomized trial comparing deep and moderate neuromuscular blockade in patients undergoing ambulatory gynecologic laparoscopy. Ain-Shams Journal of Anesthesiology2020;12(1):25. ">Bakhet 2020</a>; <a href="./references#CD013197-bbs2-0005" title="BarrioJ , ErrandoCL , Garcia-RamonJ , SellesR , San MiguelG , GallegoJ . Influence of depth of neuromuscular blockade on surgical conditions during low-pressure pneumoperitoneum laparoscopic cholecystectomy: a randomized blinded study. Journal of Clinical Anesthesia2017;42:26-30. ">Barrio 2017</a>; <a href="./references#CD013197-bbs2-0010" title="Choi B-M, Ki S-H, Lee Y-H, Gong C-S, Kim H-S, Lee I-S, et al. Effects of depth of neuromuscular block on postoperative pain during laparoscopic gastrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(11):863-70. ">Choi 2019</a>; <a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0016" title="HuangH , ZhouL , YuY , LiuS , XuH , XuZ , et al. Comparison of deep and moderate neuromuscular blockade on intestinal mucosal barrier in laparoscopic gastrectomy: a prospective, randomized, double-blind clinical trial. Frontiers in Medicine2021;8:789597. ">Huang 2021</a>; <a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0017" title="KathopoulisN , ProtopapasA , StamatakisE , ChatzipapasI , ZacharakisD , GrigoriadisT , et al. Deep versus moderate neuromuscular blockade in gynecologic laparoscopic operations: randomized controlled trial. Journal of Personalized Medicine2022;12(4):561. ">Kathopoulis 2022</a>; <a href="./references#CD013197-bbs2-0020" title="KimJE , MinSK , HaE , LeeD , KimJY , KwakHJ . Effects of deep neuromuscular block with low-pressure pneumoperitoneum on respiratory mechanics and biotrauma in a steep Trendelenburg position. Scientific Reports2021;11(1):1935. ">Kim 2021a</a>; <a href="./references#CD013197-bbs2-0021" title="KimMH , KimNY , YooYC , KongHJ , LeeHS , JoA , et al. Influence of deep neuromuscular blockade on perioperative stress response in patients undergoing robot-assisted gastrectomy: a prospective double-blinded randomized-controlled trial. Journal of Personalized Medicine2021;11(12):1308. ">Kim 2021b</a>; <a href="./references#CD013197-bbs2-0023" title="KooBW , OhAY , NaHS , LeeHJ , KangSB , KimDW , et al. Effects of depth of neuromuscular block on surgical conditions during laparoscopic colorectal surgery: a randomised controlled trial. Anaesthesia2018;73(9):1090-6. ">Koo 2018</a>; <a href="./references#CD013197-bbs2-0024" title="KooBW , OhAY , RyuJH , LeeYJ , HanJW , NamSW , et al. Effects of deep neuromuscular blockade on the stress response during laparoscopic gastrectomy randomized controlled trials. Scientific Reports2019;9(1):12411. ">Koo 2019</a>; <a href="./references#CD013197-bbs2-0026" title="LeeJ , AnJ , LeeDH , KimE , WooK , KimKH . Cortisol secretory patterns in deep and moderate neuromuscular blockades in laparoscopic surgery under total intravenous anesthesia: a prospective, single-blinded, randomized controlled trial. Medicine2022;101(39):e30702. ">Lee 2022</a>; <a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a>; <a href="./references#CD013197-bbs2-0031" title="Na H-S, Lim D-J, Koo B-W, Oh A-Y, Lee P-B. The influence of moderate or deep neuromuscular block status on anesthetic depth monitoring system during total intravenous anesthesia using propofol and remifentanil: a randomized trial. Science Progress2021;104(2):368504211010629. ">Na 2021</a>; <a href="./references#CD013197-bbs2-0032" title="NamSW , OhAY , KooBW , KimBY , HanJ , ChungSH . Effects of depth of neuromuscular blockade on the BIS-guided propofol requirement: a randomized controlled trial. Medicine2021;100(29):e26576. ">Nam 2021</a>; <a href="./references#CD013197-bbs2-0035" title="DuboisPE , PutzL , JamartJ , MarottaML , GourdinM , DonnezO . Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. European Journal of Anaesthesiology2014;31(8):430-6. PutzL , DransartC , JamartJ , Marotta M-L, DelnoozG , DuboisPE . Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial. Journal of Clinical Anesthesia2016;35:107-13. ">Putz 2016</a>; <a href="./references#CD013197-bbs2-0036" title="RosenbergJ , HerringWJ , BlobnerM , MulierJP , Rahe-MeyerN , WooT , et al. Deep neuromuscular blockade improves laparoscopic surgical conditions: a randomized, controlled study. Advances in Therapy2017;34(4):925-36. ">Rosenberg 2017</a>; <a href="./references#CD013197-bbs2-0038" title="TorensmaB , MartiniCH , BoonM , OlofsenE , VeldBI , LiemRS , et al. Deep neuromuscular block improves surgical conditions during bariatric surgery and reduces postoperative pain: a randomized double blind controlled trial. PLOS One2016;11(12):e0167907. ">Torensma 2016</a>; <a href="./references#CD013197-bbs2-0040" title="YiIK , KimJS , HurH , HanDG , KimJE . Effects of deep neuromuscular block on surgical pleth index-guided remifentanil administration in laparoscopic herniorrhaphy: a prospective randomized trial. Scientific Reports2022;12(1):19176. ">Yi 2022</a>; <a href="./references#CD013197-bbs2-0041" title="YooYC , KimNY , ShinS , ChoiYD , HongJH , KimCY , et al. The intraocular pressure under deep versus moderate neuromuscular blockade during low-pressure robot assisted laparoscopic radical prostatectomy in a randomized trial. PLOS One2015;10(8):e0135412. ">Yoo 2015</a>). In three trials it was unclear whether postrandomisation dropouts were related to outcomes (<a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0022" title="KooBW , OhAY , SeoKS , HanJW , HanHS , YoonYS . Randomized clinical trial of moderate versus deep neuromuscular block for low-pressure pneumoperitoneum during laparoscopic cholecystectomy. World Journal of Surgery2016;40(12):2898-903. ">Koo 2016</a>; <a href="./references#CD013197-bbs2-0025" title="Koo C-H, ParkI , AhnS , LeeS , Ryu J-H. Effect of neuromuscular blockade on intraoperative respiratory mechanics and surgical space conditions during robot-assisted radical prostatectomy: a prospective randomized controlled trial. Journal of Clinical Medicine2021;10(21):5090. ">Koo 2021</a>), and in three trials there was a risk that postrandomisation dropouts were related to the outcomes (<a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>; <a href="./references#CD013197-bbs2-0042" title="ZhuSJ , ZhangXL , XieQ , ZhouYF , WangKR . Comparison of the effects of deep and moderate neuromuscular block on respiratory system compliance and surgical space conditions during robot-assisted laparoscopic radical prostatectomy: a randomized clinical study. Journal of Zhejiang University. Science B2020;21(8):637-45. ">Zhu 2020</a>). </p> <p>Seven trials assessed participants up to the end of the intervention (surgery) without additional followâup (<a href="./references#CD013197-bbs2-0005" title="BarrioJ , ErrandoCL , Garcia-RamonJ , SellesR , San MiguelG , GallegoJ . Influence of depth of neuromuscular blockade on surgical conditions during low-pressure pneumoperitoneum laparoscopic cholecystectomy: a randomized blinded study. Journal of Clinical Anesthesia2017;42:26-30. ">Barrio 2017</a>; <a href="./references#CD013197-bbs2-0020" title="KimJE , MinSK , HaE , LeeD , KimJY , KwakHJ . Effects of deep neuromuscular block with low-pressure pneumoperitoneum on respiratory mechanics and biotrauma in a steep Trendelenburg position. Scientific Reports2021;11(1):1935. ">Kim 2021a</a>; <a href="./references#CD013197-bbs2-0023" title="KooBW , OhAY , NaHS , LeeHJ , KangSB , KimDW , et al. Effects of depth of neuromuscular block on surgical conditions during laparoscopic colorectal surgery: a randomised controlled trial. Anaesthesia2018;73(9):1090-6. ">Koo 2018</a>; <a href="./references#CD013197-bbs2-0024" title="KooBW , OhAY , RyuJH , LeeYJ , HanJW , NamSW , et al. Effects of deep neuromuscular blockade on the stress response during laparoscopic gastrectomy randomized controlled trials. Scientific Reports2019;9(1):12411. ">Koo 2019</a>; <a href="./references#CD013197-bbs2-0031" title="Na H-S, Lim D-J, Koo B-W, Oh A-Y, Lee P-B. The influence of moderate or deep neuromuscular block status on anesthetic depth monitoring system during total intravenous anesthesia using propofol and remifentanil: a randomized trial. Science Progress2021;104(2):368504211010629. ">Na 2021</a>; <a href="./references#CD013197-bbs2-0040" title="YiIK , KimJS , HurH , HanDG , KimJE . Effects of deep neuromuscular block on surgical pleth index-guided remifentanil administration in laparoscopic herniorrhaphy: a prospective randomized trial. Scientific Reports2022;12(1):19176. ">Yi 2022</a>; <a href="./references#CD013197-bbs2-0042" title="ZhuSJ , ZhangXL , XieQ , ZhouYF , WangKR . Comparison of the effects of deep and moderate neuromuscular block on respiratory system compliance and surgical space conditions during robot-assisted laparoscopic radical prostatectomy: a randomized clinical study. Journal of Zhejiang University. Science B2020;21(8):637-45. ">Zhu 2020</a>). Another seven trials assessed participants up to discharge from PACU (<a href="./references#CD013197-bbs2-0001" title="Abu YazedMM , AhmedSA . Deep versus moderate neuromuscular block in laparoscopic bariatric surgeries: effect on surgical conditions and pulmonary complications. Egyptian Journal of Anaesthesia2019;35(1):5-58. ">Abu Yazed 2019</a>; <a href="./references#CD013197-bbs2-0003" title="BaeteS , VercruysseG , Vander LaenenM , De VooghtP , Van MelkebeekJ , DylstD , et al. The effect of deep versus moderate neuromuscular block on surgical conditions and postoperative respiratory function in bariatric laparoscopic surgery: a randomized, double blind clinical trial. Anesthesia &amp; Analgesia2017;124(5):1469-75. ">Baete 2017</a>; <a href="./references#CD013197-bbs2-0025" title="Koo C-H, ParkI , AhnS , LeeS , Ryu J-H. Effect of neuromuscular blockade on intraoperative respiratory mechanics and surgical space conditions during robot-assisted radical prostatectomy: a prospective randomized controlled trial. Journal of Clinical Medicine2021;10(21):5090. ">Koo 2021</a>; <a href="./references#CD013197-bbs2-0026" title="LeeJ , AnJ , LeeDH , KimE , WooK , KimKH . Cortisol secretory patterns in deep and moderate neuromuscular blockades in laparoscopic surgery under total intravenous anesthesia: a prospective, single-blinded, randomized controlled trial. Medicine2022;101(39):e30702. ">Lee 2022</a>; <a href="./references#CD013197-bbs2-0030" title="MartiniCH , BoonM , BeversRF , AartsLP , DahanA , ThompsonJP . Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. British Journal of Anaesthesia2014;112(3):498-505. ">Martini 2014</a>; <a href="./references#CD013197-bbs2-0035" title="DuboisPE , PutzL , JamartJ , MarottaML , GourdinM , DonnezO . Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. European Journal of Anaesthesiology2014;31(8):430-6. PutzL , DransartC , JamartJ , Marotta M-L, DelnoozG , DuboisPE . Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial. Journal of Clinical Anesthesia2016;35:107-13. ">Putz 2016</a>; <a href="./references#CD013197-bbs2-0041" title="YooYC , KimNY , ShinS , ChoiYD , HongJH , KimCY , et al. The intraocular pressure under deep versus moderate neuromuscular blockade during low-pressure robot assisted laparoscopic radical prostatectomy in a randomized trial. PLOS One2015;10(8):e0135412. ">Yoo 2015</a>). Eight trials followed up participants to 24 hours postoperative (<a href="./references#CD013197-bbs2-0004" title="BakhetWZ . A randomized trial comparing deep and moderate neuromuscular blockade in patients undergoing ambulatory gynecologic laparoscopy. Ain-Shams Journal of Anesthesiology2020;12(1):25. ">Bakhet 2020</a>; <a href="./references#CD013197-bbs2-0006" title="BlobnerM , FrickC , StaubleR , FeussnerH , SchallerS , UnterbuchnerC , et al. Neuromuscular blockade improves surgical conditions (NISCO). Surgical Endoscopy2014;29(3):627-36. ">Blobner 2014</a>; <a href="./references#CD013197-bbs2-0010" title="Choi B-M, Ki S-H, Lee Y-H, Gong C-S, Kim H-S, Lee I-S, et al. Effects of depth of neuromuscular block on postoperative pain during laparoscopic gastrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(11):863-70. ">Choi 2019</a>; <a href="./references#CD013197-bbs2-0011" title="CovielloA , IannielloM , BuonannoP , Di FalcoN , IacovazzoC , MarescaA , et al. Effects of depth of neuromuscular block on surgical operating conditions in women undergoing gynecologic laparoscopic surgery: a randomized clinical trial. Journal of Anesthesia, Analgesia and Critical Care2023;3(1):2. [DOI: 10.1186/s44158-023-00086-7]">Coviello 2023</a>; <a href="./references#CD013197-bbs2-0018" title="KimMH , LeeKY , LeeKY , MinBS , YooYC . Maintaining optimal surgical conditions with low insufflation pressures is possible with deep neuromuscular blockade during laparoscopic colorectal surgery: a prospective, randomized, double-blind, parallel-group clinical trial. Medicine2016;95(9):e2920. ">Kim 2016</a>; <a href="./references#CD013197-bbs2-0021" title="KimMH , KimNY , YooYC , KongHJ , LeeHS , JoA , et al. Influence of deep neuromuscular blockade on perioperative stress response in patients undergoing robot-assisted gastrectomy: a prospective double-blinded randomized-controlled trial. Journal of Personalized Medicine2021;11(12):1308. ">Kim 2021b</a>; <a href="./references#CD013197-bbs2-0022" title="KooBW , OhAY , SeoKS , HanJW , HanHS , YoonYS . Randomized clinical trial of moderate versus deep neuromuscular block for low-pressure pneumoperitoneum during laparoscopic cholecystectomy. World Journal of Surgery2016;40(12):2898-903. ">Koo 2016</a>; <a href="./references#CD013197-bbs2-0038" title="TorensmaB , MartiniCH , BoonM , OlofsenE , VeldBI , LiemRS , et al. Deep neuromuscular block improves surgical conditions during bariatric surgery and reduces postoperative pain: a randomized double blind controlled trial. PLOS One2016;11(12):e0167907. ">Torensma 2016</a>). <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a> followed participants up to three days postoperative, and <a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a> and <a href="./references#CD013197-bbs2-0036" title="RosenbergJ , HerringWJ , BlobnerM , MulierJP , Rahe-MeyerN , WooT , et al. Deep neuromuscular blockade improves laparoscopic surgical conditions: a randomized, controlled study. Advances in Therapy2017;34(4):925-36. ">Rosenberg 2017</a> up to one week postoperative. Seven trials followed up participants to discharge from the hospital (<a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0016" title="HuangH , ZhouL , YuY , LiuS , XuH , XuZ , et al. Comparison of deep and moderate neuromuscular blockade on intestinal mucosal barrier in laparoscopic gastrectomy: a prospective, randomized, double-blind clinical trial. Frontiers in Medicine2021;8:789597. ">Huang 2021</a>; <a href="./references#CD013197-bbs2-0017" title="KathopoulisN , ProtopapasA , StamatakisE , ChatzipapasI , ZacharakisD , GrigoriadisT , et al. Deep versus moderate neuromuscular blockade in gynecologic laparoscopic operations: randomized controlled trial. Journal of Personalized Medicine2022;12(4):561. ">Kathopoulis 2022</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>). <a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a> and <a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a> followed participants up to 21 days postoperative. Followâup was 30 days in seven trials (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0013" title="Fuchs-BuderT , SchmartzD , BaumannC , HiltL , Nomine-CriquiC , MeistelmanC , et al. Deep neuromuscular blockade improves surgical conditions during gastric bypass surgery for morbid obesity: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):486-93. ">FuchsâBuder 2019</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0032" title="NamSW , OhAY , KooBW , KimBY , HanJ , ChungSH . Effects of depth of neuromuscular blockade on the BIS-guided propofol requirement: a randomized controlled trial. Medicine2021;100(29):e26576. ">Nam 2021</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0034" title="ParkSH , HuhH , ChoiSI , KimJH , JangYJ , ParkJM , et al. Impact of the deep neuromuscular block on oncologic quality of laparoscopic surgery in obese gastric cancer patients: a randomized clinical trial. Journal of the American College of Surgeons2022;234(3):326-39. ">Park 2022</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>); however, <a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a> reported healthârelated quality of life up to three months postoperative. <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a> followed participants for up to 60 days. </p> </section> <section id="CD013197-sec-0056"> <h5 class="title">Funding</h5> <p>Twentyâtwo trials were funded by industry or a forâprofit organisation (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0003" title="BaeteS , VercruysseG , Vander LaenenM , De VooghtP , Van MelkebeekJ , DylstD , et al. The effect of deep versus moderate neuromuscular block on surgical conditions and postoperative respiratory function in bariatric laparoscopic surgery: a randomized, double blind clinical trial. Anesthesia &amp; Analgesia2017;124(5):1469-75. ">Baete 2017</a>; <a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0010" title="Choi B-M, Ki S-H, Lee Y-H, Gong C-S, Kim H-S, Lee I-S, et al. Effects of depth of neuromuscular block on postoperative pain during laparoscopic gastrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(11):863-70. ">Choi 2019</a>; <a href="./references#CD013197-bbs2-0011" title="CovielloA , IannielloM , BuonannoP , Di FalcoN , IacovazzoC , MarescaA , et al. Effects of depth of neuromuscular block on surgical operating conditions in women undergoing gynecologic laparoscopic surgery: a randomized clinical trial. Journal of Anesthesia, Analgesia and Critical Care2023;3(1):2. [DOI: 10.1186/s44158-023-00086-7]">Coviello 2023</a>; <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a>; <a href="./references#CD013197-bbs2-0013" title="Fuchs-BuderT , SchmartzD , BaumannC , HiltL , Nomine-CriquiC , MeistelmanC , et al. Deep neuromuscular blockade improves surgical conditions during gastric bypass surgery for morbid obesity: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):486-93. ">FuchsâBuder 2019</a>; <a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0020" title="KimJE , MinSK , HaE , LeeD , KimJY , KwakHJ . Effects of deep neuromuscular block with low-pressure pneumoperitoneum on respiratory mechanics and biotrauma in a steep Trendelenburg position. Scientific Reports2021;11(1):1935. ">Kim 2021a</a>; <a href="./references#CD013197-bbs2-0024" title="KooBW , OhAY , RyuJH , LeeYJ , HanJW , NamSW , et al. Effects of deep neuromuscular blockade on the stress response during laparoscopic gastrectomy randomized controlled trials. Scientific Reports2019;9(1):12411. ">Koo 2019</a>; <a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a>; <a href="./references#CD013197-bbs2-0030" title="MartiniCH , BoonM , BeversRF , AartsLP , DahanA , ThompsonJP . Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. British Journal of Anaesthesia2014;112(3):498-505. ">Martini 2014</a>; <a href="./references#CD013197-bbs2-0031" title="Na H-S, Lim D-J, Koo B-W, Oh A-Y, Lee P-B. The influence of moderate or deep neuromuscular block status on anesthetic depth monitoring system during total intravenous anesthesia using propofol and remifentanil: a randomized trial. Science Progress2021;104(2):368504211010629. ">Na 2021</a>; <a href="./references#CD013197-bbs2-0034" title="ParkSH , HuhH , ChoiSI , KimJH , JangYJ , ParkJM , et al. Impact of the deep neuromuscular block on oncologic quality of laparoscopic surgery in obese gastric cancer patients: a randomized clinical trial. Journal of the American College of Surgeons2022;234(3):326-39. ">Park 2022</a>; <a href="./references#CD013197-bbs2-0036" title="RosenbergJ , HerringWJ , BlobnerM , MulierJP , Rahe-MeyerN , WooT , et al. Deep neuromuscular blockade improves laparoscopic surgical conditions: a randomized, controlled study. Advances in Therapy2017;34(4):925-36. ">Rosenberg 2017</a>; <a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a>; <a href="./references#CD013197-bbs2-0038" title="TorensmaB , MartiniCH , BoonM , OlofsenE , VeldBI , LiemRS , et al. Deep neuromuscular block improves surgical conditions during bariatric surgery and reduces postoperative pain: a randomized double blind controlled trial. PLOS One2016;11(12):e0167907. ">Torensma 2016</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>; <a href="./references#CD013197-bbs2-0040" title="YiIK , KimJS , HurH , HanDG , KimJE . Effects of deep neuromuscular block on surgical pleth index-guided remifentanil administration in laparoscopic herniorrhaphy: a prospective randomized trial. Scientific Reports2022;12(1):19176. ">Yi 2022</a>; <a href="./references#CD013197-bbs2-0041" title="YooYC , KimNY , ShinS , ChoiYD , HongJH , KimCY , et al. The intraocular pressure under deep versus moderate neuromuscular blockade during low-pressure robot assisted laparoscopic radical prostatectomy in a randomized trial. PLOS One2015;10(8):e0135412. ">Yoo 2015</a>). One trial did not describe whether they received any funding (<a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>). </p> </section> </section> <section id="CD013197-sec-0057"> <h4 class="title">Excluded studies</h4> <p>We excluded 57 studies during the fullâtext screening. Reasons for exclusion are described in the <a href="./references#CD013197-sec-0152" title="">Characteristics of excluded studies</a> table. One of the main reasons for excluding studies was ineligible interventions (11 studies), where a specific level of NMB was a facilitator in interventions with varying pneumoperitoneum levels (<a href="./references#CD013197-bbs2-0049" title="CelarierS , MonziolsS , CelerierB , AssenatV , CarlesP , NapolitanoG , et al. Low-pressure versus standard pressure laparoscopic colorectal surgery (PAROS trial): a phase III randomized controlled trial. British Journal of Surgery2021;108(8):998-1005. ">Celarier 2021</a>; <a href="./references#CD013197-bbs2-0054" title="ChiCTR2100052183. Protective effect of deep neuromuscular blockade and low intraabdominal pressures on organs of patients robot-assisted radical prostatectomy. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR2100052183 (first received 21 October 2021). ">ChiCTR2100052183</a>; <a href="./references#CD013197-bbs2-0070" title="NCT02146417. Comparison of low versus normal pressure pneumoperitoneum â with profound low versus normal pressure pneumoperitoneum â with profound muscle relaxation â during laparoscopic donor nephrectomy. clinicaltrials.gov/show/NCT02146417 (first received 23 May 2014). ">NCT02146417</a>; <a href="./references#CD013197-bbs2-0087" title="NCT05040022. Quality of recovery under low or standard pneumoperitoneum pressure. clinicaltrials.gov/show/NCT05040022 (first received 10 September 2021). ">NCT05040022</a>), or different strategies for reversing NMB (<a href="./references#CD013197-bbs2-0057" title="EUCTR2014-005116-41-IT. Comparison between sugammadex and neostigmine in the recovery of rocuronium-induced neuromuscular blockade and impact on postoperative pulmonary function in patients undergoing laparoscopic sleeve gastrectomy. A double-blind, randomized controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=EUCTR2014-005116-41-IT (first received 13 April 2015). ">EUCTR2014â005116â41âIT</a>; <a href="./references#CD013197-bbs2-0067" title="NCT01629394. Comparative study of sugammadex versus neostigmine for reversal of neuromuscular blockade in morbidly obese patients. clinicaltrials.gov/show/NCT01629394 (first received 27 June 2012). ">NCT01629394</a>; <a href="./references#CD013197-bbs2-0088" title="OhTK , JiE , NaHS . The effect of neuromuscular reversal agent on postoperative pain after laparoscopic gastric cancer surgery: comparison between the neostigmine and sugammadex. Medicine2019;98(26):e16142. ">Oh 2019</a>). Four studies were excluded for an ineligible comparison, involving the use of deep NMB against something other than a different level of NMB. <a href="./references#CD013197-bbs2-0097" title="VeeloDP , GisbertzSS , BinnekadeJM , HannivoortRA , BosmanJA , GeertsBF , et al. On-demand versus continuous rocuronium infusion for deep neuromuscular relaxation in patients undergoing thoraco-laparoscopic esophagectomy: a randomized-controlled clinical trial (DEPTH). Canadian Journal of Anesthesia2019;66(9):1062-74. VeeloDP , GisbertzSS , HannivoortRA , vanDierenS , GeertsBF , HenegouwenMI , et al. The effect of on-demand vs deep neuromuscular relaxation on rating of surgical and anaesthesiologic conditions in patients undergoing thoracolaparoscopic esophagectomy (Depth trial): study protocol for a randomized controlled trial. Trials2015;16(1):331. ">Veelo 2019</a> did compare different levels of NMB strategies, but it did not aim to maintain a consistent TOF or PTC level intraoperatively. Another important reasons for exclusion was the absence of one of our predefined primary or secondary outcomes, mainly due to solely focusing on nonâclinical outcomes such as surgical rating scores. Seventeen trials were excluded on the grounds of being 'unavailable', primarily comprising trial registrations marked as completed without any corresponding data publication, or trial registration with an unknown status for several years. Last, we identified and excluded three crossâover trials because interpreting our predefined outcomes was not feasible in this study design (<a href="./references#CD013197-bbs2-0064" title="MadsenMV , GatkeMR , SpringborgHH , RosenbergJ , LundJ , IstreO . Optimising abdominal space with deep neuromuscular blockade in gynaecologic laparoscopy â a randomised, blinded crossover study. Acta Anaesthesiologica Scandinavica2015;59(4):441-7. ">Madsen 2015</a>; <a href="./references#CD013197-bbs2-0068" title="NCT02025075. Hemodynamic and respiratory variations during laparoscopic surgery with and without deep neuromuscular blockade. clinicaltrials.gov/show/NCT02025075 (first received 31 December 2013). ">NCT02025075</a>; <a href="./references#CD013197-bbs2-0092" title="EUCTR2014-002802-19-DK. Optimizing surgical conditions in surgery for hernia with or without use of muscle relaxation (The Hernia Study). trialsearch.who.int/Trial2.aspx?TrialID=EUCTR2014-002802-19-DK (first received 3 July 2014). MediciR , MadsenMV , AsadzadehS , FolsgaardS , RosenbergJ , GatkeMR . Neuromuscular blockade during laparoscopic ventral herniotomy: protocol for a randomised controlled trial. Danish Medical Journal2015;62(8):A5120. NCT02247466. Optimizing surgical conditions during laparoscopic herniotomy with deep neuromuscular blockade. clinicaltrials.gov/show/NCT02247466 (first received 25 September 2014). SoderstromCM , Borregaard MediciR , AssadzadehS , FolsgaardS , RosenbergJ , GatkeMR , et al. Deep neuromuscular blockade and surgical conditions during laparoscopic ventral hernia repair: a randomised, blinded study. European Journal of Anaesthesiology2018;35(11):876-82. ">Soderstrom 2018</a>). Moreover, these trials concentrated on outcomes beyond the scope of this review. </p> <section id="CD013197-sec-0058"> <h5 class="title">Studies awaiting classification</h5> <p>There were no studies awaiting classification.</p> </section> <section id="CD013197-sec-0059"> <h5 class="title">Ongoing studies</h5> <p>We identified 21 ongoing trials; 14 trials are currently recruiting (<a href="./references#CD013197-bbs2-0100" title="ChiCTR1800017435. Effect of different degree of neuromuscular blockade and pneumoperitoneum pressure on laparoscopic cholecystectomy. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR1800017435 (first received 30 July 2018). ">ChiCTR1800017435</a>; <a href="./references#CD013197-bbs2-0102" title="ChiCTR1900024267. The effect of depth of neuromuscular blockade on liver's perfusion and function during pneumoperitoneum for laparoscopic hepatic surgery. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR1900024267 (first received 3 July 2019). ">ChiCTR1900024267</a>; <a href="./references#CD013197-bbs2-0104" title="ChiCTR2100043323. Effects of different depth of neuromuscular block on cardiovascular adverse events after laparoscopic surgery in elderly patients: a randomized controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR2100043323 (first received 10 February 2021). ">ChiCTR2100043323</a>; <a href="./references#CD013197-bbs2-0105" title="ChiCTR2100047360. The effect of deep neuromuscular block combined with low pneumoperitoneum pressure on renal function in elderly patients undergoing robotic laparoscopic radical prostatectomy. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR2100047360 (first received 12 June 2021). ">ChiCTR2100047360</a>; <a href="./references#CD013197-bbs2-0106" title="ChiCTR2100054215. Evaluation of pulmonary complications during laparoscopic surgery in patients with protective mechanical ventilation combined deep neuromuscular block. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR2100054215 (first received 11 December 2021). ">ChiCTR2100054215</a>; <a href="./references#CD013197-bbs2-0107" title="ChiCTR2200059498. Influence of deep neuromuscular blockade on the organ perfusion and metabolism of patients receiving laparoscopic surgery. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR2200059498 (first received 2 May 2022). ">ChiCTR2200059498</a>; <a href="./references#CD013197-bbs2-0108" title="ChiCTR2200060195. The lung protective effect of driving pressure-guided pulmonary protective ventilation combined deep neuromuscular block in patients undergoing laparoscopic surgery for colorectal cancer. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR2200060195 (first received 21 May 2022). ">ChiCTR2200060195</a>; <a href="./references#CD013197-bbs2-0109" title="ChiCTR2200063179. Effect of neuromuscular blockade on surgical space in obese female patients undergoing laparoscopic bariatric surgery. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR2200063179 (first received 1 September 2022). ">ChiCTR2200063179</a>; <a href="./references#CD013197-bbs2-0110" title="ChiCTR2300068711. Effect of different depth of neuromuscular blockade on optic nerve sheath diameter in obese patients undergoing laparoscopic sleeve gastrectomy. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR2300068711 (first received 28 February 2023). ">ChiCTR2300068711</a>; <a href="./references#CD013197-bbs2-0113" title="HoningM , Reijnders-BoerboomG , Dell-KusterS , vanVelzenM , MartiniC , ValenzaF , et al. The impact of deep versus standard neuromuscular block on intraoperative safety during laparoscopic surgery: an international multicenter randomized controlled double-blind strategy trial â EURO-RELAX TRIAL. Trials2021;22(1):744. ">Honing 2021</a>; <a href="./references#CD013197-bbs2-0114" title="Long Y-Q, Shan X-S, Feng X-M, LiuH , Ji F-H, PengK . Deep neuromuscular blockade combined with low pneumoperitoneum pressure for nociceptive recovery after major laparoscopic gastrointestinal surgery: study protocol for a randomized controlled trial. Journal of Pain Research2021;14:3573-81. ">Long 2021</a>; <a href="./references#CD013197-bbs2-0115" title="NCT03910998. Impact of intraoperative deep neuromuscular blockade on NOL-guided opioid requirement in LSC colorectal surgeries. clinicaltrials.gov/show/NCT03910998 (first received 10 April 2019). ">NCT03910998</a>; <a href="./references#CD013197-bbs2-0119" title="NCT05689957. Moderate vs deep neuromuscular block in lower pressure pneumoperitoneum. clinicaltrials.gov/show/NCT05689957 (first received 19 January 2023). ">NCT05689957</a>; <a href="./references#CD013197-bbs2-0120" title="PACTR202210785932208. Efficacy of light versus intense neuromuscular block on postoperative respiratory function and measurable operative workspace in morbid obese patients subjected to laparoscopic surgeries. trialsearch.who.int/Trial2.aspx?TrialID=PACTR202210785932208 (first received 6 October 2022). ">PACTR202210785932208</a>), and seven trials are not yet recruiting (<a href="./references#CD013197-bbs2-0101" title="ChiCTR1900021989. Evaluation of pulmonary complications during laparoscopic surgery in patients with protective mechanical ventilation combined deep neuromuscular block. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR1900021989 (first received 19 March 2019). ">ChiCTR1900021989</a>; <a href="./references#CD013197-bbs2-0103" title="ChiCTR2000038699. Effects of perioperative goal-directed fluid therapy combined with the deep neuromuscular block on laparoscopic colorectal surgery. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR2000038699 (first received 29 September 2020). ">ChiCTR2000038699</a>; <a href="./references#CD013197-bbs2-0111" title="CTRI/2021/02/030999. Deep neuromuscular block on consumption of fentanyl in laparoscopic cholecystectomy. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2021/02/030999 (first received 4 February 2021). ">CTRI/2021/02/030999</a>; <a href="./references#CD013197-bbs2-0112" title="CTRI/2021/08/035975. Effect of low pressure pneumoperitoneum with deep neuromuscular block in patients undergoing laparoscopic cholecystectomy. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2021/08/035975 (first received 26 August 2021). ">CTRI/2021/08/035975</a>; <a href="./references#CD013197-bbs2-0116" title="NCT04211064. Comparison of the effects of deep and moderate neuromuscular blockade on optic nerve sheath diameter. clinicaltrials.gov/show/NCT04211064 (first received 26 December 2019). ">NCT04211064</a>; <a href="./references#CD013197-bbs2-0117" title="NCT04259112. Effect of pneumoperitoneum and neuromuscular block on renal function in diabetes patients. clinicaltrials.gov/show/NCT04259112 (first received 6 February 2020). ">NCT04259112</a>; <a href="./references#CD013197-bbs2-0118" title="NCT05344417. Low pressure pneumoperitoneum and postoperative ileus. clinicaltrials.gov/show/NCT05344417 (first received 25 April 2022). ">NCT05344417</a>). </p> </section> </section> </section> <section id="CD013197-sec-0060"> <h3 class="title">Risk of bias in included studies</h3> <p>The assessment of the risk of bias in the predefined domains is summarised in the risk of bias graph (<a href="#CD013197-fig-0002">Figure 2</a>) and the risk of bias summary (<a href="#CD013197-fig-0003">Figure 3</a>). We identified five trials at low risk of bias overall because they were at low risk of bias in all domains (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0013" title="Fuchs-BuderT , SchmartzD , BaumannC , HiltL , Nomine-CriquiC , MeistelmanC , et al. Deep neuromuscular blockade improves surgical conditions during gastric bypass surgery for morbid obesity: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):486-93. ">FuchsâBuder 2019</a>; <a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a>; <a href="./references#CD013197-bbs2-0040" title="YiIK , KimJS , HurH , HanDG , KimJE . Effects of deep neuromuscular block on surgical pleth index-guided remifentanil administration in laparoscopic herniorrhaphy: a prospective randomized trial. Scientific Reports2022;12(1):19176. ">Yi 2022</a>). </p> <div class="figure" id="CD013197-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013197-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD013197-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013197-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD013197-sec-0061"> <h4 class="title">Allocation</h4> <p>Forty trials (95%) provided sufficient information on random sequence generation to be considered at low risk of bias. Two trials did not describe random sequence generation and were at unclear risk of bias (<a href="./references#CD013197-bbs2-0026" title="LeeJ , AnJ , LeeDH , KimE , WooK , KimKH . Cortisol secretory patterns in deep and moderate neuromuscular blockades in laparoscopic surgery under total intravenous anesthesia: a prospective, single-blinded, randomized controlled trial. Medicine2022;101(39):e30702. ">Lee 2022</a>; <a href="./references#CD013197-bbs2-0038" title="TorensmaB , MartiniCH , BoonM , OlofsenE , VeldBI , LiemRS , et al. Deep neuromuscular block improves surgical conditions during bariatric surgery and reduces postoperative pain: a randomized double blind controlled trial. PLOS One2016;11(12):e0167907. ">Torensma 2016</a>). </p> <p>Twentyânine trials (69%) described adequate allocation concealment. Thirteen trials were regarded at unclear risk of bias as allocation concealment was not described properly (<a href="./references#CD013197-bbs2-0005" title="BarrioJ , ErrandoCL , Garcia-RamonJ , SellesR , San MiguelG , GallegoJ . Influence of depth of neuromuscular blockade on surgical conditions during low-pressure pneumoperitoneum laparoscopic cholecystectomy: a randomized blinded study. Journal of Clinical Anesthesia2017;42:26-30. ">Barrio 2017</a>; <a href="./references#CD013197-bbs2-0006" title="BlobnerM , FrickC , StaubleR , FeussnerH , SchallerS , UnterbuchnerC , et al. Neuromuscular blockade improves surgical conditions (NISCO). Surgical Endoscopy2014;29(3):627-36. ">Blobner 2014</a>; <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a>; <a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0020" title="KimJE , MinSK , HaE , LeeD , KimJY , KwakHJ . Effects of deep neuromuscular block with low-pressure pneumoperitoneum on respiratory mechanics and biotrauma in a steep Trendelenburg position. Scientific Reports2021;11(1):1935. ">Kim 2021a</a>; <a href="./references#CD013197-bbs2-0023" title="KooBW , OhAY , NaHS , LeeHJ , KangSB , KimDW , et al. Effects of depth of neuromuscular block on surgical conditions during laparoscopic colorectal surgery: a randomised controlled trial. Anaesthesia2018;73(9):1090-6. ">Koo 2018</a>; <a href="./references#CD013197-bbs2-0024" title="KooBW , OhAY , RyuJH , LeeYJ , HanJW , NamSW , et al. Effects of deep neuromuscular blockade on the stress response during laparoscopic gastrectomy randomized controlled trials. Scientific Reports2019;9(1):12411. ">Koo 2019</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0030" title="MartiniCH , BoonM , BeversRF , AartsLP , DahanA , ThompsonJP . Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. British Journal of Anaesthesia2014;112(3):498-505. ">Martini 2014</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0034" title="ParkSH , HuhH , ChoiSI , KimJH , JangYJ , ParkJM , et al. Impact of the deep neuromuscular block on oncologic quality of laparoscopic surgery in obese gastric cancer patients: a randomized clinical trial. Journal of the American College of Surgeons2022;234(3):326-39. ">Park 2022</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>; <a href="./references#CD013197-bbs2-0042" title="ZhuSJ , ZhangXL , XieQ , ZhouYF , WangKR . Comparison of the effects of deep and moderate neuromuscular block on respiratory system compliance and surgical space conditions during robot-assisted laparoscopic radical prostatectomy: a randomized clinical study. Journal of Zhejiang University. Science B2020;21(8):637-45. ">Zhu 2020</a>). </p> </section> <section id="CD013197-sec-0062"> <h4 class="title">Blinding</h4> <p>Thirty trials (71%) were at low risk of bias regarding blinding of participants and personnel (performance bias). </p> <p>Thirtyâone trials (74%) were at low risk of bias regarding blinding of outcome assessment (detection bias). </p> <p>Eleven trials were at unclear risk of performance bias (<a href="./references#CD013197-bbs2-0006" title="BlobnerM , FrickC , StaubleR , FeussnerH , SchallerS , UnterbuchnerC , et al. Neuromuscular blockade improves surgical conditions (NISCO). Surgical Endoscopy2014;29(3):627-36. ">Blobner 2014</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0010" title="Choi B-M, Ki S-H, Lee Y-H, Gong C-S, Kim H-S, Lee I-S, et al. Effects of depth of neuromuscular block on postoperative pain during laparoscopic gastrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(11):863-70. ">Choi 2019</a>; <a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0024" title="KooBW , OhAY , RyuJH , LeeYJ , HanJW , NamSW , et al. Effects of deep neuromuscular blockade on the stress response during laparoscopic gastrectomy randomized controlled trials. Scientific Reports2019;9(1):12411. ">Koo 2019</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0030" title="MartiniCH , BoonM , BeversRF , AartsLP , DahanA , ThompsonJP . Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. British Journal of Anaesthesia2014;112(3):498-505. ">Martini 2014</a>; <a href="./references#CD013197-bbs2-0031" title="Na H-S, Lim D-J, Koo B-W, Oh A-Y, Lee P-B. The influence of moderate or deep neuromuscular block status on anesthetic depth monitoring system during total intravenous anesthesia using propofol and remifentanil: a randomized trial. Science Progress2021;104(2):368504211010629. ">Na 2021</a>; <a href="./references#CD013197-bbs2-0032" title="NamSW , OhAY , KooBW , KimBY , HanJ , ChungSH . Effects of depth of neuromuscular blockade on the BIS-guided propofol requirement: a randomized controlled trial. Medicine2021;100(29):e26576. ">Nam 2021</a>; <a href="./references#CD013197-bbs2-0035" title="DuboisPE , PutzL , JamartJ , MarottaML , GourdinM , DonnezO . Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. European Journal of Anaesthesiology2014;31(8):430-6. PutzL , DransartC , JamartJ , Marotta M-L, DelnoozG , DuboisPE . Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial. Journal of Clinical Anesthesia2016;35:107-13. ">Putz 2016</a>; <a href="./references#CD013197-bbs2-0038" title="TorensmaB , MartiniCH , BoonM , OlofsenE , VeldBI , LiemRS , et al. Deep neuromuscular block improves surgical conditions during bariatric surgery and reduces postoperative pain: a randomized double blind controlled trial. PLOS One2016;11(12):e0167907. ">Torensma 2016</a>), and 10 trials at unclear risk of detection bias (<a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0010" title="Choi B-M, Ki S-H, Lee Y-H, Gong C-S, Kim H-S, Lee I-S, et al. Effects of depth of neuromuscular block on postoperative pain during laparoscopic gastrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(11):863-70. ">Choi 2019</a>; <a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0030" title="MartiniCH , BoonM , BeversRF , AartsLP , DahanA , ThompsonJP . Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. British Journal of Anaesthesia2014;112(3):498-505. ">Martini 2014</a>; <a href="./references#CD013197-bbs2-0031" title="Na H-S, Lim D-J, Koo B-W, Oh A-Y, Lee P-B. The influence of moderate or deep neuromuscular block status on anesthetic depth monitoring system during total intravenous anesthesia using propofol and remifentanil: a randomized trial. Science Progress2021;104(2):368504211010629. ">Na 2021</a>; <a href="./references#CD013197-bbs2-0032" title="NamSW , OhAY , KooBW , KimBY , HanJ , ChungSH . Effects of depth of neuromuscular blockade on the BIS-guided propofol requirement: a randomized controlled trial. Medicine2021;100(29):e26576. ">Nam 2021</a>; <a href="./references#CD013197-bbs2-0035" title="DuboisPE , PutzL , JamartJ , MarottaML , GourdinM , DonnezO . Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. European Journal of Anaesthesiology2014;31(8):430-6. PutzL , DransartC , JamartJ , Marotta M-L, DelnoozG , DuboisPE . Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial. Journal of Clinical Anesthesia2016;35:107-13. ">Putz 2016</a>; <a href="./references#CD013197-bbs2-0038" title="TorensmaB , MartiniCH , BoonM , OlofsenE , VeldBI , LiemRS , et al. Deep neuromuscular block improves surgical conditions during bariatric surgery and reduces postoperative pain: a randomized double blind controlled trial. PLOS One2016;11(12):e0167907. ">Torensma 2016</a>), mostly due to inadequate description of blinding of participants, which is important for reporting healthârelated quality of life and postoperative pain scores. </p> <p>One trial was at high risk of both performance and detection bias since it was singleâblinded with only the surgeon blinded (<a href="./references#CD013197-bbs2-0026" title="LeeJ , AnJ , LeeDH , KimE , WooK , KimKH . Cortisol secretory patterns in deep and moderate neuromuscular blockades in laparoscopic surgery under total intravenous anesthesia: a prospective, single-blinded, randomized controlled trial. Medicine2022;101(39):e30702. ">Lee 2022</a>). </p> <p>Although in several trials the attending anaesthesiologist was not blinded as he or she was responsible for the depth of NMB, this was not regarded as a risk of bias as this anaesthesiologist had no role in outcome measures (unclear risk of bias). </p> </section> <section id="CD013197-sec-0063"> <h4 class="title">Incomplete outcome data</h4> <p>Most trials (86%) adequately reported missing data, and how missing data were handled (low risk of bias). Four trials were at unclear risk of attrition bias (<a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0022" title="KooBW , OhAY , SeoKS , HanJW , HanHS , YoonYS . Randomized clinical trial of moderate versus deep neuromuscular block for low-pressure pneumoperitoneum during laparoscopic cholecystectomy. World Journal of Surgery2016;40(12):2898-903. ">Koo 2016</a>; <a href="./references#CD013197-bbs2-0025" title="Koo C-H, ParkI , AhnS , LeeS , Ryu J-H. Effect of neuromuscular blockade on intraoperative respiratory mechanics and surgical space conditions during robot-assisted radical prostatectomy: a prospective randomized controlled trial. Journal of Clinical Medicine2021;10(21):5090. ">Koo 2021</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>). Two trials were at high risk of attrition bias (<a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0042" title="ZhuSJ , ZhangXL , XieQ , ZhouYF , WangKR . Comparison of the effects of deep and moderate neuromuscular block on respiratory system compliance and surgical space conditions during robot-assisted laparoscopic radical prostatectomy: a randomized clinical study. Journal of Zhejiang University. Science B2020;21(8):637-45. ">Zhu 2020</a>). </p> </section> <section id="CD013197-sec-0064"> <h4 class="title">Selective reporting</h4> <p>Twentyâthree trials were at low risk of selective outcome reporting. Three trials were at unclear risk of selective reporting bias (<a href="./references#CD013197-bbs2-0004" title="BakhetWZ . A randomized trial comparing deep and moderate neuromuscular blockade in patients undergoing ambulatory gynecologic laparoscopy. Ain-Shams Journal of Anesthesiology2020;12(1):25. ">Bakhet 2020</a>; <a href="./references#CD013197-bbs2-0018" title="KimMH , LeeKY , LeeKY , MinBS , YooYC . Maintaining optimal surgical conditions with low insufflation pressures is possible with deep neuromuscular blockade during laparoscopic colorectal surgery: a prospective, randomized, double-blind, parallel-group clinical trial. Medicine2016;95(9):e2920. ">Kim 2016</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>). Sixteen trials were at high risk of selective reporting bias (<a href="./references#CD013197-bbs2-0003" title="BaeteS , VercruysseG , Vander LaenenM , De VooghtP , Van MelkebeekJ , DylstD , et al. The effect of deep versus moderate neuromuscular block on surgical conditions and postoperative respiratory function in bariatric laparoscopic surgery: a randomized, double blind clinical trial. Anesthesia &amp; Analgesia2017;124(5):1469-75. ">Baete 2017</a>; <a href="./references#CD013197-bbs2-0011" title="CovielloA , IannielloM , BuonannoP , Di FalcoN , IacovazzoC , MarescaA , et al. Effects of depth of neuromuscular block on surgical operating conditions in women undergoing gynecologic laparoscopic surgery: a randomized clinical trial. Journal of Anesthesia, Analgesia and Critical Care2023;3(1):2. [DOI: 10.1186/s44158-023-00086-7]">Coviello 2023</a>; <a href="./references#CD013197-bbs2-0017" title="KathopoulisN , ProtopapasA , StamatakisE , ChatzipapasI , ZacharakisD , GrigoriadisT , et al. Deep versus moderate neuromuscular blockade in gynecologic laparoscopic operations: randomized controlled trial. Journal of Personalized Medicine2022;12(4):561. ">Kathopoulis 2022</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0020" title="KimJE , MinSK , HaE , LeeD , KimJY , KwakHJ . Effects of deep neuromuscular block with low-pressure pneumoperitoneum on respiratory mechanics and biotrauma in a steep Trendelenburg position. Scientific Reports2021;11(1):1935. ">Kim 2021a</a>; <a href="./references#CD013197-bbs2-0021" title="KimMH , KimNY , YooYC , KongHJ , LeeHS , JoA , et al. Influence of deep neuromuscular blockade on perioperative stress response in patients undergoing robot-assisted gastrectomy: a prospective double-blinded randomized-controlled trial. Journal of Personalized Medicine2021;11(12):1308. ">Kim 2021b</a>; <a href="./references#CD013197-bbs2-0022" title="KooBW , OhAY , SeoKS , HanJW , HanHS , YoonYS . Randomized clinical trial of moderate versus deep neuromuscular block for low-pressure pneumoperitoneum during laparoscopic cholecystectomy. World Journal of Surgery2016;40(12):2898-903. ">Koo 2016</a>; <a href="./references#CD013197-bbs2-0023" title="KooBW , OhAY , NaHS , LeeHJ , KangSB , KimDW , et al. Effects of depth of neuromuscular block on surgical conditions during laparoscopic colorectal surgery: a randomised controlled trial. Anaesthesia2018;73(9):1090-6. ">Koo 2018</a>; <a href="./references#CD013197-bbs2-0025" title="Koo C-H, ParkI , AhnS , LeeS , Ryu J-H. Effect of neuromuscular blockade on intraoperative respiratory mechanics and surgical space conditions during robot-assisted radical prostatectomy: a prospective randomized controlled trial. Journal of Clinical Medicine2021;10(21):5090. ">Koo 2021</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0030" title="MartiniCH , BoonM , BeversRF , AartsLP , DahanA , ThompsonJP . Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. British Journal of Anaesthesia2014;112(3):498-505. ">Martini 2014</a>; <a href="./references#CD013197-bbs2-0031" title="Na H-S, Lim D-J, Koo B-W, Oh A-Y, Lee P-B. The influence of moderate or deep neuromuscular block status on anesthetic depth monitoring system during total intravenous anesthesia using propofol and remifentanil: a randomized trial. Science Progress2021;104(2):368504211010629. ">Na 2021</a>; <a href="./references#CD013197-bbs2-0036" title="RosenbergJ , HerringWJ , BlobnerM , MulierJP , Rahe-MeyerN , WooT , et al. Deep neuromuscular blockade improves laparoscopic surgical conditions: a randomized, controlled study. Advances in Therapy2017;34(4):925-36. ">Rosenberg 2017</a>; <a href="./references#CD013197-bbs2-0038" title="TorensmaB , MartiniCH , BoonM , OlofsenE , VeldBI , LiemRS , et al. Deep neuromuscular block improves surgical conditions during bariatric surgery and reduces postoperative pain: a randomized double blind controlled trial. PLOS One2016;11(12):e0167907. ">Torensma 2016</a>; <a href="./references#CD013197-bbs2-0041" title="YooYC , KimNY , ShinS , ChoiYD , HongJH , KimCY , et al. The intraocular pressure under deep versus moderate neuromuscular blockade during low-pressure robot assisted laparoscopic radical prostatectomy in a randomized trial. PLOS One2015;10(8):e0135412. ">Yoo 2015</a>; <a href="./references#CD013197-bbs2-0042" title="ZhuSJ , ZhangXL , XieQ , ZhouYF , WangKR . Comparison of the effects of deep and moderate neuromuscular block on respiratory system compliance and surgical space conditions during robot-assisted laparoscopic radical prostatectomy: a randomized clinical study. Journal of Zhejiang University. Science B2020;21(8):637-45. ">Zhu 2020</a>). This was due to discrepancies between protocol or trial registries in 14 trials (33%) or due to nonâreporting of clinically relevant outcomes in 10 trials (24%), or both. </p> </section> <section id="CD013197-sec-0065"> <h4 class="title">Other potential sources of bias</h4> <p>Thirtyâthree trial were at low risk of other bias. Five trials were at unclear risk of other bias (<a href="./references#CD013197-bbs2-0001" title="Abu YazedMM , AhmedSA . Deep versus moderate neuromuscular block in laparoscopic bariatric surgeries: effect on surgical conditions and pulmonary complications. Egyptian Journal of Anaesthesia2019;35(1):5-58. ">Abu Yazed 2019</a>; <a href="./references#CD013197-bbs2-0016" title="HuangH , ZhouL , YuY , LiuS , XuH , XuZ , et al. Comparison of deep and moderate neuromuscular blockade on intestinal mucosal barrier in laparoscopic gastrectomy: a prospective, randomized, double-blind clinical trial. Frontiers in Medicine2021;8:789597. ">Huang 2021</a>; <a href="./references#CD013197-bbs2-0021" title="KimMH , KimNY , YooYC , KongHJ , LeeHS , JoA , et al. Influence of deep neuromuscular blockade on perioperative stress response in patients undergoing robot-assisted gastrectomy: a prospective double-blinded randomized-controlled trial. Journal of Personalized Medicine2021;11(12):1308. ">Kim 2021b</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0036" title="RosenbergJ , HerringWJ , BlobnerM , MulierJP , Rahe-MeyerN , WooT , et al. Deep neuromuscular blockade improves laparoscopic surgical conditions: a randomized, controlled study. Advances in Therapy2017;34(4):925-36. ">Rosenberg 2017</a>). Four trials were at high risk of other bias (<a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0023" title="KooBW , OhAY , NaHS , LeeHJ , KangSB , KimDW , et al. Effects of depth of neuromuscular block on surgical conditions during laparoscopic colorectal surgery: a randomised controlled trial. Anaesthesia2018;73(9):1090-6. ">Koo 2018</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a>). Trials were at high risk or unclear risk mainly due to inadequate description of dosing or measurement of NMB or due to poor description of outcome units. </p> <p>Detailed reasoning is provided in the <a href="./references#CD013197-sec-0151" title="">Characteristics of included studies</a> table. </p> </section> </section> <section id="CD013197-sec-0066"> <h3 class="title" id="CD013197-sec-0066">Effects of interventions</h3> <p>See: <a href="./full#CD013197-tbl-0001"><b>Summary of findings 1</b> Summary of findings table â Deep neuromuscular blockade (NMB) compared to moderate NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</a>; <a href="./full#CD013197-tbl-0002"><b>Summary of findings 2</b> Summary of findings table â Deep neuromuscular blockade (NMB) compared to shallow NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</a>; <a href="./full#CD013197-tbl-0003"><b>Summary of findings 3</b> Summary of findings table â Deep neuromuscular blockade (NMB) compared to no NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</a> </p> <section id="CD013197-sec-0067"> <h4 class="title">Comparison 1. Deep neuromuscular blockade versus moderate neuromuscular blockade</h4> <p>See <a href="./full#CD013197-tbl-0001">summary of findings Table 1</a> and <a href="#CD013197-tbl-0004">Table 1</a>. </p> <section id="CD013197-sec-0068"> <h5 class="title">Primary outcome: mortality</h5> <section id="CD013197-sec-0069"> <h6 class="title">Start of surgery until eight hours after surgery</h6> <p>Seventeen trials reported intraoperative mortality data (<a href="./references#CD013197-bbs2-0001" title="Abu YazedMM , AhmedSA . Deep versus moderate neuromuscular block in laparoscopic bariatric surgeries: effect on surgical conditions and pulmonary complications. Egyptian Journal of Anaesthesia2019;35(1):5-58. ">Abu Yazed 2019</a>; <a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0005" title="BarrioJ , ErrandoCL , Garcia-RamonJ , SellesR , San MiguelG , GallegoJ . Influence of depth of neuromuscular blockade on surgical conditions during low-pressure pneumoperitoneum laparoscopic cholecystectomy: a randomized blinded study. Journal of Clinical Anesthesia2017;42:26-30. ">Barrio 2017</a>; <a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0010" title="Choi B-M, Ki S-H, Lee Y-H, Gong C-S, Kim H-S, Lee I-S, et al. Effects of depth of neuromuscular block on postoperative pain during laparoscopic gastrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(11):863-70. ">Choi 2019</a>; <a href="./references#CD013197-bbs2-0013" title="Fuchs-BuderT , SchmartzD , BaumannC , HiltL , Nomine-CriquiC , MeistelmanC , et al. Deep neuromuscular blockade improves surgical conditions during gastric bypass surgery for morbid obesity: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):486-93. ">FuchsâBuder 2019</a>; <a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0016" title="HuangH , ZhouL , YuY , LiuS , XuH , XuZ , et al. Comparison of deep and moderate neuromuscular blockade on intestinal mucosal barrier in laparoscopic gastrectomy: a prospective, randomized, double-blind clinical trial. Frontiers in Medicine2021;8:789597. ">Huang 2021</a>; <a href="./references#CD013197-bbs2-0018" title="KimMH , LeeKY , LeeKY , MinBS , YooYC . Maintaining optimal surgical conditions with low insufflation pressures is possible with deep neuromuscular blockade during laparoscopic colorectal surgery: a prospective, randomized, double-blind, parallel-group clinical trial. Medicine2016;95(9):e2920. ">Kim 2016</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0032" title="NamSW , OhAY , KooBW , KimBY , HanJ , ChungSH . Effects of depth of neuromuscular blockade on the BIS-guided propofol requirement: a randomized controlled trial. Medicine2021;100(29):e26576. ">Nam 2021</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>). There was zero mortality in either group in these trials (888 participants in the deep NMB group and 812 participants in the moderate NMB group). </p> <section id="CD013197-sec-0070"> <p><b>Sensitivity analysis</b></p> <p>Since no mortality occurred, no Trial Sequential Analysis was performed.</p> </section> </section> <section id="CD013197-sec-0071"> <h6 class="title">Shortâterm mortality: inâhospital or within three months</h6> <p>Twelve trials reported data on shortâterm mortality (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a>; <a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0016" title="HuangH , ZhouL , YuY , LiuS , XuH , XuZ , et al. Comparison of deep and moderate neuromuscular blockade on intestinal mucosal barrier in laparoscopic gastrectomy: a prospective, randomized, double-blind clinical trial. Frontiers in Medicine2021;8:789597. ">Huang 2021</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>). Ten of these trials reported no events in either group (<a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0016" title="HuangH , ZhouL , YuY , LiuS , XuH , XuZ , et al. Comparison of deep and moderate neuromuscular blockade on intestinal mucosal barrier in laparoscopic gastrectomy: a prospective, randomized, double-blind clinical trial. Frontiers in Medicine2021;8:789597. ">Huang 2021</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>). Followâup ranged from three to 60 days postoperative. </p> <p>Only <a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a> and <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a> registered one death of a participant, both in the deep NMB group (Peto OR 7.22, 95% CI 0.45 to 115.43; 12 trials, 1390 participants; very lowâcertainty evidence; <a href="./references#CD013197-fig-0020" title="">Analysis 1.1</a>). There was no change in the interpretation of the results using the randomâeffects model. </p> <section id="CD013197-sec-0072"> <p><b>Sensitivity analysis</b></p> <p>Trial Sequential Analysis revealed that the DARIS was 266,217 participants, calculated based on a proportion of events of 2% in the control group, a risk ratio reduction of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 12 trials (1390 participants). The alpha spending function was ignored because we accrued less than 5% of the required participants, hence no conclusive evidence was found (<a href="#CD013197-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD013197-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on allâcause mortality (short term) in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) represents the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 266,217 participants, calculated based on an assumed proportion of events of 2% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 12 trials (1390 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of a Zâvalue, corresponding to a P value of 0.05." data-id="CD013197-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on allâcause mortality (short term) in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) represents the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 266,217 participants, calculated based on an assumed proportion of events of 2% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 12 trials (1390 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of a Zâvalue, corresponding to a P value of 0.05. </p> </div> </div> </div> </section> </section> <section id="CD013197-sec-0073"> <h6 class="title">Longâterm mortality: more than three months</h6> <p>No trials reported longâterm mortality.</p> </section> </section> <section id="CD013197-sec-0074"> <h5 class="title">Primary outcome: healthârelated quality of life</h5> <section id="CD013197-sec-0075"> <h6 class="title">Shortâterm (within three months)</h6> <p>Five trials reported shortâterm healthârelated quality of life (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0004" title="BakhetWZ . A randomized trial comparing deep and moderate neuromuscular blockade in patients undergoing ambulatory gynecologic laparoscopy. Ain-Shams Journal of Anesthesiology2020;12(1):25. ">Bakhet 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>). All trial used the Quality of Recovery questionnaire. Four trials measured on the first postoperative day (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0004" title="BakhetWZ . A randomized trial comparing deep and moderate neuromuscular blockade in patients undergoing ambulatory gynecologic laparoscopy. Ain-Shams Journal of Anesthesiology2020;12(1):25. ">Bakhet 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>). <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a> measured on the fourth postoperative day. </p> <p>Deep NMB likely results in little to no difference in healthârelated quality of life up to four days postoperative (MD 4.53 favouring deep NMB on the Quality of Recoveryâ40 score, 95% CI 0.96 to 8.09; 5 trials, 440 participants; moderateâcertainty evidence; difference lower than the mean clinically important difference of 10 points). The standard deviation was imputed in one trial (<a href="./references#CD013197-bbs2-0004" title="BakhetWZ . A randomized trial comparing deep and moderate neuromuscular blockade in patients undergoing ambulatory gynecologic laparoscopy. Ain-Shams Journal of Anesthesiology2020;12(1):25. ">Bakhet 2020</a>). Exclusion of the latter trial did not alter the results (MD 5.03 points on the Quality of Recoveryâ40, 95% CI 0.89 to 9.17). </p> <section id="CD013197-sec-0076"> <p><b>Sensitivity analysis</b></p> <p>Trial Sequential Analysis showed that the DARIS was 213 participants, calculated based on a variance of 317.48 in the control group, MIREDIF of 10 points, alpha (type I error) of 1.25%, beta (type II error) of 10%, and diversity of 0%. The cumulative Zâcurve breached the futility boundary, entering the futility area after one trial (91 participants) and crossing the DARIS after three trials (231 participants). This demonstrates that deep NMB may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with moderate NMB on healthârelated quality of life. The 95% CIs were 0.96 to 8.09 (<a href="#CD013197-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD013197-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on health related quality of life (short term) in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. TSA showed that the diversityâadjusted required information size (DARIS) was 213 participants, calculated based on a variance of 317.48 in the control group, minimal relevant difference (MIREDIF) of 10 points, alpha (type I error) of 1.25%, beta (type II error) of 10%, and diversity of 0%. The cumulative Zâcurve breached the futility boundary entering the futility area after one trial (91 participants) and crossed the DARIS after three trials (231 participants), demonstrating that deep neuromuscular blockade may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with moderate neuromuscular blockade on healthârelated quality of life. The 95% CIs were 0.96 to 8.09. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of a Zâvalue, corresponding to a P value of 0.05. The red lines from the left top and bottom corners show the trial sequential boundaries for benefit and harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows the futility boundaries and futility area of the TSA." data-id="CD013197-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on health related quality of life (short term) in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. TSA showed that the diversityâadjusted required information size (DARIS) was 213 participants, calculated based on a variance of 317.48 in the control group, minimal relevant difference (MIREDIF) of 10 points, alpha (type I error) of 1.25%, beta (type II error) of 10%, and diversity of 0%. The cumulative Zâcurve breached the futility boundary entering the futility area after one trial (91 participants) and crossed the DARIS after three trials (231 participants), demonstrating that deep neuromuscular blockade may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with moderate neuromuscular blockade on healthârelated quality of life. The 95% CIs were 0.96 to 8.09. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of a Zâvalue, corresponding to a P value of 0.05. The red lines from the left top and bottom corners show the trial sequential boundaries for benefit and harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows the futility boundaries and futility area of the TSA. </p> </div> </div> </div> </section> </section> <section id="CD013197-sec-0077"> <h6 class="title">Mediumâterm (longer than three months to one year)</h6> <p>Only one trial reported mediumâterm healthârelated quality of life (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>). This was measured by the RANDâ36 questionnaire after three months. </p> <p>The study authors found no difference between groups (MD â0.50 points on the RANDâ36, 95% CI â5.17 to 4.17; 178 participants; <a href="./references#CD013197-fig-0022" title="">Analysis 1.3</a>). </p> <section id="CD013197-sec-0078"> <p><b>Sensitivity analysis</b></p> <p>No Trial Sequential Analysis was not performed since only one trial reported this outcome. </p> </section> </section> </section> <section id="CD013197-sec-0079"> <h5 class="title">Primary outcome: proportion of participants with serious adverse events</h5> <section id="CD013197-sec-0080"> <h6 class="title">Start of surgery until eight hours after surgery</h6> <p>Twentyâone trials reported SAEs up to eight hours after surgery (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0005" title="BarrioJ , ErrandoCL , Garcia-RamonJ , SellesR , San MiguelG , GallegoJ . Influence of depth of neuromuscular blockade on surgical conditions during low-pressure pneumoperitoneum laparoscopic cholecystectomy: a randomized blinded study. Journal of Clinical Anesthesia2017;42:26-30. ">Barrio 2017</a>; <a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0010" title="Choi B-M, Ki S-H, Lee Y-H, Gong C-S, Kim H-S, Lee I-S, et al. Effects of depth of neuromuscular block on postoperative pain during laparoscopic gastrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(11):863-70. ">Choi 2019</a>; <a href="./references#CD013197-bbs2-0011" title="CovielloA , IannielloM , BuonannoP , Di FalcoN , IacovazzoC , MarescaA , et al. Effects of depth of neuromuscular block on surgical operating conditions in women undergoing gynecologic laparoscopic surgery: a randomized clinical trial. Journal of Anesthesia, Analgesia and Critical Care2023;3(1):2. [DOI: 10.1186/s44158-023-00086-7]">Coviello 2023</a>; <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a>; <a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0016" title="HuangH , ZhouL , YuY , LiuS , XuH , XuZ , et al. Comparison of deep and moderate neuromuscular blockade on intestinal mucosal barrier in laparoscopic gastrectomy: a prospective, randomized, double-blind clinical trial. Frontiers in Medicine2021;8:789597. ">Huang 2021</a>; <a href="./references#CD013197-bbs2-0018" title="KimMH , LeeKY , LeeKY , MinBS , YooYC . Maintaining optimal surgical conditions with low insufflation pressures is possible with deep neuromuscular blockade during laparoscopic colorectal surgery: a prospective, randomized, double-blind, parallel-group clinical trial. Medicine2016;95(9):e2920. ">Kim 2016</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0024" title="KooBW , OhAY , RyuJH , LeeYJ , HanJW , NamSW , et al. Effects of deep neuromuscular blockade on the stress response during laparoscopic gastrectomy randomized controlled trials. Scientific Reports2019;9(1):12411. ">Koo 2019</a>; <a href="./references#CD013197-bbs2-0026" title="LeeJ , AnJ , LeeDH , KimE , WooK , KimKH . Cortisol secretory patterns in deep and moderate neuromuscular blockades in laparoscopic surgery under total intravenous anesthesia: a prospective, single-blinded, randomized controlled trial. Medicine2022;101(39):e30702. ">Lee 2022</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0032" title="NamSW , OhAY , KooBW , KimBY , HanJ , ChungSH . Effects of depth of neuromuscular blockade on the BIS-guided propofol requirement: a randomized controlled trial. Medicine2021;100(29):e26576. ">Nam 2021</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0040" title="YiIK , KimJS , HurH , HanDG , KimJE . Effects of deep neuromuscular block on surgical pleth index-guided remifentanil administration in laparoscopic herniorrhaphy: a prospective randomized trial. Scientific Reports2022;12(1):19176. ">Yi 2022</a>; <a href="./references#CD013197-bbs2-0041" title="YooYC , KimNY , ShinS , ChoiYD , HongJH , KimCY , et al. The intraocular pressure under deep versus moderate neuromuscular blockade during low-pressure robot assisted laparoscopic radical prostatectomy in a randomized trial. PLOS One2015;10(8):e0135412. ">Yoo 2015</a>). Seven of these trials reported SAEs; however, they encountered no SAEs in any of the groups (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0005" title="BarrioJ , ErrandoCL , Garcia-RamonJ , SellesR , San MiguelG , GallegoJ . Influence of depth of neuromuscular blockade on surgical conditions during low-pressure pneumoperitoneum laparoscopic cholecystectomy: a randomized blinded study. Journal of Clinical Anesthesia2017;42:26-30. ">Barrio 2017</a>; <a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0032" title="NamSW , OhAY , KooBW , KimBY , HanJ , ChungSH . Effects of depth of neuromuscular blockade on the BIS-guided propofol requirement: a randomized controlled trial. Medicine2021;100(29):e26576. ">Nam 2021</a>). </p> <p>The proportion of the events was low in both groups (deep NMB 38/1155 versus moderate NMB 38/1076). There may be no effect of deep NMB on the proportion of SAEs (Peto OR 0.95, 95% CI 0.59 to 1.52; 21 trials, 2231 participants; very lowâcertainty evidence; <a href="./references#CD013197-fig-0023" title="">Analysis 1.4</a>). There was no change in the interpretation of the results using the randomâeffects model. </p> <section id="CD013197-sec-0081"> <p><b>Sensitivity analysis</b></p> <p>Trial Sequential Analysis showed that the DARIS was 149,915 participants, calculated based on the proportion of events of 3.5% in the control group, a risk ratio reduction of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross the conventional boundaries after the inclusion of 21 trials (2231 participants). The alpha spending function was ignored because we accrued less than 5% of the required participants. As a result, there was no conclusive evidence (<a href="#CD013197-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD013197-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on serious adverse event (start of surgery until 8 hours after surgery) in adults undergoing an abdominal laparoscopic procedureâ¨The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 149,915 participants, calculated based on the proportion of events of 3.5% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross the conventional boundaries after inclusion of 21 trials (2231 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05." data-id="CD013197-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on serious adverse event (start of surgery until 8 hours after surgery) in adults undergoing an abdominal laparoscopic procedure</b><br/>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 149,915 participants, calculated based on the proportion of events of 3.5% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross the conventional boundaries after inclusion of 21 trials (2231 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. </p> </div> </div> </div> </section> </section> <section id="CD013197-sec-0082"> <h6 class="title">Shortâterm (within three months)</h6> <p>Sixteen trials reported on shortâterm SAEs, followâup differed from three to 60 days postoperative (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a>; <a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0021" title="KimMH , KimNY , YooYC , KongHJ , LeeHS , JoA , et al. Influence of deep neuromuscular blockade on perioperative stress response in patients undergoing robot-assisted gastrectomy: a prospective double-blinded randomized-controlled trial. Journal of Personalized Medicine2021;11(12):1308. ">Kim 2021b</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0032" title="NamSW , OhAY , KooBW , KimBY , HanJ , ChungSH . Effects of depth of neuromuscular blockade on the BIS-guided propofol requirement: a randomized controlled trial. Medicine2021;100(29):e26576. ">Nam 2021</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0034" title="ParkSH , HuhH , ChoiSI , KimJH , JangYJ , ParkJM , et al. Impact of the deep neuromuscular block on oncologic quality of laparoscopic surgery in obese gastric cancer patients: a randomized clinical trial. Journal of the American College of Surgeons2022;234(3):326-39. ">Park 2022</a>; <a href="./references#CD013197-bbs2-0036" title="RosenbergJ , HerringWJ , BlobnerM , MulierJP , Rahe-MeyerN , WooT , et al. Deep neuromuscular blockade improves laparoscopic surgical conditions: a randomized, controlled study. Advances in Therapy2017;34(4):925-36. ">Rosenberg 2017</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>). Two of these trials encountered no SAEs in either group (<a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>). </p> <p>There was very lowâcertainty evidence that there may be no difference in the proportion of shortâterm SAEs between the two groups (Peto OR 0.90, 95% CI 0.56 to 1.42; 16 trials, 1764 participants; very lowâcertainty evidence; <a href="./references#CD013197-fig-0024" title="">Analysis 1.5</a>). There was no change in the interpretation of the results using the randomâeffects model. </p> <section id="CD013197-sec-0083"> <p><b>Sensitivity analysis</b></p> <p>Trial Sequential Analysis showed that the DARIS was 105,609 participants, calculated based on the proportion of events of 4.9% in the control group, a risk ratio reduction of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross the conventional boundaries after the inclusion of 16 trials (1764 participants). The alpha spending function was ignored because we accrued less than 5% of the required participants, hence there was no conclusive evidence found (<a href="#CD013197-fig-0007">Figure 7</a>). </p> <div class="figure" id="CD013197-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on serious adverse event (short term) in adults undergoing an abdominal laparoscopic procedure. The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 105,609 participants, calculated based on the proportion of events of 4.9% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 16 trials (1764 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function is ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naive metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05." data-id="CD013197-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on serious adverse event (short term) in adults undergoing an abdominal laparoscopic procedure.</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 105,609 participants, calculated based on the proportion of events of 4.9% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 16 trials (1764 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function is ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naive metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. </p> </div> </div> </div> </section> </section> </section> <section id="CD013197-sec-0084"> <h5 class="title">Secondary outcome: proportion of participants with nonâserious adverse events</h5> <section id="CD013197-sec-0085"> <h6 class="title">Start of surgery until eight hours after surgery</h6> <p>Eleven trials reported nSAEs from the start of surgery until eight hours after surgery (<a href="./references#CD013197-bbs2-0001" title="Abu YazedMM , AhmedSA . Deep versus moderate neuromuscular block in laparoscopic bariatric surgeries: effect on surgical conditions and pulmonary complications. Egyptian Journal of Anaesthesia2019;35(1):5-58. ">Abu Yazed 2019</a>; <a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0003" title="BaeteS , VercruysseG , Vander LaenenM , De VooghtP , Van MelkebeekJ , DylstD , et al. The effect of deep versus moderate neuromuscular block on surgical conditions and postoperative respiratory function in bariatric laparoscopic surgery: a randomized, double blind clinical trial. Anesthesia &amp; Analgesia2017;124(5):1469-75. ">Baete 2017</a>; <a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0011" title="CovielloA , IannielloM , BuonannoP , Di FalcoN , IacovazzoC , MarescaA , et al. Effects of depth of neuromuscular block on surgical operating conditions in women undergoing gynecologic laparoscopic surgery: a randomized clinical trial. Journal of Anesthesia, Analgesia and Critical Care2023;3(1):2. [DOI: 10.1186/s44158-023-00086-7]">Coviello 2023</a>; <a href="./references#CD013197-bbs2-0017" title="KathopoulisN , ProtopapasA , StamatakisE , ChatzipapasI , ZacharakisD , GrigoriadisT , et al. Deep versus moderate neuromuscular blockade in gynecologic laparoscopic operations: randomized controlled trial. Journal of Personalized Medicine2022;12(4):561. ">Kathopoulis 2022</a>; <a href="./references#CD013197-bbs2-0018" title="KimMH , LeeKY , LeeKY , MinBS , YooYC . Maintaining optimal surgical conditions with low insufflation pressures is possible with deep neuromuscular blockade during laparoscopic colorectal surgery: a prospective, randomized, double-blind, parallel-group clinical trial. Medicine2016;95(9):e2920. ">Kim 2016</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0040" title="YiIK , KimJS , HurH , HanDG , KimJE . Effects of deep neuromuscular block on surgical pleth index-guided remifentanil administration in laparoscopic herniorrhaphy: a prospective randomized trial. Scientific Reports2022;12(1):19176. ">Yi 2022</a>). Three of these trials reported that no nSAE had occurred (<a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>). </p> <p>The evidence is very uncertain about the effect of deep NMB on nSAEs (Peto OR 0.68, 95% CI 0.41 to 1.11; 11 trials, 1210 participants; very lowâcertainty evidence; <a href="./references#CD013197-fig-0025" title="">Analysis 1.6</a>). There was no change in the interpretation of the results using the randomâeffects model. </p> <section id="CD013197-sec-0086"> <p><b>Sensitivity analysis</b></p> <p>Trial Sequential Analysis showed that the DARIS was 107,134 participants, calculated based on the proportion of events of 6.8% in the control group, a risk ratio reduction of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 25%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 11 trials (1210 participants). The alpha spending function was ignored because we accrued less than 5% of the required participants, hence there was no conclusive evidence found (<a href="#CD013197-fig-0008">Figure 8</a>). </p> <div class="figure" id="CD013197-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on nonâserious adverse event (start of surgery until eight hours after surgery) in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 107,134 participants, calculated based on the proportion of events of 6.8% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 25%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 11 trials (1210 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05." data-id="CD013197-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on nonâserious adverse event (start of surgery until eight hours after surgery) in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 107,134 participants, calculated based on the proportion of events of 6.8% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 25%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 11 trials (1210 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. </p> </div> </div> </div> </section> </section> <section id="CD013197-sec-0087"> <h6 class="title">Shortâterm (within three months)</h6> <p>Eleven trials reported shortâterm nSAEs (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0012" title="Diaz-CambroneroO , MazzinariG , Flor LorenteB , Garcia GregorioN , Robles-HernandezD , Olmedilla ArnalLE , et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. British Journal of Surgery2020;107(12):1605-14. ">DiazâCambronero 2020</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0021" title="KimMH , KimNY , YooYC , KongHJ , LeeHS , JoA , et al. Influence of deep neuromuscular blockade on perioperative stress response in patients undergoing robot-assisted gastrectomy: a prospective double-blinded randomized-controlled trial. Journal of Personalized Medicine2021;11(12):1308. ">Kim 2021b</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0032" title="NamSW , OhAY , KooBW , KimBY , HanJ , ChungSH . Effects of depth of neuromuscular blockade on the BIS-guided propofol requirement: a randomized controlled trial. Medicine2021;100(29):e26576. ">Nam 2021</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>). Two of these trials found no nSAE in either group (<a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>). Followâup ranged from three to 60 days postoperative. </p> <p>The evidence was very uncertain (Peto OR 0.94, 95% CI 0.65 to 1.35; 11 trials, 1232 participants; very lowâcertainty evidence; <a href="./references#CD013197-fig-0026" title="">Analysis 1.7</a>). There was no change in the interpretation of the results using the randomâeffects model. </p> <section id="CD013197-sec-0088"> <p><b>Sensitivity analysis</b></p> <p>Trial Sequential Analysis showed that the DARIS was 42,737 participants, calculated based on the proportion of events of 12.1% in the control group, a risk ratio reduction of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 11 trials (1232 participants). The alpha spending function was ignored because we accrued less than 5% of the required participants, hence no conclusive evidence was found (<a href="#CD013197-fig-0009">Figure 9</a>). </p> <div class="figure" id="CD013197-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on nonâserious adverse events (short term) in adults undergoing an abdominal laparoscopic procedure. The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 42,737 participants, calculated based on the proportion of events of 12.1% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 11 trials (1232 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05." data-id="CD013197-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on nonâserious adverse events (short term) in adults undergoing an abdominal laparoscopic procedure.</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 42,737 participants, calculated based on the proportion of events of 12.1% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 11 trials (1232 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. </p> </div> </div> </div> </section> </section> </section> <section id="CD013197-sec-0089"> <h5 class="title">Secondary outcome: readmission within three months</h5> <p>Six trials reported readmissions within three months (<a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>). One of these trials reported readmissions, but none occurred within three months (<a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>). </p> <p>The evidence was very uncertain about the effect of deep NMB on readmissions within three months (Peto OR 0.50, 95% CI 0.16 to 1.57; 6 trials, 675 participants; very lowâcertainty evidence; <a href="./references#CD013197-fig-0027" title="">Analysis 1.8</a>). There was no change in the interpretation of the results using the randomâeffects model. </p> <section id="CD013197-sec-0090"> <h6 class="title">Sensitivity analysis</h6> <p>Trial Sequential Analysis showed that the DARIS was 307,622 participants, calculated based on the proportion of events of 2.4% in the control group, a risk ratio reduction of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 22.7%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of six trials (675 participants). The alpha spending function was ignored because we accrued less than 5% of the required participants, hence there was no conclusive evidence found (<a href="#CD013197-fig-0010">Figure 10</a>). </p> <div class="figure" id="CD013197-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on readmission within three months after surgery in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 307,622 participants, calculated based on the proportion of events of 2.4% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 22.7%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of six trials (675 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function is ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of a Zâvalue, corresponding to a P value of 0.05." data-id="CD013197-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-10.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on readmission within three months after surgery in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 307,622 participants, calculated based on the proportion of events of 2.4% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 22.7%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of six trials (675 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function is ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of a Zâvalue, corresponding to a P value of 0.05. </p> </div> </div> </div> </section> </section> <section id="CD013197-sec-0091"> <h5 class="title">Secondary outcome: shortâterm pain</h5> <section id="CD013197-sec-0092"> <h6 class="title">One hour postoperative or during stay at the postanaesthesia care unit</h6> <p>Twentyâtwo trials reported postoperative pain scores at one hour postoperative or during PACU stay using the 11âpoint numeric rating scale for pain (<a href="./references#CD013197-bbs2-0001" title="Abu YazedMM , AhmedSA . Deep versus moderate neuromuscular block in laparoscopic bariatric surgeries: effect on surgical conditions and pulmonary complications. Egyptian Journal of Anaesthesia2019;35(1):5-58. ">Abu Yazed 2019</a>; <a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0004" title="BakhetWZ . A randomized trial comparing deep and moderate neuromuscular blockade in patients undergoing ambulatory gynecologic laparoscopy. Ain-Shams Journal of Anesthesiology2020;12(1):25. ">Bakhet 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0010" title="Choi B-M, Ki S-H, Lee Y-H, Gong C-S, Kim H-S, Lee I-S, et al. Effects of depth of neuromuscular block on postoperative pain during laparoscopic gastrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(11):863-70. ">Choi 2019</a>; <a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0016" title="HuangH , ZhouL , YuY , LiuS , XuH , XuZ , et al. Comparison of deep and moderate neuromuscular blockade on intestinal mucosal barrier in laparoscopic gastrectomy: a prospective, randomized, double-blind clinical trial. Frontiers in Medicine2021;8:789597. ">Huang 2021</a>; <a href="./references#CD013197-bbs2-0018" title="KimMH , LeeKY , LeeKY , MinBS , YooYC . Maintaining optimal surgical conditions with low insufflation pressures is possible with deep neuromuscular blockade during laparoscopic colorectal surgery: a prospective, randomized, double-blind, parallel-group clinical trial. Medicine2016;95(9):e2920. ">Kim 2016</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0021" title="KimMH , KimNY , YooYC , KongHJ , LeeHS , JoA , et al. Influence of deep neuromuscular blockade on perioperative stress response in patients undergoing robot-assisted gastrectomy: a prospective double-blinded randomized-controlled trial. Journal of Personalized Medicine2021;11(12):1308. ">Kim 2021b</a>; <a href="./references#CD013197-bbs2-0022" title="KooBW , OhAY , SeoKS , HanJW , HanHS , YoonYS . Randomized clinical trial of moderate versus deep neuromuscular block for low-pressure pneumoperitoneum during laparoscopic cholecystectomy. World Journal of Surgery2016;40(12):2898-903. ">Koo 2016</a>; <a href="./references#CD013197-bbs2-0025" title="Koo C-H, ParkI , AhnS , LeeS , Ryu J-H. Effect of neuromuscular blockade on intraoperative respiratory mechanics and surgical space conditions during robot-assisted radical prostatectomy: a prospective randomized controlled trial. Journal of Clinical Medicine2021;10(21):5090. ">Koo 2021</a>; <a href="./references#CD013197-bbs2-0026" title="LeeJ , AnJ , LeeDH , KimE , WooK , KimKH . Cortisol secretory patterns in deep and moderate neuromuscular blockades in laparoscopic surgery under total intravenous anesthesia: a prospective, single-blinded, randomized controlled trial. Medicine2022;101(39):e30702. ">Lee 2022</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0030" title="MartiniCH , BoonM , BeversRF , AartsLP , DahanA , ThompsonJP . Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. British Journal of Anaesthesia2014;112(3):498-505. ">Martini 2014</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0038" title="TorensmaB , MartiniCH , BoonM , OlofsenE , VeldBI , LiemRS , et al. Deep neuromuscular block improves surgical conditions during bariatric surgery and reduces postoperative pain: a randomized double blind controlled trial. PLOS One2016;11(12):e0167907. ">Torensma 2016</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>; <a href="./references#CD013197-bbs2-0040" title="YiIK , KimJS , HurH , HanDG , KimJE . Effects of deep neuromuscular block on surgical pleth index-guided remifentanil administration in laparoscopic herniorrhaphy: a prospective randomized trial. Scientific Reports2022;12(1):19176. ">Yi 2022</a>; <a href="./references#CD013197-bbs2-0041" title="YooYC , KimNY , ShinS , ChoiYD , HongJH , KimCY , et al. The intraocular pressure under deep versus moderate neuromuscular blockade during low-pressure robot assisted laparoscopic radical prostatectomy in a randomized trial. PLOS One2015;10(8):e0135412. ">Yoo 2015</a>). </p> <p>Deep NMB may reduce postoperative pain scores, but the evidence was very uncertain (MD â0.31 points, 95% CI â0.59 to â0.03; 1823 participants; very lowâcertainty evidence; <a href="./references#CD013197-fig-0028" title="">Analysis 1.9</a>). Pain scores up to six hours postoperative were included in this analysis. Standard deviations were imputed for four trials (<a href="./references#CD013197-bbs2-0001" title="Abu YazedMM , AhmedSA . Deep versus moderate neuromuscular block in laparoscopic bariatric surgeries: effect on surgical conditions and pulmonary complications. Egyptian Journal of Anaesthesia2019;35(1):5-58. ">Abu Yazed 2019</a>; <a href="./references#CD013197-bbs2-0004" title="BakhetWZ . A randomized trial comparing deep and moderate neuromuscular blockade in patients undergoing ambulatory gynecologic laparoscopy. Ain-Shams Journal of Anesthesiology2020;12(1):25. ">Bakhet 2020</a>; <a href="./references#CD013197-bbs2-0022" title="KooBW , OhAY , SeoKS , HanJW , HanHS , YoonYS . Randomized clinical trial of moderate versus deep neuromuscular block for low-pressure pneumoperitoneum during laparoscopic cholecystectomy. World Journal of Surgery2016;40(12):2898-903. ">Koo 2016</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>). Exclusion of these trials slightly altered the result (MD â0.28 points, 95% CI â0.58 to 0.03). The Chi<sup>2</sup> test for this analysis indicated significant heterogeneity (I<sup>2</sup> = 71%). This was further investigated in subgroup analysis. </p> <section id="CD013197-sec-0093"> <p><b>Sensitivity analysis</b></p> <p>Trial Sequential Analysis showed that the DARIS was 560 participants, calculated based on a variance of 1.9 in the control group, a MIREDIF of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 79%. The cumulative Zâcurve crossed the benefit boundary for deep NMB after the inclusion of four trials (215 participants) and the DARIS after the inclusion of nine trials (636 participants), suggesting that deep NMB may reduce postoperative pain one hour after surgery or at the PACU. The 95% CI was â0.59 to â0.03 (<a href="#CD013197-fig-0011">Figure 11</a>). </p> <div class="figure" id="CD013197-fig-0011"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 11</div> </div> <hr class="top"/><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on postoperative pain one hour after surgery or postanaesthesia care unit (PACU) in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 560 participants, calculated based on a variance of 1.9 in the control group, a minimal relevant difference (MIREDIF) of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 79%. The cumulative Zâcurve crossed the boundary for benefit for deep neuromuscular blockade after inclusion of four trials (215 participants) and the DARIS after inclusion of nine trials (636 participants), suggesting that deep neuromuscular blockade may reduce postoperative pain one hour after surgery or at the postanaesthesia care unit. The 95% CIs were â0.59 to â0.03. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit and harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape to the right shows the futility boundaries and futility area of the TSA." data-id="CD013197-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-11.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on postoperative pain one hour after surgery or postanaesthesia care unit (PACU) in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 560 participants, calculated based on a variance of 1.9 in the control group, a minimal relevant difference (MIREDIF) of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 79%. The cumulative Zâcurve crossed the boundary for benefit for deep neuromuscular blockade after inclusion of four trials (215 participants) and the DARIS after inclusion of nine trials (636 participants), suggesting that deep neuromuscular blockade may reduce postoperative pain one hour after surgery or at the postanaesthesia care unit. The 95% CIs were â0.59 to â0.03. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit and harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape to the right shows the futility boundaries and futility area of the TSA. </p> </div> </div> </div> </section> </section> <section id="CD013197-sec-0094"> <h6 class="title">Twentyâfour hours postoperative</h6> <p>Sixteen trials reported pain scores 24 hours after surgery using the 11âpoint numeric rating scale for pain (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0004" title="BakhetWZ . A randomized trial comparing deep and moderate neuromuscular blockade in patients undergoing ambulatory gynecologic laparoscopy. Ain-Shams Journal of Anesthesiology2020;12(1):25. ">Bakhet 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0010" title="Choi B-M, Ki S-H, Lee Y-H, Gong C-S, Kim H-S, Lee I-S, et al. Effects of depth of neuromuscular block on postoperative pain during laparoscopic gastrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(11):863-70. ">Choi 2019</a>; <a href="./references#CD013197-bbs2-0011" title="CovielloA , IannielloM , BuonannoP , Di FalcoN , IacovazzoC , MarescaA , et al. Effects of depth of neuromuscular block on surgical operating conditions in women undergoing gynecologic laparoscopic surgery: a randomized clinical trial. Journal of Anesthesia, Analgesia and Critical Care2023;3(1):2. [DOI: 10.1186/s44158-023-00086-7]">Coviello 2023</a>; <a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0016" title="HuangH , ZhouL , YuY , LiuS , XuH , XuZ , et al. Comparison of deep and moderate neuromuscular blockade on intestinal mucosal barrier in laparoscopic gastrectomy: a prospective, randomized, double-blind clinical trial. Frontiers in Medicine2021;8:789597. ">Huang 2021</a>; <a href="./references#CD013197-bbs2-0017" title="KathopoulisN , ProtopapasA , StamatakisE , ChatzipapasI , ZacharakisD , GrigoriadisT , et al. Deep versus moderate neuromuscular blockade in gynecologic laparoscopic operations: randomized controlled trial. Journal of Personalized Medicine2022;12(4):561. ">Kathopoulis 2022</a>; <a href="./references#CD013197-bbs2-0018" title="KimMH , LeeKY , LeeKY , MinBS , YooYC . Maintaining optimal surgical conditions with low insufflation pressures is possible with deep neuromuscular blockade during laparoscopic colorectal surgery: a prospective, randomized, double-blind, parallel-group clinical trial. Medicine2016;95(9):e2920. ">Kim 2016</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0021" title="KimMH , KimNY , YooYC , KongHJ , LeeHS , JoA , et al. Influence of deep neuromuscular blockade on perioperative stress response in patients undergoing robot-assisted gastrectomy: a prospective double-blinded randomized-controlled trial. Journal of Personalized Medicine2021;11(12):1308. ">Kim 2021b</a>; <a href="./references#CD013197-bbs2-0022" title="KooBW , OhAY , SeoKS , HanJW , HanHS , YoonYS . Randomized clinical trial of moderate versus deep neuromuscular block for low-pressure pneumoperitoneum during laparoscopic cholecystectomy. World Journal of Surgery2016;40(12):2898-903. ">Koo 2016</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0036" title="RosenbergJ , HerringWJ , BlobnerM , MulierJP , Rahe-MeyerN , WooT , et al. Deep neuromuscular blockade improves laparoscopic surgical conditions: a randomized, controlled study. Advances in Therapy2017;34(4):925-36. ">Rosenberg 2017</a>; <a href="./references#CD013197-bbs2-0038" title="TorensmaB , MartiniCH , BoonM , OlofsenE , VeldBI , LiemRS , et al. Deep neuromuscular block improves surgical conditions during bariatric surgery and reduces postoperative pain: a randomized double blind controlled trial. PLOS One2016;11(12):e0167907. ">Torensma 2016</a>). </p> <p>Deep NMB may reduce postoperative pain scores after 24 hours, but the evidence was very uncertain (MD â0.60 points, 95% CI â1.05 to â0.15; 1404 participants; lowâcertainty evidence; <a href="./references#CD013197-fig-0029" title="">Analysis 1.10</a>). There was a significant heterogeneity in this analysis (I<sup>2</sup> = 89%). <a href="./references#CD013197-bbs2-0017" title="KathopoulisN , ProtopapasA , StamatakisE , ChatzipapasI , ZacharakisD , GrigoriadisT , et al. Deep versus moderate neuromuscular blockade in gynecologic laparoscopic operations: randomized controlled trial. Journal of Personalized Medicine2022;12(4):561. ">Kathopoulis 2022</a> reported a 5âpoint numeric rating scale, which we transformed to an 11âpoint scale. In two trials, the standard deviation was imputed (<a href="./references#CD013197-bbs2-0004" title="BakhetWZ . A randomized trial comparing deep and moderate neuromuscular blockade in patients undergoing ambulatory gynecologic laparoscopy. Ain-Shams Journal of Anesthesiology2020;12(1):25. ">Bakhet 2020</a>; <a href="./references#CD013197-bbs2-0022" title="KooBW , OhAY , SeoKS , HanJW , HanHS , YoonYS . Randomized clinical trial of moderate versus deep neuromuscular block for low-pressure pneumoperitoneum during laparoscopic cholecystectomy. World Journal of Surgery2016;40(12):2898-903. ">Koo 2016</a>). Exclusion of these trials did not change the result (MD â0.61 points on the numeric rating scale, 95% CI â1.10 to â0.13). </p> <section id="CD013197-sec-0095"> <p><b>Sensitivity analysis</b></p> <p>In the Trial Sequential Analysis, the DARIS was 1240 participants, calculated based on a variance of 2.0 in the control group; MIREDIF of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 90%. The cumulative Zâcurve breached the futility boundary entering the futility area after nine trials (711 participants) and crossing the DARIS after 14 trials (1320 participants), demonstrating that deep NMB may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with moderate NMB on postoperative pain 24 hours after surgery. The 95% CIs were â1.05 to â0.15 (<a href="#CD013197-fig-0012">Figure 12</a>). </p> <div class="figure" id="CD013197-fig-0012"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 12</div> </div> <hr class="top"/><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on postoperative pain 24 hours after surgery in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. In the TSA, the diversityâadjusted required information size (DARIS) was 1240 participants, calculated based on a variance of 2.0 in the control group, minimal relevant difference (MIREDIF) of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 90%. The cumulative Zâcurve breached the futility boundary entering into the futility area after nine trial (711 participants) and crossed the DARIS after 14 trials (1320 participants), demonstrating that deep neuromuscular blockade may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with moderate neuromuscular blockade on postoperative pain 24 hours after surgery. The 95% CIs were â1.05 to â0.15. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit or harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows futility boundaries and futility." data-id="CD013197-fig-0012" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-12.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on postoperative pain 24 hours after surgery in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. In the TSA, the diversityâadjusted required information size (DARIS) was 1240 participants, calculated based on a variance of 2.0 in the control group, minimal relevant difference (MIREDIF) of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 90%. The cumulative Zâcurve breached the futility boundary entering into the futility area after nine trial (711 participants) and crossed the DARIS after 14 trials (1320 participants), demonstrating that deep neuromuscular blockade may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with moderate neuromuscular blockade on postoperative pain 24 hours after surgery. The 95% CIs were â1.05 to â0.15. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit or harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows futility boundaries and futility. </p> </div> </div> </div> </section> </section> <section id="CD013197-sec-0096"> <h6 class="title">One week postoperative</h6> <p>One trial reported pain scores one week after surgery using the 11âpoint numeric rating scale (<a href="./references#CD013197-bbs2-0036" title="RosenbergJ , HerringWJ , BlobnerM , MulierJP , Rahe-MeyerN , WooT , et al. Deep neuromuscular blockade improves laparoscopic surgical conditions: a randomized, controlled study. Advances in Therapy2017;34(4):925-36. ">Rosenberg 2017</a>). There was no difference in pain scores (MD 0.28 points, 95% CI â0.15 to 0.71; 122 participants; <a href="./references#CD013197-fig-0030" title="">Analysis 1.11</a>). </p> <section id="CD013197-sec-0097"> <p><b>Sensitivity analysis</b></p> <p>We did not perform a Trial Sequential Analysis, since only one trial reported this outcome. </p> </section> </section> <section id="CD013197-sec-0098"> <h6 class="title">Two weeks postoperative</h6> <p>No trials reported twoâweek postoperative pain scores.</p> </section> </section> <section id="CD013197-sec-0099"> <h5 class="title">Secondary outcome: measurements of postoperative recovery</h5> <section id="CD013197-sec-0100"> <h6 class="title">Length of hospital stay</h6> <p>Nineteen trials reported length of hospital stay (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0016" title="HuangH , ZhouL , YuY , LiuS , XuH , XuZ , et al. Comparison of deep and moderate neuromuscular blockade on intestinal mucosal barrier in laparoscopic gastrectomy: a prospective, randomized, double-blind clinical trial. Frontiers in Medicine2021;8:789597. ">Huang 2021</a>; <a href="./references#CD013197-bbs2-0017" title="KathopoulisN , ProtopapasA , StamatakisE , ChatzipapasI , ZacharakisD , GrigoriadisT , et al. Deep versus moderate neuromuscular blockade in gynecologic laparoscopic operations: randomized controlled trial. Journal of Personalized Medicine2022;12(4):561. ">Kathopoulis 2022</a>; <a href="./references#CD013197-bbs2-0018" title="KimMH , LeeKY , LeeKY , MinBS , YooYC . Maintaining optimal surgical conditions with low insufflation pressures is possible with deep neuromuscular blockade during laparoscopic colorectal surgery: a prospective, randomized, double-blind, parallel-group clinical trial. Medicine2016;95(9):e2920. ">Kim 2016</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0020" title="KimJE , MinSK , HaE , LeeD , KimJY , KwakHJ . Effects of deep neuromuscular block with low-pressure pneumoperitoneum on respiratory mechanics and biotrauma in a steep Trendelenburg position. Scientific Reports2021;11(1):1935. ">Kim 2021a</a>; <a href="./references#CD013197-bbs2-0021" title="KimMH , KimNY , YooYC , KongHJ , LeeHS , JoA , et al. Influence of deep neuromuscular blockade on perioperative stress response in patients undergoing robot-assisted gastrectomy: a prospective double-blinded randomized-controlled trial. Journal of Personalized Medicine2021;11(12):1308. ">Kim 2021b</a>; <a href="./references#CD013197-bbs2-0023" title="KooBW , OhAY , NaHS , LeeHJ , KangSB , KimDW , et al. Effects of depth of neuromuscular block on surgical conditions during laparoscopic colorectal surgery: a randomised controlled trial. Anaesthesia2018;73(9):1090-6. ">Koo 2018</a>; <a href="./references#CD013197-bbs2-0025" title="Koo C-H, ParkI , AhnS , LeeS , Ryu J-H. Effect of neuromuscular blockade on intraoperative respiratory mechanics and surgical space conditions during robot-assisted radical prostatectomy: a prospective randomized controlled trial. Journal of Clinical Medicine2021;10(21):5090. ">Koo 2021</a>; <a href="./references#CD013197-bbs2-0026" title="LeeJ , AnJ , LeeDH , KimE , WooK , KimKH . Cortisol secretory patterns in deep and moderate neuromuscular blockades in laparoscopic surgery under total intravenous anesthesia: a prospective, single-blinded, randomized controlled trial. Medicine2022;101(39):e30702. ">Lee 2022</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0032" title="NamSW , OhAY , KooBW , KimBY , HanJ , ChungSH . Effects of depth of neuromuscular blockade on the BIS-guided propofol requirement: a randomized controlled trial. Medicine2021;100(29):e26576. ">Nam 2021</a>; <a href="./references#CD013197-bbs2-0034" title="ParkSH , HuhH , ChoiSI , KimJH , JangYJ , ParkJM , et al. Impact of the deep neuromuscular block on oncologic quality of laparoscopic surgery in obese gastric cancer patients: a randomized clinical trial. Journal of the American College of Surgeons2022;234(3):326-39. ">Park 2022</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>; <a href="./references#CD013197-bbs2-0040" title="YiIK , KimJS , HurH , HanDG , KimJE . Effects of deep neuromuscular block on surgical pleth index-guided remifentanil administration in laparoscopic herniorrhaphy: a prospective randomized trial. Scientific Reports2022;12(1):19176. ">Yi 2022</a>). </p> <p>Deep NMB may result in no difference in length of hospital stay compared with moderate NMB (MD â0.22 days, 95% CI â0.49 to 0.06; 2084 participants; lowâcertainty evidence; <a href="./references#CD013197-fig-0031" title="">Analysis 1.12</a>). There was significant heterogeneity in this analysis (I<sup>2</sup> = 62%). Standard deviations were imputed for four trials (<a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0021" title="KimMH , KimNY , YooYC , KongHJ , LeeHS , JoA , et al. Influence of deep neuromuscular blockade on perioperative stress response in patients undergoing robot-assisted gastrectomy: a prospective double-blinded randomized-controlled trial. Journal of Personalized Medicine2021;11(12):1308. ">Kim 2021b</a>; <a href="./references#CD013197-bbs2-0026" title="LeeJ , AnJ , LeeDH , KimE , WooK , KimKH . Cortisol secretory patterns in deep and moderate neuromuscular blockades in laparoscopic surgery under total intravenous anesthesia: a prospective, single-blinded, randomized controlled trial. Medicine2022;101(39):e30702. ">Lee 2022</a>). Exclusion of these trials did not alter the result (MD â0.24 days, 95% CI â0.53 to 0.05). </p> <section id="CD013197-sec-0101"> <p><b>Sensitivity analysis</b></p> <p>Trial Sequential Analysis showed that the DARIS was 629 participants, calculated based on variance of 2.1 in the control group; MIREDIF of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 79.4%. The cumulative Zâcurve breached the futility boundary, entering the futility area after six trials (508 participants) and crossing the DARIS after seven trials (858 participants), suggesting that deep NMB may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with moderate NMB on length of hospital stay. The 95% CIs were â0.49 to 0.06 (<a href="#CD013197-fig-0013">Figure 13</a>). </p> <div class="figure" id="CD013197-fig-0013"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 13</div> </div> <hr class="top"/><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on length of hospital stay in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 629 participants, calculated based on variance of 2.1 in the control group, minimal relevant difference (MIREDIF) of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 79.4%. The cumulative Zâcurve breached the futility boundary entering the futility area after six trials (508 participants) and crossed the DARIS after seven trials (858 participants), demonstrating that deep neuromuscular blockade may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with moderate neuromuscular blockade on length of hospital stay. The 95% CIs were â0.49 to 0.06. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit or harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows the futility boundaries and futility area of the TSA." data-id="CD013197-fig-0013" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-13.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on length of hospital stay in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 629 participants, calculated based on variance of 2.1 in the control group, minimal relevant difference (MIREDIF) of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 79.4%. The cumulative Zâcurve breached the futility boundary entering the futility area after six trials (508 participants) and crossed the DARIS after seven trials (858 participants), demonstrating that deep neuromuscular blockade may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with moderate neuromuscular blockade on length of hospital stay. The 95% CIs were â0.49 to 0.06. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit or harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows the futility boundaries and futility area of the TSA. </p> </div> </div> </div> </section> </section> <section id="CD013197-sec-0102"> <h6 class="title">Time to return to normal activity</h6> <p>No trials reported time to return to normal activity.</p> </section> <section id="CD013197-sec-0103"> <h6 class="title">Time to return to work</h6> <p>No trials reported time to return to work.</p> </section> </section> <section id="CD013197-sec-0104"> <h5 class="title">Secondary outcome: operating time</h5> <p>Thirtyâfour trials reported operating time (<a href="./references#CD013197-bbs2-0001" title="Abu YazedMM , AhmedSA . Deep versus moderate neuromuscular block in laparoscopic bariatric surgeries: effect on surgical conditions and pulmonary complications. Egyptian Journal of Anaesthesia2019;35(1):5-58. ">Abu Yazed 2019</a>; <a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0003" title="BaeteS , VercruysseG , Vander LaenenM , De VooghtP , Van MelkebeekJ , DylstD , et al. The effect of deep versus moderate neuromuscular block on surgical conditions and postoperative respiratory function in bariatric laparoscopic surgery: a randomized, double blind clinical trial. Anesthesia &amp; Analgesia2017;124(5):1469-75. ">Baete 2017</a>; <a href="./references#CD013197-bbs2-0004" title="BakhetWZ . A randomized trial comparing deep and moderate neuromuscular blockade in patients undergoing ambulatory gynecologic laparoscopy. Ain-Shams Journal of Anesthesiology2020;12(1):25. ">Bakhet 2020</a>; <a href="./references#CD013197-bbs2-0005" title="BarrioJ , ErrandoCL , Garcia-RamonJ , SellesR , San MiguelG , GallegoJ . Influence of depth of neuromuscular blockade on surgical conditions during low-pressure pneumoperitoneum laparoscopic cholecystectomy: a randomized blinded study. Journal of Clinical Anesthesia2017;42:26-30. ">Barrio 2017</a>; <a href="./references#CD013197-bbs2-0007" title="BoggettS , ChahalR , GriffithsJ , LinJ , WangD , WilliamsZ , et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. Anaesthesia2020;75(9):1153-63. ">Boggett 2020</a>; <a href="./references#CD013197-bbs2-0008" title="BruintjesMH , KrijtenburgP , MartiniCH , PoyckPP , d'AnconaFC , HuurmanVA , et al. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):494-501. ">Bruintjes 2019</a>; <a href="./references#CD013197-bbs2-0009" title="ChoYJ , PaikH , JeongSY , ParkJW , JoWY , JeonY , et al. Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial. Surgical Endoscopy and other Interventional Techniques2018;32(11):4533-42. ">Cho 2018</a>; <a href="./references#CD013197-bbs2-0010" title="Choi B-M, Ki S-H, Lee Y-H, Gong C-S, Kim H-S, Lee I-S, et al. Effects of depth of neuromuscular block on postoperative pain during laparoscopic gastrectomy: a randomised controlled trial. European Journal of Anaesthesiology2019;36(11):863-70. ">Choi 2019</a>; <a href="./references#CD013197-bbs2-0014" title="GuB , FangJ , LianY , ZhouX , XieK , ZhuY , et al. Effect of deep versus moderate neuromuscular block on pain after laparoscopic colorectal surgery: a randomized clinical trial. Diseases of the Colon and Rectum2021;64(4):475-83. ">Gu 2021</a>; <a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0016" title="HuangH , ZhouL , YuY , LiuS , XuH , XuZ , et al. Comparison of deep and moderate neuromuscular blockade on intestinal mucosal barrier in laparoscopic gastrectomy: a prospective, randomized, double-blind clinical trial. Frontiers in Medicine2021;8:789597. ">Huang 2021</a>; <a href="./references#CD013197-bbs2-0017" title="KathopoulisN , ProtopapasA , StamatakisE , ChatzipapasI , ZacharakisD , GrigoriadisT , et al. Deep versus moderate neuromuscular blockade in gynecologic laparoscopic operations: randomized controlled trial. Journal of Personalized Medicine2022;12(4):561. ">Kathopoulis 2022</a>; <a href="./references#CD013197-bbs2-0018" title="KimMH , LeeKY , LeeKY , MinBS , YooYC . Maintaining optimal surgical conditions with low insufflation pressures is possible with deep neuromuscular blockade during laparoscopic colorectal surgery: a prospective, randomized, double-blind, parallel-group clinical trial. Medicine2016;95(9):e2920. ">Kim 2016</a>; <a href="./references#CD013197-bbs2-0019" title="KimHJ , LeeKY , KimMH , KimHI , BaiSJ . Effects of deep vs moderate neuromuscular block on the quality of recovery after robotic gastrectomy. Acta Anaesthesiologica Scandinavica2019;63(3):306-13. ">Kim 2019</a>; <a href="./references#CD013197-bbs2-0020" title="KimJE , MinSK , HaE , LeeD , KimJY , KwakHJ . Effects of deep neuromuscular block with low-pressure pneumoperitoneum on respiratory mechanics and biotrauma in a steep Trendelenburg position. Scientific Reports2021;11(1):1935. ">Kim 2021a</a>; <a href="./references#CD013197-bbs2-0021" title="KimMH , KimNY , YooYC , KongHJ , LeeHS , JoA , et al. Influence of deep neuromuscular blockade on perioperative stress response in patients undergoing robot-assisted gastrectomy: a prospective double-blinded randomized-controlled trial. Journal of Personalized Medicine2021;11(12):1308. ">Kim 2021b</a>; <a href="./references#CD013197-bbs2-0022" title="KooBW , OhAY , SeoKS , HanJW , HanHS , YoonYS . Randomized clinical trial of moderate versus deep neuromuscular block for low-pressure pneumoperitoneum during laparoscopic cholecystectomy. World Journal of Surgery2016;40(12):2898-903. ">Koo 2016</a>; <a href="./references#CD013197-bbs2-0023" title="KooBW , OhAY , NaHS , LeeHJ , KangSB , KimDW , et al. Effects of depth of neuromuscular block on surgical conditions during laparoscopic colorectal surgery: a randomised controlled trial. Anaesthesia2018;73(9):1090-6. ">Koo 2018</a>; <a href="./references#CD013197-bbs2-0024" title="KooBW , OhAY , RyuJH , LeeYJ , HanJW , NamSW , et al. Effects of deep neuromuscular blockade on the stress response during laparoscopic gastrectomy randomized controlled trials. Scientific Reports2019;9(1):12411. ">Koo 2019</a>; <a href="./references#CD013197-bbs2-0025" title="Koo C-H, ParkI , AhnS , LeeS , Ryu J-H. Effect of neuromuscular blockade on intraoperative respiratory mechanics and surgical space conditions during robot-assisted radical prostatectomy: a prospective randomized controlled trial. Journal of Clinical Medicine2021;10(21):5090. ">Koo 2021</a>; <a href="./references#CD013197-bbs2-0026" title="LeeJ , AnJ , LeeDH , KimE , WooK , KimKH . Cortisol secretory patterns in deep and moderate neuromuscular blockades in laparoscopic surgery under total intravenous anesthesia: a prospective, single-blinded, randomized controlled trial. Medicine2022;101(39):e30702. ">Lee 2022</a>; <a href="./references#CD013197-bbs2-0027" title="LeemanM , BiterLU , ApersJA , BirnieE , VerbruggeSJ , DunkelgrunM . Low-pressure pneumoperitoneum with deep neuromuscular blockade in metabolic surgery to reduce postoperative pain: a randomized pilot trial. Surgical Endoscopy2020;35(6):2838-45. ">Leeman 2020</a>; <a href="./references#CD013197-bbs2-0028" title="LowenDJ , HodgsonR , TaceyM , BarclayKL . Does deep neuromuscular blockade provide improved outcomes in low pressure laparoscopic colorectal surgery? A single blinded randomized pilot study. ANZ Journal of Surgery2022;92(6):1447-53. ">Lowen 2022</a>; <a href="./references#CD013197-bbs2-0030" title="MartiniCH , BoonM , BeversRF , AartsLP , DahanA , ThompsonJP . Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. British Journal of Anaesthesia2014;112(3):498-505. ">Martini 2014</a>; <a href="./references#CD013197-bbs2-0031" title="Na H-S, Lim D-J, Koo B-W, Oh A-Y, Lee P-B. The influence of moderate or deep neuromuscular block status on anesthetic depth monitoring system during total intravenous anesthesia using propofol and remifentanil: a randomized trial. Science Progress2021;104(2):368504211010629. ">Na 2021</a>; <a href="./references#CD013197-bbs2-0032" title="NamSW , OhAY , KooBW , KimBY , HanJ , ChungSH . Effects of depth of neuromuscular blockade on the BIS-guided propofol requirement: a randomized controlled trial. Medicine2021;100(29):e26576. ">Nam 2021</a>; <a href="./references#CD013197-bbs2-0033" title="Ozdemir-van BrunschotDM , BraatAE , van derJagtMF , SchefferGJ , MartiniCH , LangenhuijsenJF , et al. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surgical Endoscopy and Other Interventional Techniques2018;32(1):245-51. ">Ozdemirâvan Brunschot 2018</a>; <a href="./references#CD013197-bbs2-0034" title="ParkSH , HuhH , ChoiSI , KimJH , JangYJ , ParkJM , et al. Impact of the deep neuromuscular block on oncologic quality of laparoscopic surgery in obese gastric cancer patients: a randomized clinical trial. Journal of the American College of Surgeons2022;234(3):326-39. ">Park 2022</a>; <a href="./references#CD013197-bbs2-0038" title="TorensmaB , MartiniCH , BoonM , OlofsenE , VeldBI , LiemRS , et al. Deep neuromuscular block improves surgical conditions during bariatric surgery and reduces postoperative pain: a randomized double blind controlled trial. PLOS One2016;11(12):e0167907. ">Torensma 2016</a>; <a href="./references#CD013197-bbs2-0039" title="Williams WH 3rd, CataJP , LasalaJD , NavaiN , FengL , GottumukkalaV . Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. British Journal of Anaesthesia2019;124(2):164-72. ">Williams 2019</a>; <a href="./references#CD013197-bbs2-0040" title="YiIK , KimJS , HurH , HanDG , KimJE . Effects of deep neuromuscular block on surgical pleth index-guided remifentanil administration in laparoscopic herniorrhaphy: a prospective randomized trial. Scientific Reports2022;12(1):19176. ">Yi 2022</a>; <a href="./references#CD013197-bbs2-0041" title="YooYC , KimNY , ShinS , ChoiYD , HongJH , KimCY , et al. The intraocular pressure under deep versus moderate neuromuscular blockade during low-pressure robot assisted laparoscopic radical prostatectomy in a randomized trial. PLOS One2015;10(8):e0135412. ">Yoo 2015</a>; <a href="./references#CD013197-bbs2-0042" title="ZhuSJ , ZhangXL , XieQ , ZhouYF , WangKR . Comparison of the effects of deep and moderate neuromuscular block on respiratory system compliance and surgical space conditions during robot-assisted laparoscopic radical prostatectomy: a randomized clinical study. Journal of Zhejiang University. Science B2020;21(8):637-45. ">Zhu 2020</a>). </p> <p>There is likely no difference in duration of operating time between treatment arms (MD â0.51 minutes, 95% CI â3.35 to 2.32; 3142 participants; moderateâcertainty evidence; <a href="./references#CD013197-fig-0032" title="">Analysis 1.13</a>). Standard deviations were imputed for three trials (<a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0017" title="KathopoulisN , ProtopapasA , StamatakisE , ChatzipapasI , ZacharakisD , GrigoriadisT , et al. Deep versus moderate neuromuscular blockade in gynecologic laparoscopic operations: randomized controlled trial. Journal of Personalized Medicine2022;12(4):561. ">Kathopoulis 2022</a>; <a href="./references#CD013197-bbs2-0038" title="TorensmaB , MartiniCH , BoonM , OlofsenE , VeldBI , LiemRS , et al. Deep neuromuscular block improves surgical conditions during bariatric surgery and reduces postoperative pain: a randomized double blind controlled trial. PLOS One2016;11(12):e0167907. ">Torensma 2016</a>). Exclusion of these trials did not alter the result (MD â0.57 minutes, 95% CI â3.51 to 2.36). </p> <section id="CD013197-sec-0105"> <h6 class="title">Sensitivity analysis</h6> <p>In the Trial Sequential Analysis, the DARIS was 452 participants, calculated based on a variance of 543.3 in the control group, MIREDIF of 15 minutes, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 67%. The cumulative Zâcurve breached the futility boundary, entering the futility area after seven trials (435 participants) and crossing the DARIS after eight trials (566 participants), demonstrating that deep NMB may not affect the operating time in adults undergoing laparoscopic abdominal surgery compared with moderate NMB. The 95% CIs were â3.35 to 2.32 (<a href="#CD013197-fig-0014">Figure 14</a>). </p> <div class="figure" id="CD013197-fig-0014"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 14</div> </div> <hr class="top"/><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on operating time in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) represents the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 452 participants, calculated based on a variance of 543.3 in the control group, minimal relevant difference (MIREDIF) of 15 minutes, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 67%. The cumulative Zâcurve breached the futility boundary entering the futility area after seven trials (435 participants) and crossed the DARIS after eight trials (566 participants), demonstrating that deep neuromuscular blockade may not affect the operating time in adults undergoing laparoscopic abdominal surgery. The 95% CIs were â3.35 to 2.32. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of a Zâvalue, corresponding to a P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit and harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape to the right shows the futility boundaries and futility area of the TSA." data-id="CD013197-fig-0014" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-14.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on operating time in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) represents the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 452 participants, calculated based on a variance of 543.3 in the control group, minimal relevant difference (MIREDIF) of 15 minutes, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 67%. The cumulative Zâcurve breached the futility boundary entering the futility area after seven trials (435 participants) and crossed the DARIS after eight trials (566 participants), demonstrating that deep neuromuscular blockade may not affect the operating time in adults undergoing laparoscopic abdominal surgery. The 95% CIs were â3.35 to 2.32. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of a Zâvalue, corresponding to a P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit and harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape to the right shows the futility boundaries and futility area of the TSA. </p> </div> </div> </div> </section> </section> <section id="CD013197-sec-0106"> <h5 class="title">Subgroup analysis</h5> <p>The predefined subgroup analyses on trials at high versus low risk of bias and the four different areas of surgery were not performed since there were fewer than five trials per subgroup. </p> <p>Subgroup analyses on healthy body mass index versus overweight participants and standardâpressure versus lowâpressure pneumoperitoneum were performed for the postoperative pain outcomes to explore possible causes for heterogeneity and to assess whether these variables influence the effect of NMB. The Chi<sup>2</sup> test for subgroup differences in normal and high body mass index was not different in both outcomes; pain at one hour postoperative or during the stay in the PACU (P = 0.28; <a href="./references#CD013197-fig-0033" title="">Analysis 1.14</a>), pain at 24 hour postoperative (P = 0.31, <a href="./references#CD013197-fig-0034" title="">Analysis 1.15</a>). The Chi<sup>2</sup> test for subgroup differences in standardâpressure and lowâpressure pneumoperitoneum was significant for postoperative pain after one hour or during the stay in the PACU (P = 0.03; <a href="./references#CD013197-fig-0035" title="">Analysis 1.16</a>), but not significant for postoperative pain after 24 hours (P = 0.53; <a href="./references#CD013197-fig-0036" title="">Analysis 1.17</a>). </p> </section> <section id="CD013197-sec-0107"> <h5 class="title">Sensitivity analysis</h5> <p>In addition to the Trial Sequential Analyses reported after each outcome result, a sensitivity analysis for binary outcomes was performed in which missing data were imputed by a bestâworst case scenario and a worstâbest case scenario. This was only done for shortâterm SAEs and nSAEs since the event rates in the other outcomes were too low. The bestâworst case scenarios changed the result favouring deep NMB and the worstâbest case scenarios for shortâterm (n)SAEs changed the result favouring moderate NMB, except for the worstâbest case scenario for intraoperative (n)SAEs (<a href="./references#CD013197-fig-0037" title="">Analysis 1.18</a>; <a href="./references#CD013197-fig-0038" title="">Analysis 1.19</a>). </p> <p>We performed a sensitivity analysis on outcomes with continuous data by excluding trials in which the standard deviation was imputed. This was done for the analysis of healthârelated quality of life, postoperative pain scores, length of hospital stay, and operating time. There was no change in conclusion in the analyses on healthârelated quality of life, postoperative pain after 24 hours, length of hospital stay, and operating time. However, in the analysis of postoperative pain after one hour, imputation resulted in a result that was no longer different. </p> <p>Sensitivity analysis on clusterârandomised clinical trials as specified in the protocol was not performed as the search identified no such trials. </p> </section> <section id="CD013197-sec-0108"> <h5 class="title">Reporting bias</h5> <p>We explored reporting bias visually for SAEs at both time points, shortâterm nSAEs, postoperative pain one hour after surgery and 24 hours after surgery, length of hospital stay, and operating time. The other outcomes had fewer than 10 included trials. The funnel plot revealed evidence of reporting bias for pain scores one hour after surgery, therefore we downgraded the certainty of the evidence (<a href="#CD013197-fig-0015">Figure 15</a>). </p> <div class="figure" id="CD013197-fig-0015"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 15</div> </div> <hr class="top"/><img alt="Funnel plot: postoperative pain one hour after surgery or at postanaesthesia care unit (Analysis 1.9)." data-id="CD013197-fig-0015" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-15.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot: postoperative pain one hour after surgery or at postanaesthesia care unit (<a href="./references#CD013197-fig-0028" title="">Analysis 1.9</a>). </p> </div> </div> </div> </section> </section> <section id="CD013197-sec-0109"> <h4 class="title">Comparison 2. Deep neuromuscular blockade versus shallow neuromuscular blockade</h4> <p>See <a href="./full#CD013197-tbl-0002">summary of findings Table 2</a> and <a href="#CD013197-tbl-0004">Table 1</a>. </p> <p>Three trials compared deep NMB versus shallow NMB (<a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a>; <a href="./references#CD013197-bbs2-0035" title="DuboisPE , PutzL , JamartJ , MarottaML , GourdinM , DonnezO . Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. European Journal of Anaesthesiology2014;31(8):430-6. PutzL , DransartC , JamartJ , Marotta M-L, DelnoozG , DuboisPE . Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial. Journal of Clinical Anesthesia2016;35:107-13. ">Putz 2016</a>; <a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a>). </p> <section id="CD013197-sec-0110"> <h5 class="title">Primary outcome: mortality</h5> <p>No trials reported mortality.</p> </section> <section id="CD013197-sec-0111"> <h5 class="title">Primary outcome: healthârelated quality of life</h5> <p>No trials reported healthârelated quality of life.</p> </section> <section id="CD013197-sec-0112"> <h5 class="title">Primary outcome: proportion of participants with serious adverse events</h5> <p>Two trials reported shortâterm SAEs (<a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a>; <a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a>). </p> <p>The evidence is very uncertain about the effect of deep NMB on SAEs compared with shallow NMB (RR 1.66, 95% CI 0.50 to 5.57; 158 participants; very lowâcertainty evidence; <a href="./references#CD013197-fig-0039" title="">Analysis 2.1</a>)<i>.</i> </p> <section id="CD013197-sec-0113"> <h6 class="title">Sensitivity analysis</h6> <p>In the Trial Sequential Analysis on shortâterm SAEs, the DARIS was 101,265 participants, calculated based on a 5.1% proportion of events in the control group, a risk ratio reduction of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of two trials (158 participants). The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, there was no conclusive evidence found (<a href="#CD013197-fig-0016">Figure 16</a>). </p> <div class="figure" id="CD013197-fig-0016"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 16</div> </div> <hr class="top"/><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus shallow neuromuscular blockade on serious adverse events (shortâterm) in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. TSA showed that the diversityâadjusted required information size (DARIS) is 101,265 participants, calculated based on a 5.1% proportion of events in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of two trials (158 participants). The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05." data-id="CD013197-fig-0016" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-16.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus shallow neuromuscular blockade on serious adverse events (shortâterm) in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. TSA showed that the diversityâadjusted required information size (DARIS) is 101,265 participants, calculated based on a 5.1% proportion of events in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of two trials (158 participants). The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. </p> </div> </div> </div> </section> </section> <section id="CD013197-sec-0114"> <h5 class="title">Secondary outcome: proportion of participants with nonâserious adverse events</h5> <p>Only one trial reported nSAEs. There were 12 nSAEs in the deep NMB group and 11 in the shallow NMB group (no P value provided) (<a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a>). </p> </section> <section id="CD013197-sec-0115"> <h5 class="title">Secondary outcome: readmission within three months</h5> <p>Two trials described readmissions within three months (<a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a>; <a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a>). Evidence was very uncertain about the effect of deep NMB on readmissions (Peto OR 1.98, 95% CI 0.52 to 7.54; 158 participants; very lowâcertainty evidence; <a href="./references#CD013197-fig-0040" title="">Analysis 2.2</a>). </p> <section id="CD013197-sec-0116"> <h6 class="title">Sensitivity analysis</h6> <p>The Trial Sequential Analysis of readmissions within three months showed that the DARIS was 148,205 participants, calculated based on the proportion of events of 3.8% in the control group, a risk ratio reduction of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of two trials (158 participants). The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found (<a href="#CD013197-fig-0017">Figure 17</a>). </p> <div class="figure" id="CD013197-fig-0017"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 17</div> </div> <hr class="top"/><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus shallow neuromuscular blockade on readmission within three months after surgery in adults undergoing an abdominal laparoscopic procedure. The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 148,205 participants, calculated based on the proportion of events of 3.8% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of two trials (158 participants). The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05." data-id="CD013197-fig-0017" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-17.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus shallow neuromuscular blockade on readmission within three months after surgery in adults undergoing an abdominal laparoscopic procedure.</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 148,205 participants, calculated based on the proportion of events of 3.8% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of two trials (158 participants). The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. </p> </div> </div> </div> </section> </section> <section id="CD013197-sec-0117"> <h5 class="title">Secondary outcome: shortâterm pain</h5> <p>All trials described postoperative pain, but using different outcome measures. All trials described no difference regarding postoperative pain. <a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a> only stated there was no difference, without supporting statistics. <a href="./references#CD013197-bbs2-0035" title="DuboisPE , PutzL , JamartJ , MarottaML , GourdinM , DonnezO . Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. European Journal of Anaesthesiology2014;31(8):430-6. PutzL , DransartC , JamartJ , Marotta M-L, DelnoozG , DuboisPE . Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial. Journal of Clinical Anesthesia2016;35:107-13. ">Putz 2016</a> described no difference in the mean number of participants using a visual analogue scale higher than 3 during PACU stay (29/50 participants in deep NMB group versus 25/50 participants in shallow NMB group; P = 0.352). <a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a> measured pain scores for 14 days and presented the visual analogue scale area under the curve for the first four days and a total of 14 days (day 4 median: 101.7 (interquartile range 51.9 to 200.8) in deep NMB group versus 129.8 (interquartile range 79 to 198.1) in shallow NMB group; P = 0.24; day 14 median: 190.2 (interquartile range 118.9 to 402.5) in deep NMB group versus 256.9 (interquartile range 121.3 to 403.7) in shallow NMB group; P = 0.52). </p> </section> <section id="CD013197-sec-0118"> <h5 class="title">Secondary outcome: measurements of postoperative recovery</h5> <section id="CD013197-sec-0119"> <h6 class="title">Length of hospital stay</h6> <p>Two trials presented the length of hospital stay (<a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a>; <a href="./references#CD013197-bbs2-0035" title="DuboisPE , PutzL , JamartJ , MarottaML , GourdinM , DonnezO . Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. European Journal of Anaesthesiology2014;31(8):430-6. PutzL , DransartC , JamartJ , Marotta M-L, DelnoozG , DuboisPE . Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial. Journal of Clinical Anesthesia2016;35:107-13. ">Putz 2016</a>). Deep NMB likely does not change the length of hospital stay (MD 0.01 days, 95% CI â0.34 to 0.36; 199 participants; moderateâcertainty evidence; <a href="./references#CD013197-fig-0041" title="">Analysis 2.3</a>). Standard deviations were imputed for one trial (<a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a>). </p> <section id="CD013197-sec-0120"> <p><b>Sensitivity analysis</b></p> <p>The Trial Sequential Analysis on length of hospital stay showed that the DARIS was 100 participants, calculated based on a variance of 1.6 in the control group, MIREDIF of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 0%. The cumulative Zâcurve breached the futility boundary by entering the futility area after one trial (99 participants) and crossing the DARIS after two trials (199 participants), demonstrating that deep NMB may not have an effect on adults undergoing an abdominal laparoscopic procedure in comparison to shallow NMB on length of hospital stay. The 95% CIs were â0.34 to 0.36 (<a href="#CD013197-fig-0018">Figure 18</a>). </p> <div class="figure" id="CD013197-fig-0018"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 18</div> </div> <hr class="top"/><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus shallow neuromuscular blockade on length of hospital stay in adults undergoing an abdominal laparoscopic procedure. The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 100 participants, calculated based on variance of 1.6 in the control group, minimal relevant difference (MIREDIF) of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 0%. The cumulative Zâcurve breached the futility boundary entering the futility area after one trial (99 participants) and crossed the DARIS after two trials (199 participants), demonstrating that deep neuromuscular blockade may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with shallow neuromuscular blockade on length of hospital stay. The 95% CIs were â0.34 to 0.36. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit or harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows the futility boundaries and futility area of the TSA." data-id="CD013197-fig-0018" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-18.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus shallow neuromuscular blockade on length of hospital stay in adults undergoing an abdominal laparoscopic procedure.</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 100 participants, calculated based on variance of 1.6 in the control group, minimal relevant difference (MIREDIF) of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 0%. The cumulative Zâcurve breached the futility boundary entering the futility area after one trial (99 participants) and crossed the DARIS after two trials (199 participants), demonstrating that deep neuromuscular blockade may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with shallow neuromuscular blockade on length of hospital stay. The 95% CIs were â0.34 to 0.36. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit or harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows the futility boundaries and futility area of the TSA. </p> </div> </div> </div> </section> </section> <section id="CD013197-sec-0121"> <h6 class="title">Time to return to normal activity</h6> <p>Two trials reported time to return to normal activity (<a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a>; <a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a>). Neither trial reported a difference (P = 0.29 and P = 0.167, respectively), but both trials did not provide a mean and standard deviation. </p> </section> </section> <section id="CD013197-sec-0122"> <h5 class="title">Time to return to work</h5> <p>No trials reported time to return to work.</p> </section> <section id="CD013197-sec-0123"> <h5 class="title">Secondary outcome: operating time</h5> <p>Three trials reported operating time. There is likely no difference in operating time between groups (MD â3.96 minutes, 95% CI â9.14 to 1.23; 247 participants; moderateâcertainty evidence; <a href="./references#CD013197-fig-0042" title="">Analysis 2.4</a>). Standard deviations were imputed for one trial (<a href="./references#CD013197-bbs2-0029" title="MadsenMV , IstreO , SpringborgHH , Staehr-RyeAK , RosenbergJ , LundJ , et al. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Danish Medical Journal2017;64(5):A5364. MadsenMV , IstreO , Staehr-RyeAK , SpringborgHH , RosenbergJ , LundJ , et al. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial. European Journal of Anaesthesiology2016;33(5):341-7. ">Madsen 2016</a>). </p> <section id="CD013197-sec-0124"> <h6 class="title">Sensitivity analysis</h6> <p>The Trial Sequential Analysis for operating time showed that the DARIS was 119 participants, calculated based on a variance of 432.0 in the control group, MIREDIF of 15 minutes, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 0%. The cumulative Zâcurve breached the futility boundary by entering the futility area after one trial (48 participants) and crossing the DARIS after two trials (147 participants), demonstrating that deep NMB may affect operating time in adults undergoing an abdominal laparoscopic procedure. The 95% CIs were â9.14 to 1.23 (<a href="#CD013197-fig-0019">Figure 19</a>). </p> <div class="figure" id="CD013197-fig-0019"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 19</div> </div> <hr class="top"/><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus shallow neuromuscular blockade on operating time in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 119 participants, calculated based on a variance of 432.0 in the control group, minimal relevant difference (MIREDIF) of 15 minutes, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 0%. The cumulative Zâcurve breached the futility boundary entering the futility area after one trial (48 participants) and crossed the DARIS after two trials (147 participants), demonstrating that deep neuromuscular blockade may not have an effect on operating time in adults undergoing an abdominal laparoscopic procedure. The 95% CIs were â9.14 to 1.23. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit or harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows the futility boundaries and futility area of the TSA." data-id="CD013197-fig-0019" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-19.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus shallow neuromuscular blockade on operating time in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 119 participants, calculated based on a variance of 432.0 in the control group, minimal relevant difference (MIREDIF) of 15 minutes, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 0%. The cumulative Zâcurve breached the futility boundary entering the futility area after one trial (48 participants) and crossed the DARIS after two trials (147 participants), demonstrating that deep neuromuscular blockade may not have an effect on operating time in adults undergoing an abdominal laparoscopic procedure. The 95% CIs were â9.14 to 1.23. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit or harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows the futility boundaries and futility area of the TSA. </p> </div> </div> </div> </section> </section> <section id="CD013197-sec-0125"> <h5 class="title">Other analyses</h5> <p>Due to the low number of trials identified for this outcome, no subgroup analysis or sensitivity analysis could be performed. </p> </section> </section> <section id="CD013197-sec-0126"> <h4 class="title">Comparison 3. Deep neuromuscular blockade versus no neuromuscular blockade</h4> <p>See <a href="./full#CD013197-tbl-0003">summary of findings Table 3</a> and <a href="#CD013197-tbl-0004">Table 1</a>. </p> <p>One trial compared deep NMB versus no NMB (<a href="./references#CD013197-bbs2-0006" title="BlobnerM , FrickC , StaubleR , FeussnerH , SchallerS , UnterbuchnerC , et al. Neuromuscular blockade improves surgical conditions (NISCO). Surgical Endoscopy2014;29(3):627-36. ">Blobner 2014</a>). No metaâanalysis was performed. </p> <section id="CD013197-sec-0127"> <h5 class="title">Primary outcomes</h5> <p>In the trial, there was no mortality and only one intraoperative SAEs occurred in the no NMB group. In two participants in the no NMB group and three participants in the deep NMB group, there was conversion to open surgery after randomisation. These five participants were excluded from the analysis. Healthârelated quality of life was not reported. </p> </section> <section id="CD013197-sec-0128"> <h5 class="title">Secondary outcomes</h5> <p>nSAEs and readmission were not discussed. Pain scores at 15, 30, 45, 60 minutes; six hours; and 24 hours after surgery were presented. Overall, there was no difference between the treatment arms (P = 0.723). Measures of early postoperative recovery were not discussed. Duration of surgery did not differ between study arms in both groups (MD 2 minutes, 95% CI â13 to 9; P = 0.701). </p> </section> </section> <section id="CD013197-sec-0129"> <h4 class="title">Harms reported in studies retrieved through searches for randomised clinical trials</h4> <p>We identified two observational studies in our search for randomised clinical trials, that reported on harms and compared deep NMB to shallow NMB (<a href="./references#CD013197-bbs2-0046" title="BoonM , MartiniC , YangHK , SenSS , BeversR , WarlÃ©M , et al. Impact of high- versus low-dose neuromuscular blocking agent administration on unplanned 30-day readmission rates in retroperitoneal laparoscopic surgery. PLOS One2018;13(5):e0197036. ">Boon 2018</a>), and moderate NMB (<a href="./references#CD013197-bbs2-0047" title="BrusascoC , GerminaleF , DottaF , BenelliA , GuanoG , CampodonicoF , et al. Low intra-abdominal pressure with complete neuromuscular blockage reduces post-operative complications in major laparoscopic urologic surgery: a before-after study. Journal of Clinical Medicine2022;11(23):7201. [DOI: 10.3390/jcm11237201]">Brusasco 2022</a>). <a href="./references#CD013197-bbs2-0046" title="BoonM , MartiniC , YangHK , SenSS , BeversR , WarlÃ©M , et al. Impact of high- versus low-dose neuromuscular blocking agent administration on unplanned 30-day readmission rates in retroperitoneal laparoscopic surgery. PLOS One2018;13(5):e0197036. ">Boon 2018</a> compared 130 participants receiving deep NMB to 130 participants receiving shallow NMB during laparoscopic retroperitoneal surgery. They found a higher unplanned readmission rate within 30 days in the shallow NMB group (10.8% with shallow NMB versus 3.7% with deep NMB; OR 0.33, 95% CI 0.12 to 0.95; P = 0.03). They specifically found a higher rate of readmissions related to infections in the shallow NMB group (7 with shallow NMB versus 1 with deep NMB). <a href="./references#CD013197-bbs2-0047" title="BrusascoC , GerminaleF , DottaF , BenelliA , GuanoG , CampodonicoF , et al. Low intra-abdominal pressure with complete neuromuscular blockage reduces post-operative complications in major laparoscopic urologic surgery: a before-after study. Journal of Clinical Medicine2022;11(23):7201. [DOI: 10.3390/jcm11237201]">Brusasco 2022</a> compared 115 participants receiving moderate NMB to 148 participants receiving deep NMB during major urological surgery. They reported fewer complications in the deep NMB group (22.3% with deep NMB versus 41.7% with moderate NMB; P &lt; 0.001) and a lower ClavienâDindo severity score in the deep NMB group. However, further specifications on the type of complications were not provided. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013197-sec-0130" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013197-sec-0130"></div> <section id="CD013197-sec-0131"> <h3 class="title" id="CD013197-sec-0131">Summary of main results</h3> <p>In this systematic review, we compared deep NMB to various levels of more superficial or no NMB. We included 42 trials with 3898 participants contributing to one or more of the outcomes. </p> <p>Metaâanalysis of 38 trials comparing deep NMB to moderate NMB revealed with very low certainty evidence that there might be no difference in shortâterm mortality and morbidity between the two treatment groups. Regarding shortâterm healthârelated quality of life, there is likely no difference between treatment groups. A mean difference of 4.53 points (95% CI 0.96 to 8.09) on the Quality of Recoveryâ40 questionnaire was found to favour deep NMB. This is lower than the mean clinically important difference of 6 to 10 points on the 40â to 200âpoint scale (<a href="./references#CD013197-bbs2-0134" title="De Oliveira GS Jr, FitzgeraldPC , MarcusRJ , AhmadS , McCarthyRJ . A dose-ranging study of the effect of transversus abdominis block on postoperative quality of recovery and analgesia after outpatient laparoscopy. Anesthesia &amp; Analgesia2011;113(5):1218-25.">De Oliveira 2011</a>; <a href="./references#CD013197-bbs2-0166" title="MylesPS , MylesDB , GalagherW , ChewC , MacDonaldN , DennisA . Minimal clinically important difference for three quality of recovery scales. Anesthesiology2016;125(1):39-45.">Myles 2016</a>; <a href="./references#CD013197-bbs2-0193" title="Ãzdemir-van BrunschotDM , SchefferGJ , van derJagtM , LangenhuijsenH , DahanA , MulderJE , et al. Quality of recovery after low-pressure laparoscopic donor nephrectomy facilitated by deep neuromuscular blockade: a randomized controlled study. World Journal of Surgery2017;41(11):2950-8.">Ãzdemirâvan Brunschot 2017</a>). Accordingly, this small difference is not clinically relevant and does not support the routine application of deep NMB over moderate NMB. The same holds true for the length of hospital stay and (also sparsely reported) the number of readmissions, as there was no difference between groups for these outcomes. </p> <p>Deep NMB may reduce pain scores one and 24 hours after surgery, but the evidence is very uncertain. Moreover, for both outcomes, the MD was lower than the minimal clinically important difference at 1 point on the visual analogue scale (<a href="./references#CD013197-bbs2-0184" title="ToddKH , FunkJP . The minimum clinically important difference in physician-assigned visual analog pain scores. Academic Emergency Medicine1996;3(2):142-6.">Todd 1996</a>), and there was substantial heterogeneity in these outcomes. Predefined subgroup analyses showed no reduction and, therefore, no explanation for heterogeneity, but there was a significant subgroup difference in postoperative pain scores one hour after surgery between laparoscopic surgery performed under standard or low intraâabdominal pressure. A considerable number of the assessed trials used deep NMB to facilitate the use of lowâpressure pneumoperitoneum. One recent systematic review and metaâanalysis showed lowâpressure pneumoperitoneum leads to lower pain scores in a broad group of laparoscopic procedures (<a href="./references#CD013197-bbs2-0173" title="Reijnders-BoerboomGT , AlbersKI , JacobsLM , HeldenEV , RosmanC , DÃ­az-CambroneroO , et al. Low intra-abdominal pressure in laparoscopic surgery: a systematic review and meta-analysis. International Journal of Surgery2023;109(5):1400-11.">ReijndersâBoerboom 2023</a>). Subgroup analyses on the level of NMB could not be performed in that review due to a lack of trials reporting on the level of NMB used. However, subgroup analysis of our metaâanalysis supports the small observed difference in pain scores that can likely be attributed to low intraâabdominal pressure and not deep NMB. </p> <p>We identified only three trials for the comparison of deep NMB and shallow or no NMB. All three trials included in the deep NMB versus shallow NMB performed the strategy in the control group closest to 'dailyâpractice', as all participants in the control group received rocuronium during induction of anaesthesia and additional boluses only upon request. Mortality and healthârelated quality of life events did not occur or were not reported in these trials. As it is unusual not to apply any NMBA in laparoscopic surgery, it is unsurprising that only one trial was identified for the comparison with no NMB. The evidence on the effect of deep NMB compared to shallow or no NMB on SAEs is very uncertain. </p> </section> <section id="CD013197-sec-0132"> <h3 class="title" id="CD013197-sec-0132">Overall completeness and applicability of evidence</h3> <p>The review of the first comparison of deep NMB versus moderate NMB consisted of 38 trials performed in a wide range of countries. Trials included participants undergoing several types of elective intraâ and transperitoneal laparoscopic surgery. Therefore, the conclusions are applicable to a wide range of hepatobiliary, gastrointestinal, gynaecological, and urological surgeries. Nonetheless, taking into account the considerable heterogeneity between trials, it is important to keep in mind that some surgical procedures (e.g. surgeries close to the diaphragm or procedures hindered by contraction of the abdominal wall) may benefit more from muscle relaxation than others. Postoperative mortality and perioperative complications are two of the five core outcome measures that are considered critically important in perioperative and anaesthesia research (<a href="./references#CD013197-bbs2-0124" title="BoneyO , MoonesingheSR , MylesPS , GrocottMP , StEP-COMPAC Group. Core Outcome Measures for Perioperative and Anaesthetic Care (COMPAC): a modified Delphi process to develop a core outcome set for trials in perioperative care and anaesthesia. British Journal of Anaesthesia2022;128(1):174-85.">Boney 2022</a>). Only 12 trials including 1390 participants reported shortâterm mortality (within three months after surgery); two deaths occurred. This number is in line with the mortality rates after elective laparoscopic colorectal surgery (0.5%), gastrectomy (0.09%), and donor nephrectomy (0.03%) as reported in the majority of respective trials (<a href="./references#CD013197-bbs2-0145" title="GuerrierJB , DietchZC , SchirmerBD , HallowellP . Laparoscopic sleeve gastrectomy is associated with lower 30-day morbidity versus laparoscopic gastric bypass: an analysis of the American College of Surgeons NSQIP. Obesity Surgery2018;28(11):3567-72.">Guerrier 2018</a>; <a href="./references#CD013197-bbs2-0165" title="MunasingheA , SinghB , MahmoudN , JoyM , ChangDC , PenninckxF , et al. Reduced perioperative death following laparoscopic colorectal resection: results of an international observational study. Surgical Endoscopy2015;29(12):3628-39.">Munasinghe 2015</a>; <a href="./references#CD013197-bbs2-0177" title="SegevDL , MuzaaleAD , CaffoBS , MehtaSH , SingerAL , TarantoSE , et al. Perioperative mortality and long-term survival following live kidney donation. JAMA2010;303(10):959-66.">Segev 2010</a>). Remarkably, less than half of the trials reported intraâ and postoperative (serious) adverse events and complications. For the trials that did assess adverse events and SAEs, there appeared to be a high level of underâreporting. From validation of the International ClassIntra score for intraâ and postoperative complications, we know that for all types of surgery combined, 24% of patients experience at least one intraoperative adverse event and 33% experience at least one postoperative complication (<a href="./references#CD013197-bbs2-0135" title="Dell-KusterS , GomesNV , GawriaL , AghlmandiS , Aduse-PokuM , BissettI , et al. Prospective validation of classification of intraoperative adverse events (ClassIntra): international, multicentre cohort study. BMJ (Clinical Research Ed.)2020;370:m2917.">DellâKuster 2020</a>). The European Association of Endoscopic Surgeons classification of intraoperative surgical (not including the anaesthesia complications) adverse events in laparoscopic surgery reveals 60% grade I (nonâconsequential), 37% grade II (requiring minor corrective action), 2.4% grade III (major correction or change in postoperative care), and 0.1% grade IV (lifeâthreatening) complications (<a href="./references#CD013197-bbs2-0139" title="FrancisNK , CurtisNJ , ContiJA , FosterJD , BonjerHJ , HannaGB , et al, on behalf of the EAES committees. EAES classification of intraoperative adverse events in laparoscopic surgery. Surgical Endoscopy2018;32(9):3822-9.">Francis 2018</a>). Therefore, in the combined 3.4% intraoperative SAEs and 5.8% intraoperative adverse events presented in this metaâanalysis, a large part of these events is missing despite the fact that patients who receive NMB are constantly being monitored. Analysis of the available adverse event and SAE data suggests no benefit from the deep or moderate NMB, but we are hesitant to draw this conclusion when a considerable part of the supporting information was evidently incomplete. This is unfortunate considering the consensus that these core outcomes are the most critically important to perioperative and anaesthesia research. However, reporting biases are likely to favour deep NMB rather than the control group. One large ongoing trial evaluating adverse events and SAEs as primary endpoints for deep versus standard NMB in 922 participants will likely provide more certainty (<a href="./references#CD013197-bbs2-0113" title="HoningM , Reijnders-BoerboomG , Dell-KusterS , vanVelzenM , MartiniC , ValenzaF , et al. The impact of deep versus standard neuromuscular block on intraoperative safety during laparoscopic surgery: an international multicenter randomized controlled double-blind strategy trial â EURO-RELAX TRIAL. Trials2021;22(1):744. ">Honing 2021</a>). However, the trial is being performed in people undergoing laparoscopy at standardâpressure pneumoperitoneum, so the accompanying effect of lowâpressure pneumoperitoneum will still remain unclear. </p> <p>As a result of the low number of trials in the second (deep NMB versus shallow NMB) and third (deep NMB versus no NMB) comparisons, no definitive conclusion can be formed on the effect of deep NMB on the three primary outcomes. </p> </section> <section id="CD013197-sec-0133"> <h3 class="title" id="CD013197-sec-0133">Quality of the evidence</h3> <p>The overall certainty of the evidence was moderate to very low (<a href="./full#CD013197-tbl-0001">summary of findings Table 1</a>; <a href="./full#CD013197-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD013197-tbl-0003">summary of findings Table 3</a>; <a href="#CD013197-tbl-0004">Table 1</a>). Most trials were at unclear risk of bias, with high rates of selective reporting bias. Moreover, due to the low number of events, the certainty of the evidence was downgraded because of the wide CIs of the effect estimates. For several outcomes, there was significant heterogeneity in the analyses. We analysed heterogeneity by performing subgroup analyses, but this did not result in a lower I<sup>2</sup> statistic. Therefore, we downgraded the certainty of the evidence. </p> <p>Another serious possible weakness in the evidence was that only seven out of 42 trials reported the adequacy of the intended intervention (<a href="./references#CD013197-bbs2-0002" title="AlbersKI , PolatF , HelderL , PanhuizenIF , SnoeckMM , PolleSB , et al. Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (recover): a randomized controlled trial. Annals of Surgery2022;276(6):e664-73. ">Albers 2022</a>; <a href="./references#CD013197-bbs2-0013" title="Fuchs-BuderT , SchmartzD , BaumannC , HiltL , Nomine-CriquiC , MeistelmanC , et al. Deep neuromuscular blockade improves surgical conditions during gastric bypass surgery for morbid obesity: a randomised controlled trial. European Journal of Anaesthesiology2019;36(7):486-93. ">FuchsâBuder 2019</a>; <a href="./references#CD013197-bbs2-0015" title="HoningGH , MartiniCH , OlofsenE , BeversRF , HuurmanVA , AlwaynIP , et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. British Journal of Anaesthesia2020;126(2):377-85. ">Honing 2020</a>; <a href="./references#CD013197-bbs2-0030" title="MartiniCH , BoonM , BeversRF , AartsLP , DahanA , ThompsonJP . Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. British Journal of Anaesthesia2014;112(3):498-505. ">Martini 2014</a>; <a href="./references#CD013197-bbs2-0037" title="Staehr-RyeAK , RasmussenLS , RosenbergJ , JuulP , LindekaerAL , RiberC , et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesthesia &amp; Analgesia2014;119(5):1084-92. ">StaehrâRye 2014</a>; <a href="./references#CD013197-bbs2-0038" title="TorensmaB , MartiniCH , BoonM , OlofsenE , VeldBI , LiemRS , et al. Deep neuromuscular block improves surgical conditions during bariatric surgery and reduces postoperative pain: a randomized double blind controlled trial. PLOS One2016;11(12):e0167907. ">Torensma 2016</a>; <a href="./references#CD013197-bbs2-0041" title="YooYC , KimNY , ShinS , ChoiYD , HongJH , KimCY , et al. The intraocular pressure under deep versus moderate neuromuscular blockade during low-pressure robot assisted laparoscopic radical prostatectomy in a randomized trial. PLOS One2015;10(8):e0135412. ">Yoo 2015</a>). Adequate deep NMB requires frequent monitoring and can prove challenging even for experienced anaesthesiologists. The potency of NMBAs is influenced by many factors such as age, body mass index, race, and the type of anaesthetic used, so the required dose is highly variable between patients (<a href="./references#CD013197-bbs2-0121" title="AhlstrÃ¶mS , BergmanP , JokelaR , OttensmannL , Ahola-OlliA , PirinenM , et al. First genome-wide association study on rocuronium dose requirements shows association with SLCO1A2. British Journal of Anaesthesia2021;126(5):949-57.">AhlstrÃ¶m 2021</a>; <a href="./references#CD013197-bbs2-0132" title="CollinsLM , BevanJC , BevanDR , VillarGC , KahwajiR , SmithMF , et al. The prolonged duration of rocuronium in Chinese patients. Anesthesia &amp; Analgesia2000;91(6):1526-30.">Collins 2000</a>; <a href="./references#CD013197-bbs2-0164" title="MoererO , BittnerJ , HinzJ , SydowM . Effect of rocuronium on the diaphragm, musculus adductor pollicis and orbicularis oculi in two groups of different age [NeuromuskulÃ¤re Wirkzeiten von Rocuronium am Diaphragma, Musculus adductor pollicis und orbicularis oculi in zwei Altersgruppen]. AnÃ¤sthesiol Intensivmed Notfallmed Schmerzther2005;40(4):217-24.">Moerer 2005</a>; <a href="./references#CD013197-bbs2-0167" title="OrisB , CrulJF , VandermeerschE , vanAkenH , vanEgmondJ , SabbeMB . Muscle paralysis by rocuronium during halothane, enflurane, isoflurane, and total intravenous anesthesia. Anesthesia &amp; Analgesia1993;77(3):570-3.">Oris 1993</a>; <a href="./references#CD013197-bbs2-0180" title="StÃ¤ubleCG , StÃ¤ubleRB , SchallerSJ , UnterbuchnerC , FinkH , BlobnerM . Effects of single-shot and steady-state propofol anaesthesia on rocuronium doseâresponse relationship: a randomised trial. Acta Anaesthesiologica Scandinavica2015;59(7):902-11.">StÃ¤uble 2015</a>). Without neuromuscular monitoring data, the accuracy of the intervention remains questionable. Moreover, a consistent moderate NMB is presumably already deeper than conventional clinical practice and may also explain why there was no difference for moderate versus deep NMB. </p> </section> <section id="CD013197-sec-0134"> <h3 class="title" id="CD013197-sec-0134">Potential biases in the review process</h3> <p>The search process was conducted according to the standard methodology of Cochrane HepatoâBiliary Group. Therefore, we believe that this review is comprehensive in identifying all eligible studies. We searched trial registries to identify unpublished trials to explore reporting bias, but none of them could be included as none provided methodological descriptions and trial data. At least two review authors independently performed identification of trials for inclusion and extraction of data, thus minimising errors. The large number of predefined outcomes may have led to a multiple comparison bias. We attempted to minimise this effect by performing sensitivity analyses and subgroup analyses only as predefined in the protocol. We imputed the mean and standard deviation as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013197-bbs2-0150" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageM , et al, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.">Higgins 2022</a>), which may have introduced bias. Sensitivity analyses, by excluding these trials, did not change the results. </p> </section> <section id="CD013197-sec-0135"> <h3 class="title" id="CD013197-sec-0135">Agreements and disagreements with other studies or reviews</h3> <p>Several systematic reviews have evaluated the effect of deep NMB (<a href="./references#CD013197-bbs2-0127" title="BruintjesMH , vanHeldenEV , BraatAE , DahanA , SchefferGJ , vanLaarhovenCJ , et al. Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery: a systematic review and meta-analysis. British Journal of Anaesthesia2017;118(6):834-42.">Bruintjes 2017</a>; <a href="./references#CD013197-bbs2-0161" title="LiuS , HeB , DengL , LiQ , WangX . Does deep neuromuscular blockade provide improved perioperative outcomes in adult patients? A systematic review and meta-analysis of randomized controlled trials. PLOS One2023;18(3):e0282790.">Liu 2023</a>; <a href="./references#CD013197-bbs2-0162" title="MadsenMV , Staehr-RyeAK , GÃ¤tkeMR , ClaudiusC . Neuromuscular blockade for optimising surgical conditions during abdominal and gynaecological surgery: a systematic review. Acta Anaesthesiologica Scandinavica2015;59(1):1-16.">Madsen 2015</a>; <a href="./references#CD013197-bbs2-0171" title="ParkSK , SonYG , YooS , LimT , KimWH , KimJT . Deep vs. moderate neuromuscular blockade during laparoscopic surgery: a systematic review and meta-analysis. European Journal of Anaesthesiology2018;35(11):867-75.">Park 2018</a>; <a href="./references#CD013197-bbs2-0172" title="RavalAD , DeshpandeS , RabarS , KoufopoulouM , NeupaneB , IheanachoI , et al. Does deep neuromuscular blockade during laparoscopy procedures change patient, surgical, and healthcare resource outcomes? A systematic review and meta-analysis of randomized controlled trials. PLOS One2020;15(4):e0231452.">Raval 2020</a>). The main outcome of all these reviews was the effect of deep NMB on surgical conditions. All five systematic reviews concluded that deep NMB enables better surgical vision during surgery. As the improvement of surgical conditions by deep NMB could lead to higher safety and lower mortality, our review aimed to investigate this by solely focussing on clinical outcomes. Here, we found too little evidence to support a higher safety or lower mortality for deep NMB. The previous systematic reviews and metaâanalyses did not cover these outcomes. <a href="./references#CD013197-bbs2-0127" title="BruintjesMH , vanHeldenEV , BraatAE , DahanA , SchefferGJ , vanLaarhovenCJ , et al. Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery: a systematic review and meta-analysis. British Journal of Anaesthesia2017;118(6):834-42.">Bruintjes 2017</a>, <a href="./references#CD013197-bbs2-0161" title="LiuS , HeB , DengL , LiQ , WangX . Does deep neuromuscular blockade provide improved perioperative outcomes in adult patients? A systematic review and meta-analysis of randomized controlled trials. PLOS One2023;18(3):e0282790.">Liu 2023</a>, and <a href="./references#CD013197-bbs2-0172" title="RavalAD , DeshpandeS , RabarS , KoufopoulouM , NeupaneB , IheanachoI , et al. Does deep neuromuscular blockade during laparoscopy procedures change patient, surgical, and healthcare resource outcomes? A systematic review and meta-analysis of randomized controlled trials. PLOS One2020;15(4):e0231452.">Raval 2020</a> did report a metaâanalysis of five, 10, and six trials, respectively, on the effect of deep NMB on postoperative pain scores. All stated lower pain scores after surgery in the deep NMB groups. However, in our review, evidence about the effect of deep NMB on pain scores was very uncertain. The observed effect is presumably due to the accompanying lowâpressure pneumoperitoneum that was used. </p> <p>Altogether, there was a very limited certainty of evidence regarding deep NMB versus moderate, shallow, or no NMB in laparoscopic surgery and routine application of deep NMB is not supported. The major impediments to this conclusion are poor reporting of core outcome measures such as mortality, adverse events, and SAEs, confounding of intraâabdominal pressure, and possible variation in effect between different abdominal surgical procedures. It is paramount for future trials to accurately monitor and describe complications according to standardised classifications such as ClassIntra and ClavienâDindo. Moreover, further evaluation of the optimal depth of NMB to facilitate lowâpressure pneumoperitoneum for different types of laparoscopic surgery is still warranted. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013197-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-01" target="_blank"><b></b></a></p> </div><img alt=": PRISMA flow diagram (Page 2021a; Page 2021b). Date of search 31 July 2023." data-id="CD013197-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p><a href="#CD013197-fig-0001">Figure 1</a>: PRISMA flow diagram (<a href="./references#CD013197-bbs2-0168" title="PageMJ , McKenzieJE , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.)2021;372:n71.">Page 2021a</a>; <a href="./references#CD013197-bbs2-0169" title="PageMJ , MoherD , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ (Clinical Research Ed.)2021;372:n160.">Page 2021b</a>). Date of search 31 July 2023. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013197-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013197-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on allâcause mortality (short term) in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) represents the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 266,217 participants, calculated based on an assumed proportion of events of 2% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 12 trials (1390 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of a Zâvalue, corresponding to a P value of 0.05." data-id="CD013197-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-04.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on allâcause mortality (short term) in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) represents the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 266,217 participants, calculated based on an assumed proportion of events of 2% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 12 trials (1390 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of a Zâvalue, corresponding to a P value of 0.05. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on health related quality of life (short term) in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. TSA showed that the diversityâadjusted required information size (DARIS) was 213 participants, calculated based on a variance of 317.48 in the control group, minimal relevant difference (MIREDIF) of 10 points, alpha (type I error) of 1.25%, beta (type II error) of 10%, and diversity of 0%. The cumulative Zâcurve breached the futility boundary entering the futility area after one trial (91 participants) and crossed the DARIS after three trials (231 participants), demonstrating that deep neuromuscular blockade may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with moderate neuromuscular blockade on healthârelated quality of life. The 95% CIs were 0.96 to 8.09. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of a Zâvalue, corresponding to a P value of 0.05. The red lines from the left top and bottom corners show the trial sequential boundaries for benefit and harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows the futility boundaries and futility area of the TSA." data-id="CD013197-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-05.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on health related quality of life (short term) in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. TSA showed that the diversityâadjusted required information size (DARIS) was 213 participants, calculated based on a variance of 317.48 in the control group, minimal relevant difference (MIREDIF) of 10 points, alpha (type I error) of 1.25%, beta (type II error) of 10%, and diversity of 0%. The cumulative Zâcurve breached the futility boundary entering the futility area after one trial (91 participants) and crossed the DARIS after three trials (231 participants), demonstrating that deep neuromuscular blockade may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with moderate neuromuscular blockade on healthârelated quality of life. The 95% CIs were 0.96 to 8.09. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of a Zâvalue, corresponding to a P value of 0.05. The red lines from the left top and bottom corners show the trial sequential boundaries for benefit and harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows the futility boundaries and futility area of the TSA. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on serious adverse event (start of surgery until 8 hours after surgery) in adults undergoing an abdominal laparoscopic procedureâ¨The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 149,915 participants, calculated based on the proportion of events of 3.5% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross the conventional boundaries after inclusion of 21 trials (2231 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05." data-id="CD013197-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-06.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on serious adverse event (start of surgery until 8 hours after surgery) in adults undergoing an abdominal laparoscopic procedure</b><br/>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 149,915 participants, calculated based on the proportion of events of 3.5% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross the conventional boundaries after inclusion of 21 trials (2231 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-07" target="_blank"><b></b></a></p> </div><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on serious adverse event (short term) in adults undergoing an abdominal laparoscopic procedure. The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 105,609 participants, calculated based on the proportion of events of 4.9% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 16 trials (1764 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function is ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naive metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05." data-id="CD013197-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-07.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on serious adverse event (short term) in adults undergoing an abdominal laparoscopic procedure.</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 105,609 participants, calculated based on the proportion of events of 4.9% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 16 trials (1764 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function is ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naive metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-08" target="_blank"><b></b></a></p> </div><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on nonâserious adverse event (start of surgery until eight hours after surgery) in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 107,134 participants, calculated based on the proportion of events of 6.8% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 25%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 11 trials (1210 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05." data-id="CD013197-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-08.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on nonâserious adverse event (start of surgery until eight hours after surgery) in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 107,134 participants, calculated based on the proportion of events of 6.8% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 25%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 11 trials (1210 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-09" target="_blank"><b></b></a></p> </div><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on nonâserious adverse events (short term) in adults undergoing an abdominal laparoscopic procedure. The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 42,737 participants, calculated based on the proportion of events of 12.1% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 11 trials (1232 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05." data-id="CD013197-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-09.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on nonâserious adverse events (short term) in adults undergoing an abdominal laparoscopic procedure.</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 42,737 participants, calculated based on the proportion of events of 12.1% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of 11 trials (1232 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-10" target="_blank"><b></b></a></p> </div><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on readmission within three months after surgery in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 307,622 participants, calculated based on the proportion of events of 2.4% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 22.7%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of six trials (675 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function is ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of a Zâvalue, corresponding to a P value of 0.05." data-id="CD013197-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-10.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on readmission within three months after surgery in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 307,622 participants, calculated based on the proportion of events of 2.4% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 22.7%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of six trials (675 participants). A continuity correction of 0.01 was used to account for zero event groups. The alpha spending function is ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of a Zâvalue, corresponding to a P value of 0.05. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-11" target="_blank"><b></b></a></p> </div><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on postoperative pain one hour after surgery or postanaesthesia care unit (PACU) in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 560 participants, calculated based on a variance of 1.9 in the control group, a minimal relevant difference (MIREDIF) of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 79%. The cumulative Zâcurve crossed the boundary for benefit for deep neuromuscular blockade after inclusion of four trials (215 participants) and the DARIS after inclusion of nine trials (636 participants), suggesting that deep neuromuscular blockade may reduce postoperative pain one hour after surgery or at the postanaesthesia care unit. The 95% CIs were â0.59 to â0.03. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit and harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape to the right shows the futility boundaries and futility area of the TSA." data-id="CD013197-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-11.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 11</div> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on postoperative pain one hour after surgery or postanaesthesia care unit (PACU) in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 560 participants, calculated based on a variance of 1.9 in the control group, a minimal relevant difference (MIREDIF) of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 79%. The cumulative Zâcurve crossed the boundary for benefit for deep neuromuscular blockade after inclusion of four trials (215 participants) and the DARIS after inclusion of nine trials (636 participants), suggesting that deep neuromuscular blockade may reduce postoperative pain one hour after surgery or at the postanaesthesia care unit. The 95% CIs were â0.59 to â0.03. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit and harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape to the right shows the futility boundaries and futility area of the TSA. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-12" target="_blank"><b></b></a></p> </div><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on postoperative pain 24 hours after surgery in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. In the TSA, the diversityâadjusted required information size (DARIS) was 1240 participants, calculated based on a variance of 2.0 in the control group, minimal relevant difference (MIREDIF) of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 90%. The cumulative Zâcurve breached the futility boundary entering into the futility area after nine trial (711 participants) and crossed the DARIS after 14 trials (1320 participants), demonstrating that deep neuromuscular blockade may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with moderate neuromuscular blockade on postoperative pain 24 hours after surgery. The 95% CIs were â1.05 to â0.15. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit or harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows futility boundaries and futility." data-id="CD013197-fig-0012" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-12.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 12</div> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on postoperative pain 24 hours after surgery in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. In the TSA, the diversityâadjusted required information size (DARIS) was 1240 participants, calculated based on a variance of 2.0 in the control group, minimal relevant difference (MIREDIF) of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 90%. The cumulative Zâcurve breached the futility boundary entering into the futility area after nine trial (711 participants) and crossed the DARIS after 14 trials (1320 participants), demonstrating that deep neuromuscular blockade may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with moderate neuromuscular blockade on postoperative pain 24 hours after surgery. The 95% CIs were â1.05 to â0.15. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit or harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows futility boundaries and futility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-13" target="_blank"><b></b></a></p> </div><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on length of hospital stay in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 629 participants, calculated based on variance of 2.1 in the control group, minimal relevant difference (MIREDIF) of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 79.4%. The cumulative Zâcurve breached the futility boundary entering the futility area after six trials (508 participants) and crossed the DARIS after seven trials (858 participants), demonstrating that deep neuromuscular blockade may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with moderate neuromuscular blockade on length of hospital stay. The 95% CIs were â0.49 to 0.06. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit or harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows the futility boundaries and futility area of the TSA." data-id="CD013197-fig-0013" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-13.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 13</div> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on length of hospital stay in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 629 participants, calculated based on variance of 2.1 in the control group, minimal relevant difference (MIREDIF) of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 79.4%. The cumulative Zâcurve breached the futility boundary entering the futility area after six trials (508 participants) and crossed the DARIS after seven trials (858 participants), demonstrating that deep neuromuscular blockade may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with moderate neuromuscular blockade on length of hospital stay. The 95% CIs were â0.49 to 0.06. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit or harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows the futility boundaries and futility area of the TSA. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-14" target="_blank"><b></b></a></p> </div><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on operating time in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) represents the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 452 participants, calculated based on a variance of 543.3 in the control group, minimal relevant difference (MIREDIF) of 15 minutes, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 67%. The cumulative Zâcurve breached the futility boundary entering the futility area after seven trials (435 participants) and crossed the DARIS after eight trials (566 participants), demonstrating that deep neuromuscular blockade may not affect the operating time in adults undergoing laparoscopic abdominal surgery. The 95% CIs were â3.35 to 2.32. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of a Zâvalue, corresponding to a P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit and harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape to the right shows the futility boundaries and futility area of the TSA." data-id="CD013197-fig-0014" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-14.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 14</div> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus moderate neuromuscular blockade on operating time in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) represents the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 452 participants, calculated based on a variance of 543.3 in the control group, minimal relevant difference (MIREDIF) of 15 minutes, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 67%. The cumulative Zâcurve breached the futility boundary entering the futility area after seven trials (435 participants) and crossed the DARIS after eight trials (566 participants), demonstrating that deep neuromuscular blockade may not affect the operating time in adults undergoing laparoscopic abdominal surgery. The 95% CIs were â3.35 to 2.32. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of a Zâvalue, corresponding to a P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit and harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape to the right shows the futility boundaries and futility area of the TSA. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-15" target="_blank"><b></b></a></p> </div><img alt="Funnel plot: postoperative pain one hour after surgery or at postanaesthesia care unit (Analysis 1.9)." data-id="CD013197-fig-0015" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 15</div> <div class="figure-caption"> <p>Funnel plot: postoperative pain one hour after surgery or at postanaesthesia care unit (<a href="./references#CD013197-fig-0028" title="">Analysis 1.9</a>). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-16" target="_blank"><b></b></a></p> </div><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus shallow neuromuscular blockade on serious adverse events (shortâterm) in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. TSA showed that the diversityâadjusted required information size (DARIS) is 101,265 participants, calculated based on a 5.1% proportion of events in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of two trials (158 participants). The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05." data-id="CD013197-fig-0016" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-16.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 16</div> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus shallow neuromuscular blockade on serious adverse events (shortâterm) in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. TSA showed that the diversityâadjusted required information size (DARIS) is 101,265 participants, calculated based on a 5.1% proportion of events in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 1.25%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of two trials (158 participants). The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-17" target="_blank"><b></b></a></p> </div><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus shallow neuromuscular blockade on readmission within three months after surgery in adults undergoing an abdominal laparoscopic procedure. The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 148,205 participants, calculated based on the proportion of events of 3.8% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of two trials (158 participants). The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05." data-id="CD013197-fig-0017" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-17.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 17</div> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus shallow neuromuscular blockade on readmission within three months after surgery in adults undergoing an abdominal laparoscopic procedure.</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 148,205 participants, calculated based on the proportion of events of 3.8% in the control group, a risk ratio reduction (RRR) of 10%, an alpha (type I error) of 0.83%, a beta (type II error) of 10%, and a diversity of 0%. The cumulative Zâcurve did not cross conventional boundaries after the inclusion of two trials (158 participants). The alpha spending function was ignored because we accrued less than 5% of the required participants; hence, no conclusive evidence was found. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-18" target="_blank"><b></b></a></p> </div><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus shallow neuromuscular blockade on length of hospital stay in adults undergoing an abdominal laparoscopic procedure. The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 100 participants, calculated based on variance of 1.6 in the control group, minimal relevant difference (MIREDIF) of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 0%. The cumulative Zâcurve breached the futility boundary entering the futility area after one trial (99 participants) and crossed the DARIS after two trials (199 participants), demonstrating that deep neuromuscular blockade may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with shallow neuromuscular blockade on length of hospital stay. The 95% CIs were â0.34 to 0.36. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit or harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows the futility boundaries and futility area of the TSA." data-id="CD013197-fig-0018" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-18.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 18</div> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus shallow neuromuscular blockade on length of hospital stay in adults undergoing an abdominal laparoscopic procedure.</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 100 participants, calculated based on variance of 1.6 in the control group, minimal relevant difference (MIREDIF) of 1 point, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 0%. The cumulative Zâcurve breached the futility boundary entering the futility area after one trial (99 participants) and crossed the DARIS after two trials (199 participants), demonstrating that deep neuromuscular blockade may not have an effect on adults undergoing an abdominal laparoscopic procedure compared with shallow neuromuscular blockade on length of hospital stay. The 95% CIs were â0.34 to 0.36. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit or harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows the futility boundaries and futility area of the TSA. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-FIG-19" target="_blank"><b></b></a></p> </div><img alt="Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus shallow neuromuscular blockade on operating time in adults undergoing an abdominal laparoscopic procedure The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 119 participants, calculated based on a variance of 432.0 in the control group, minimal relevant difference (MIREDIF) of 15 minutes, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 0%. The cumulative Zâcurve breached the futility boundary entering the futility area after one trial (48 participants) and crossed the DARIS after two trials (147 participants), demonstrating that deep neuromuscular blockade may not have an effect on operating time in adults undergoing an abdominal laparoscopic procedure. The 95% CIs were â9.14 to 1.23. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit or harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows the futility boundaries and futility area of the TSA." data-id="CD013197-fig-0019" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-19.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-FIG-19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 19</div> <div class="figure-caption"> <p><b>Trial Sequential Analysis (TSA) for deep neuromuscular blockade versus shallow neuromuscular blockade on operating time in adults undergoing an abdominal laparoscopic procedure</b> </p> <p>The TSA is constructed with the xâaxis denoting the accumulated number of participants and the required number of participants. The yâaxis denotes the cumulative Zâvalues in the TSA. The blue line (Zâcurve) shows the cumulative Zâvalue. The TSA showed that the diversityâadjusted required information size (DARIS) was 119 participants, calculated based on a variance of 432.0 in the control group, minimal relevant difference (MIREDIF) of 15 minutes, alpha (type I error) of 0.83%, beta (type II error) of 10%, and diversity of 0%. The cumulative Zâcurve breached the futility boundary entering the futility area after one trial (48 participants) and crossed the DARIS after two trials (147 participants), demonstrating that deep neuromuscular blockade may not have an effect on operating time in adults undergoing an abdominal laparoscopic procedure. The 95% CIs were â9.14 to 1.23. The horizontal green dotted lines show the threshold for significance in conventional naÃ¯ve metaâanalysis, at 1.96 of the Zâvalue, corresponding to the P value of 0.05. The red dotted lines from the left top and bottom corners show the trial sequential boundaries for benefit or harm, respectively, representing the threshold for statistical significance in the TSA. The red dotted triangular shape on the right shows the futility boundaries and futility area of the TSA. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-FIG-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 1: Allâcause mortality shortâterm" data-id="CD013197-fig-0020" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 1: Allâcause mortality shortâterm </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 2: Healthârelated quality of life shortâterm" data-id="CD013197-fig-0021" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 2: Healthârelated quality of life shortâterm </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 3: Healthârelated quality of life mediumâterm" data-id="CD013197-fig-0022" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 3: Healthârelated quality of life mediumâterm </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 4: Serious adverse events (SAEs) start of surgery until eight hours after surgery" data-id="CD013197-fig-0023" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 4: Serious adverse events (SAEs) start of surgery until eight hours after surgery </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 5: Serious adverse events (SAEs) shortâterm" data-id="CD013197-fig-0024" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 5: Serious adverse events (SAEs) shortâterm </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 6: Nonâserious adverse events (nSAEs) start of surgery until eight hours after surgery" data-id="CD013197-fig-0025" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 6: Nonâserious adverse events (nSAEs) start of surgery until eight hours after surgery </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 7: Nonâserious adverse events (nSAEs) shortâterm" data-id="CD013197-fig-0026" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 7: Nonâserious adverse events (nSAEs) shortâterm </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 8: Readmissions within three months after surgery" data-id="CD013197-fig-0027" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 8: Readmissions within three months after surgery </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 9: Postoperative pain one hour after surgery or at postanaesthesia care unit (PACU)" data-id="CD013197-fig-0028" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 9: Postoperative pain one hour after surgery or at postanaesthesia care unit (PACU) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 10: Postoperative pain 24 hours after surgery" data-id="CD013197-fig-0029" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 10: Postoperative pain 24 hours after surgery </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 11: Postoperative pain one week after surgery" data-id="CD013197-fig-0030" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 11: Postoperative pain one week after surgery </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 12: Measures of early postoperative recovery: length of hospital stay" data-id="CD013197-fig-0031" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 12: Measures of early postoperative recovery: length of hospital stay </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 13: Operating time" data-id="CD013197-fig-0032" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 13: Operating time </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 14: Postoperative pain one hour after surgery or at PACU: subgroup BMI" data-id="CD013197-fig-0033" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 14: Postoperative pain one hour after surgery or at PACU: subgroup BMI </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 15: Postoperative pain 24 hours after surgery: subgroup BMI" data-id="CD013197-fig-0034" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 15: Postoperative pain 24 hours after surgery: subgroup BMI </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 16: Postoperative pain one hour after surgery or at PACU: subgroup intraâabdominal pressure" data-id="CD013197-fig-0035" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 16: Postoperative pain one hour after surgery or at PACU: subgroup intraâabdominal pressure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 17: Postoperative pain 24 hours after surgery: subgroup intraâabdominal pressure" data-id="CD013197-fig-0036" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 17: Postoperative pain 24 hours after surgery: subgroup intraâabdominal pressure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 18: Serious adverse events (sensitivity analysis)" data-id="CD013197-fig-0037" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 18: Serious adverse events (sensitivity analysis) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-001.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 19: Nonâserious adverse events (sensitivity analysis)" data-id="CD013197-fig-0038" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-001.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1: Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB, Outcome 19: Nonâserious adverse events (sensitivity analysis) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-001.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Comparison 2: deep neuromuscular blockade (NMB) versus shallow NMB, Outcome 1: Serious adverse events (SAEs) shortâterm" data-id="CD013197-fig-0039" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Comparison 2: deep neuromuscular blockade (NMB) versus shallow NMB, Outcome 1: Serious adverse events (SAEs) shortâterm </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Comparison 2: deep neuromuscular blockade (NMB) versus shallow NMB, Outcome 2: Readmissions within three months after surgery" data-id="CD013197-fig-0040" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Comparison 2: deep neuromuscular blockade (NMB) versus shallow NMB, Outcome 2: Readmissions within three months after surgery </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Comparison 2: deep neuromuscular blockade (NMB) versus shallow NMB, Outcome 3: Measures of early postoperative recovery: length of hospital stay" data-id="CD013197-fig-0041" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Comparison 2: deep neuromuscular blockade (NMB) versus shallow NMB, Outcome 3: Measures of early postoperative recovery: length of hospital stay </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013197-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/urn:x-wiley:14651858:media:CD013197:CD013197-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Comparison 2: deep neuromuscular blockade (NMB) versus shallow NMB, Outcome 4: Operating time" data-id="CD013197-fig-0042" src="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_t/tCD013197-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Comparison 2: deep neuromuscular blockade (NMB) versus shallow NMB, Outcome 4: Operating time </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/media/CDSR/CD013197/image_n/nCD013197-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013197-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span>Â <span class="table-title">Summary of findings table â Deep neuromuscular blockade (NMB) compared to moderate NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Deep neuromuscular blockade (NMB) compared to moderate NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults undergoing intraâ and transperitoneal laparoscopic procedures<br/><b>Setting:</b> secondary or tertiary care setting<br/><b>Intervention:</b> deep neuromuscular blockade (NMB)<br/><b>Comparison:</b> moderate NMB </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>â of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with moderate NMB</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with deep neuromuscular blockade (NMB)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allâcause mortality shortâterm<br/>followâup: 3 to 60 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/>(0 to 0) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Peto OR 7.22</b><br/>(0.45 to 115.43) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1390<br/>(12 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Healthârelated quality of life<br/>assessed with: Quality of Recovery questionnaire<br/>Scale from: 40 to 200<br/>followâup: 1 to 4 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean healthârelated quality of life ranged from <b>142 to 175</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>4.53 higher</b><br/>(0.96 higher to 8.09 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>440<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Moderate<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD smaller than minimal clinical important difference of 6 to 10 points on the Quality of Recoveryâ40 </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events (SAEs) start of surgery until 8 hours after surgery</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b><br/>(21 to 54) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Peto OR 0.95</b><br/>(0.59 to 1.52) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2231<br/>(21 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Shortâterm serious adverse events (SAEs)<br/>followâup: 3 to 60 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>49 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 1000</b><br/>(28 to 70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Peto OR 0.90</b><br/>(0.56 to 1.42) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1764<br/>(16 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_440720204377651870" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_440720204377651870</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Summary of findings of secondary outcomes can be found in additional table 1. <br/><sup>b</sup> Downgraded one level for serious risk of bias: most trials were at unclear risk of bias.<br/><sup>c</sup> Downgraded two levels for very serious imprecision: the optimal information size was not met, none of the sequential boundaries for benefit, harm, or futility were crossed; number of events was below 100; and the confidence interval of the point estimate included both benefit and harm. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span>Â <span class="table-title">Summary of findings table â Deep neuromuscular blockade (NMB) compared to moderate NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013197-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span>Â <span class="table-title">Summary of findings table â Deep neuromuscular blockade (NMB) compared to shallow NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Deep neuromuscular blockade (NMB) compared to shallow NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults undergoing intraâ and transperitoneal laparoscopic procedures<br/><b>Setting:</b> secondary or tertiary care setting<br/><b>Intervention:</b> deep neuromuscular blockade (NMB)<br/><b>Comparison:</b> shallow NMB </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>â of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with shallow NMB</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with deep neuromuscular blockade (NMB)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allâcause mortality â not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not assessed in the trials</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Healthârelated quality of life â not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not assessed in the trials</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Shortâterm serious adverse events (SAEs)<br/>followâup: 21 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>51 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b><br/>(26 to 286) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.66</b><br/>(0.50 to 5.57) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>158<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>a,</sup><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_445519884891204110" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_445519884891204110</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level for serious risk of bias: one trial was at unclear risk of bias due to methodological limitations.<br/><sup>b</sup> Downgraded two levels for very serious imprecision: the optimal information size was not met, none of the sequential boundaries for benefit, harm, or futility were crossed; number of events was below 100; and the confidence interval of the point estimate included both benefit and harm. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span>Â <span class="table-title">Summary of findings table â Deep neuromuscular blockade (NMB) compared to shallow NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013197-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span>Â <span class="table-title">Summary of findings table â Deep neuromuscular blockade (NMB) compared to no NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Deep neuromuscular blockade (NMB) compared to no NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults undergoing intraâ and transperitoneal laparoscopic procedures<br/><b>Setting:</b> secondary or tertiary care setting<br/><b>Intervention:</b> deep neuromuscular blockade (NMB)<br/><b>Comparison:</b> no NMB </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>â of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with no NMB</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with deep neuromuscular blockade (NMB)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allâcause mortality start of surgery â not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported in the trial</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Healthârelated quality of life â not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not assessed in the trial</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious adverse events (SAEs) start of surgery until 8 hours after surgery</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>25<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Very low<sup>a,</sup><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1/25 SAE occurred intraoperatively in the no NMB group and 0/25 in the deep NMB group.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_445520113909905564" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_445520113909905564</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level for serious risk of bias as the trial was at unclear risk of bias. <br/><sup>b</sup> Downgraded two levels for very serious imprecision: few events and no point estimation calculation possible. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span>Â <span class="table-title">Summary of findings table â Deep neuromuscular blockade (NMB) compared to no NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013197-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span>Â <span class="table-title">Summary of findings table secondary outcomes â deep neuromuscular blockade (NMB) compared to moderate NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Summary of findings secondary outcomes: deep neuromuscular blockade (NMB) compared to moderate NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> adults undergoing intraâ and transperitoneal laparoscopic procedures </p> <p><b>Setting:</b> secondary or tertiary care setting </p> <p><b>Intervention:</b> deep NMB </p> <p><b>Comparison:</b> moderate NMB </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> </b> (95% CI) </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect</b> <br/><b>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>â of participants</b> <br/><b>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence</b> <br/><b>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with moderate NMB</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with deep NMB</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nonâserious adverse events (nSAEs) start of surgery until 8 hours after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>43 per 1000</b><br/>(26 to 70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Peto OR 0.68</b><br/>(0.41 to 1.11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1210<br/>(11 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>a,b,c</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Shortâterm nonâserious adverse events (nSAEs)<br/>followâup: 3 to 60 days </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>121 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>114 per 1000</b><br/>(79 to 163) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Peto OR 0.94</b><br/>(0.65 to 1.35) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1232<br/>(11 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>a,d</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Readmissions<br/>followâup: 7 days to 3 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>12 per 1000</b><br/>(4 to 38) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Peto OR 0.50</b><br/>(0.16 to 1.57) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>675<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>a,b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain 1 hour after surgery or at post anaesthesia care unit<br/>Scale: 0 to 10 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain 1 hour after surgery or at postanaesthesia care unit ranged from <b>2.6 to 6.5</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.31 lower</b><br/>(0.59 lower to 0.03 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1823<br/>(22 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>a,c,e</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain 24 hours<br/>Scale: 0 to 10 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain 24 hours ranged from <b>2.3 to 5.6</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.6 lower</b><br/>(1.05 lower to 0.15 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1404<br/>(16 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Very low<sup>a,f</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Length of hospital stay</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay ranged from <b>1.6 to 11.5</b> days </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.22 days lower</b><br/>(0.49 lower to 0.06 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2084<br/>(19 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Low<sup>a,c</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Operating time</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean operating time ranged from <b>38 to 250</b> minutes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.51 minutes lower</b><br/>(3.35 lower to 2.32 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3143<br/>(34 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ</p> <p>Moderate<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>NMB:</b> neuromuscular blockade; <b>MD:</b> mean difference; <b>RCT:</b> randomised clinical trial. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level for serious risk of bias: most trials were at unclear risk of bias.<br/><sup>b</sup> Downgraded two levels for very serious imprecision: the optimal information size was not met, none of the sequential boundaries for benefit, harm, or futility were crossed; number of events was below 100; and the confidence interval of the point estimate included both benefit and harm.<br/><sup>c</sup> Downgraded one level for serious inconsistency: there may be substantial heterogeneity as noted by the I<sup>2</sup> statistic (IÂ² = 71%).<br/><sup>d</sup> Downgraded two levels for very serious imprecision: the optimal information size was not met, none of the sequential boundaries for benefit, harm, or futility were crossed; and the confidence interval of the point estimate included both benefit and harm.<br/><sup>e</sup> Downgraded one level for publication bias: there may be a high probability of publication bias as observed in the funnel plot.<br/><sup>f</sup> Downgraded two levels for very serious inconsistency: there may be considerable heterogeneity as noted by the I<sup>2</sup> statistic (IÂ² = 88%). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span>Â <span class="table-title">Summary of findings table secondary outcomes â deep neuromuscular blockade (NMB) compared to moderate NMB in adults undergoing intraâ and transperitoneal laparoscopic procedures</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/full#CD013197-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013197-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span>Â <span class="table-title">Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Allâcause mortality shortâterm <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1390</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.22 [0.45, 115.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Healthârelated quality of life shortâterm <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.53 [0.96, 8.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Healthârelated quality of life mediumâterm <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Serious adverse events (SAEs) start of surgery until eight hours after surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.59, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Serious adverse events (SAEs) shortâterm <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1764</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.56, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Nonâserious adverse events (nSAEs) start of surgery until eight hours after surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.41, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Nonâserious adverse events (nSAEs) shortâterm <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.65, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Readmissions within three months after surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>675</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.16, 1.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Postoperative pain one hour after surgery or at postanaesthesia care unit (PACU) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.31 [â0.59, â0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Postoperative pain 24 hours after surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1404</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.60 [â1.05, â0.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Postoperative pain one week after surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Measures of early postoperative recovery: length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2084</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.22 [â0.49, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Operating time <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.51 [â3.35, 2.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Postoperative pain one hour after surgery or at PACU: subgroup BMI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1756</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.30 [â0.59, â0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.1 Normal BMI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.19 [â0.58, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.2 High BMI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>771</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.48 [â0.81, â0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 Postoperative pain 24 hours after surgery: subgroup BMI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1404</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.60 [â1.05, â0.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.1 Normal BMI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>794</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.73 [â1.39, â0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.2 High BMI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>610</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.35 [â0.69, â0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.16 Postoperative pain one hour after surgery or at PACU: subgroup intraâabdominal pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.31 [â0.59, â0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.1 Standardâpressure pneumoperitoneum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1163</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.10 [â0.35, 0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.2 Lowâpressure pneumoperitoneum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>660</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.63 [â1.05, â0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.17 Postoperative pain 24 hours after surgery: subgroup intraâabdominal pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1404</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.60 [â1.05, â0.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.1 Standardâpressure pneumoperitoneum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>772</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.45 [â1.29, 0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.2 Lowâpressure pneumoperitoneum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>632</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.76 [â1.22, â0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.18 Serious adverse events (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.18.1 Bestâworst case start of surgery until 8 hours after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2192</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.42, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.18.2 Worstâbest case start of surgery until 8 hours after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2192</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.51 [0.99, 2.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.18.3 Bestâworst case shortâterm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1917</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.22, 0.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.18.4 Worstâbest case shortâterm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1917</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.79 [2.00, 3.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.19 Nonâserious adverse events (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.19.1 Bestâworst case start of surgery until 8 hours after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.27, 0.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.19.2 Worstâbest case start of surgery until 8 hours after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.92, 2.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.19.3 Bestâworst shortâterm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.31, 0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.19.4 Worstâbest shortâterm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.11 [1.56, 2.85]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>Â <span class="table-title">Comparison 1: deep neuromuscular blockade (NMB) versus moderate NMB</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013197-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span>Â <span class="table-title">Comparison 2: deep neuromuscular blockade (NMB) versus shallow NMB</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Serious adverse events (SAEs) shortâterm <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.66 [0.50, 5.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Readmissions within three months after surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.98 [0.52, 7.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Measures of early postoperative recovery: length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [â0.34, 0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Operating time <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â3.96 [â9.14, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span>Â <span class="table-title">Comparison 2: deep neuromuscular blockade (NMB) versus shallow NMB</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013197.pub2/references#CD013197-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013197.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013197-note-0015">EspaÃ±ol</a> </li> <li class="section-language"> <a class="" href="fa#CD013197-note-0012">ÙØ§Ø±Ø³Û</a> </li> <li class="section-language"> <a class="" href="fr#CD013197-note-0013">FranÃ§ais</a> </li> <li class="section-language"> <a class="" href="ko#CD013197-note-0010">íêµ­ì´</a> </li> <li class="section-language"> <a class="" href="ms#CD013197-note-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD013197-note-0014">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013197-note-0008">ç®ä½ä¸­æ</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD013197-note-0009">ç¹é«ä¸­æ</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright Â© 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">Â Â Facebook</a> <a class="a2a_button_x share-button">Â Â X(Twitter)</a> <a class="a2a_button_whatsapp share-button">Â Â WhatsApp</a> <a class="a2a_dd share-button">Â Â View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013197\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013197\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013197\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013197\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013197\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013197\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013197\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013197\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013197\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013197\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013197\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013197\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013197\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013197\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013197\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013197\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013197\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013197\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013197.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013197.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">EspaÃ±ol</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">ÙØ§Ø±Ø³Û</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">FranÃ§ais</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">à¤¹à¤¿à¤¨à¥à¤¦à¥</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">æ¥æ¬èª</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">íêµ­ì´</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">PortuguÃªs</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Ð ÑÑÑÐºÐ¸Ð¹</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">RomÃ¢nÄ</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">à®¤à®®à®¿à®´à¯</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">à¸ à¸²à¸©à¸²à¹à¸à¸¢</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">ç¹é«ä¸­æ</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">ç®ä½ä¸­æ</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013197.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013197.pub2/full/es">EspaÃ±ol</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013197.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726556786"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013197.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726556790"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013197.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e96867b7df3c9',t:'MTc0MDcyNjU1Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 